WO2015169734A1 - Pyrazoles for controlling invertebrate pests - Google Patents

Pyrazoles for controlling invertebrate pests Download PDF

Info

Publication number
WO2015169734A1
WO2015169734A1 PCT/EP2015/059695 EP2015059695W WO2015169734A1 WO 2015169734 A1 WO2015169734 A1 WO 2015169734A1 EP 2015059695 W EP2015059695 W EP 2015059695W WO 2015169734 A1 WO2015169734 A1 WO 2015169734A1
Authority
WO
WIPO (PCT)
Prior art keywords
cio
alkyl
unsubstituted
spp
carry
Prior art date
Application number
PCT/EP2015/059695
Other languages
French (fr)
Inventor
Daniel Saelinger
Birgit GOCKEL
Sebastian Soergel
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of WO2015169734A1 publication Critical patent/WO2015169734A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/561,2-Diazoles; Hydrogenated 1,2-diazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/48Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with two nitrogen atoms as the only ring hetero atoms
    • A01N43/581,2-Diazines; Hydrogenated 1,2-diazines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dentistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Plant Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The present invention relates to novel pyrazoles of formula (I). Moreover, the invention relates to processes and intermediates for preparing the pyrazoles of formula (I), and also to active compound combinations comprising them, to compositions comprising them, and to their use for protecting growing plants from attack or infestation by invertebrate pests. Furthermore, the invention relates to methods of applying such compounds. The present invention also relates to seed comprising such compounds.

Description

Pyrazoles for controlling invertebrate pests Description The present invention relates to novel pyrazoles of formula I. Moreover, the invention relates to processes and intermediates for preparing the pyrazoles of formula I, and also to active compound combinations comprising them, to compositions comprising them, and to their use for protecting growing plants from attack or infestation by invertebrate pests. Furthermore, the invention relates to methods of applying such compounds. The present invention also relates to seed comprising such compounds.
Invertebrate pests and in particular arthropods and nematodes destroy growing and harvested crops and attack wooden dwelling and commercial structures, thereby causing large economic loss to the food supply and to property. There is an ongoing need for new agents for combating invertebrate pests such as insects, arachnids and nematodes.
WO 2009/027393, WO 2010/034737, WO 2010/034738, and WO 2010/1 12177 describe derivatives of N-arylamides, derived from pyrazole carboxylic acids. These compounds are mentioned to be useful for combating invertebrate pests.
Nevertheless, there remains a need for highly effective and versatile agents for combating in- vertebrate pests. It is therefore an object of the present invention to provide compounds having a good pesticidal activity and showing a broad activity spectrum against a large number of different invertebrate pests, especially against difficult to control pests, such as insects.
It has been found that these objects can be achieved by compounds of formula I as depicted and defined below, and by their stereoisomers, salts, tautomers and N-oxides, in particular their agriculturally acceptable salts.
In a first aspect, the present invention relates to compounds of formula I
Figure imgf000002_0001
(i)
wherein
U is N or CRu;
T is S, O or NR1b, wherein R1b is selected from H , Ci-Cio-alkyl, Ci-C4-haloalkyl, C3-C10- cycloalkyl, C3-Cio-cycloalkylmethyl, C3-Cio-halocycloalkyl, C2-Cio-alkenyl, C2-C10- haloalkenyl, C2-Cio-alkynyl, Ci-Cio-alkoxy-Ci-C4-alkyl, ORa, heterocyclyl, heterocyclyl- Ci-C4-alkyl, aryl, hetaryl, aryl-Ci-C4-alkyl and hetaryl-Ci-C4-alkyl, wherein the cyclic moi- eties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from halogen, CN, NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4- haloalkoxy; ' , RP2, RP3, and Ru are independently of each other selected from H , halogen, Ci-C4-alkyl, Ci- C3-haloalkyl, Ci-C4-alkoxy, Ci-C3-haloalkoxy, Ci-C4-alkylthio, Ci-C3-haloalkylthio, C1-C4- alkylsulfinyl, Ci-C3-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C3-haloalkylsulfonyl, C3-C6- cycloalkyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl and Ci- C4-alkoxy-Ci-C4-alkyl; and
is
(i) C3-Cio-cycloalkenyl, C3-Cio-cycloalkenyloxy, C3-Cio-cycloalkenylthio or C3-C10- cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx;
or
(ii) La-C3-Cio-cycloalkenyl, La-C3-Cio-cycloalkenyloxy, La-C3-Cio-cycloalkenylthio or La- C3-Cio-cycloalkenylamino , wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx, and wherein
La is C(Y), C(Y)NR9, S(0)n, Ci-C8-alkylene, C2-C8-alkenylene, C2-C8-alkynylene, C3- C6-cycloalkylene, phenylene, hetarylene, wherein the carbon chains and cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
or
(iii) Lb-La1-C3-Cio-cycloalkenyl, Lb-La1-C3-Cio-cycloalkenyloxy, L -La1-C3-Cio- cycloalkenylthio or Lb-La1-C3-Cio-cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx, and wherein
Lb is d-Ce-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx; and
La1 is C(Y), C(Y)NR9, S(0)n, phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
or
(iv) Lc-Ld-C3-Cio-cycloalkenyl, Lc-Ld-C3-Cio-cycloalkenyloxy, Lc-Ld-C3-Cio-cycloalkenylthio or Lc-Ld-C3-Cio-cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals Ry and Rx, and wherein
Lc is O, S, NRe, C(Y), C(Y)0, C(Y)NR9, C(Y)NR'NRe, S(0)n, S(0)nNRe, phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx; and
Ld is Ci-Ce-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
or
(v) L -Lc-Ld-C3-Cio-cycloalkenyl, L -Lc-Ld-C3-Cio-cycloalkenyloxy, L -Lc-Ld-C3-Cio- cycloalkenylthio or Lb-Lc-Ld-C3-Cio-cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx, and wherein Lb is d-Ce-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2,
3, 4 or 5 identical or different substituents Rx;
Lc is O, S, NRe, C(Y), C(Y)0, C(Y)NRg, C(Y)NR'NRe, S(0)n, S(0)nNRe, phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3,
4 or 5 identical or different substituents Rx; and
Ld is Ci-C5-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2,
3, 4 or 5 identical or different substituents Rx;
and wherein
R2 and R3 are independently of each other selected from H, halogen, CN , NO2, Ci-Cio-alkyl, C2- Cio-alkenyl, C2-Cio-alkynyl, wherein the C-atoms may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2 or 3 identical or different substituents Rx;
ORa, SRa, C(Y)Rb, C(Y)ORc, S(0)Rd, S(0)2Rd, NReRf, C(Y)NR9Rh, heterocyclyl, hetaryl, C3-Cio-cycloalkyl, C3-Cio-cycloalkenyl, aryl, wherein the cyclic moieties may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx;
L-C3-Cio-cycloalkenyl, L-C3-Cio-cycloalkenyloxy and L-C3-Cio-cycloalkenylthio, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals Ry and Rx; and wherein
L is Ci-Cs-alkylene, C2-Cs-alkenylene, C2-Cs-alkynylene, or C3-C6-cycloalkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
and wherein
R4 is
(i) H, CN, NO2, Ci-Cio-alkyl, C2-Cio-alkenyl or C2-Cio-alkynyl, wherein the C-atoms may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2 or 3 identical or different substituents Rx; or
ORa, SRa, C(Y)Rb, C(Y)ORc, S(0)Rd, S(0)2Rd, NReRf, C(Y)NR9Rh, S(0)mNReRf,
C(Y)NR'NReRf, Ci-C5-alkylene-ORa, Ci-C5-alkylene-CN, Ci-C5-alkylene-C(Y)Rb, Ci-C5- alkylene-C(Y)ORc, Ci-C5-alkylene-NReRf, Ci-C5-alkylene-C(Y)NR9Rh, Ci-C5-alkylene- S(0)mRd, Ci-C5-alkylene-S(0)mNReRf, d-Cs-alkylene-NRiNR^f, heterocyclyl, hetaryl, C3-Cio-cycloalkyl, C3-Cio-cycloalkenyl, heterocyclyl-d-Cs-alkyl, hetaryl-d-Cs-alkyl, C3- Cio-cycloalkyl-Ci-C5-alkyl, C3-Cio-cycloalkenyl-Ci-C5-alkyl, aryl-d-Cs-alkyl or aryl, wherein the cyclic moieties may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents R ;
or
(ii) L-C3-Cio-cycloalkenyl, L-C3-Cio-cycloalkenyloxy or L-C3-Cio-cycloalkenylthio, where- in the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, and wherein L is Ci-Cs-alkylene, C2-C8-alkenylene, C2-C8-alkynylene, or C3-C6-cycloalkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
or
(iii) any one of the following groups
Figure imgf000005_0001
(iiid);
or
(iv) any one of the following groups
Figure imgf000005_0002
wherein
R4a, R4b and R4c are independently of each other selected from H, halogen, CN, NO2, Ci- Cio-alkyl, C2-Cio-alkenyl, C2-Cio-alkynyl, wherein the C-atoms may be unsubstituted, may be partially or fully halogenated or may carry 1 , 2 or 3 identical or dif- ferent substituents Rx;
Ci-Cio-haloalkyl, Ci-Cio-alkoxy, Ci-C4-alkoxy-Ci-Cio-alkyl, wherein the C-atoms may be unsubstituted, or partially or fully substituted by identical or different substituents Ry;
ORa, SRa, C(Y)Rb, C(Y)ORc, C(Y)NR9Rh, C(Y)NR'NReRf, S(0)mRd, S(0)mNReRf, Ci-C5-alkylen-ORa, Ci-C5-alkylen-CN, Ci-C5-alkylen-C(Y)Rb, Ci-C5-alkylen-
C(Y)ORc, Ci-C5-alkylen-NReRf, Ci-C5-alkylen-C(Y)NR9Rh, Ci-C5-alkylen-S(0)mRd, Ci-C5-alkylen-S(0)mNReRf,
Figure imgf000005_0003
heterocyclyl, C3-Cio-cycloalkyl, C3-Cio-cycloalkenyl, hetaryl, aryl, heterocyclyl-Ci- C5-alkyl, C3-Cio-cycloalkyl-Ci-C5-alkyl, C3-Cio-cycloalkenyl-Ci-C5-alkyl, hetaryl- Ci-Ce-alkyl, and aryl-C-i-Cs-alkyl, wherein the cyclic moieties may be
unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents R ;
and wherein
A is a 3- to 12-membered non-aromatic carbo- or heterocycle, which heterocycle may contain 1 , 2, 3, 4 or 5 heteroatoms selected from N, O, and S, wherein S may be oxidised, and which carbo- or heterocycle may be partially or fully substituted by R and/or R' radicals;
and wherein
D is a direct bond, Ci-C6-alkylene, C2-C6-alkenylene, or C2-C6-alkynylene, which carbon chains can be partially or fully substituted Rn;
E is a non-aromatic 3- to 12-membered carbo- or heterocycle, which may contain 1 , 2, 3, or 4 heteroatoms selected from N, O, and S, wherein S may be oxidised, which carbo- or heterocycle may be partially or fully substituted by Rn and/or R' radicals;
and wherein G is Ci-C6-alkylene, C2-C6-alkenylene, C2-C6-alkynylene, C3-C6-cycloalkylene, or
C3-C6-cycloalkenylene, wherein the C-atoms may be unsubstituted, or partially or fully substituted by RP;
R4d is Ci-C4-haloalkyl or C3-C6-cycloalkyl, which may be halogenated;
and wherein
Q is a direct bond, d-Cs-alkylene, C2-Cs-alkenylene, or C2-Cs-alkynylene, which carbon chains can be partially or fully substituted by Rr;
R4e is H, d-Cs-alkyl, C2-C8-alkenyl, C2-C8-alkynyl, C3-C6-cycloalkyl, C3-C6- cycloalkenyl, 3- to 6-membered heterocycle, which may contain 1 or 2 heteroa- toms selected from N, O, and S, wherein S may be oxidised, which groups can be unsubstituted, or partially or fully substituted by Rr and/or R' radicals; or R4e and Q together may form a 3- to 6-membered carbocyclic ring or a 4- to 6- membered heterocyclic ring with a direct bond to the pyrazole moiety, which ring may contain 1 or 2 heteroatom moieties selected from N, O, and S, wherein S may be oxidized, and which ring can be partially or fully substituted by Rr and/or
R' radicals;
M is O, S, NRM, NORM, or NSRM, wherein
RMis a group mentioned for R4e, or wherein
RM and Q may together form a 4- to 6-membered unsaturated, non-aromatic N- containing heterocyclic ring, which ring may contain an additional heteroatom selected from O, and S, wherein S may be oxidized, and which ring can be partially or fully substituted by Rr;
and wherein
W is Ci-Cs-alkylene, Cs-Cs-cycloalkylene, Cs-Cs-heterocycloalkylene, C2-C8- alkenylene, Cs-Cs-cycloalkenylene, Cs-Cs-heterocycloalkenylene, or C2-C8- alkynylene, wherein W may be unsubstituted or may be partially or fully substituted by substituents which, independently of each other, are selected from R1 and/or R1 radicals;
V is O, S or NR1a, wherein R1a is selected from H , Ci-Cio-alkyl, Ci-C4-haloalkyl, C3- Cio-cycloalkyl, C3-Cio-cycloalkylmethyl, C3-Cio-halocycloalkyl, C2-Cio-alkenyl, C2-
Cio-haloalkenyl, C2-Cio-alkynyl, Ci-Cio-alkoxy-Ci-C4-alkyl, ORa, heterocyclyl, heterocyclyl-Ci-C4-alkyl, aryl, hetaryl, aryl-Ci-C4-alkyl and hetaryl-Ci-C4-alkyl, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from halogen, CN , NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy, or
wherein R1a and R4^ together with the carbon atom to which R49 is bonded and the nitrogen atom to which R1a is bonded as well as the nitrogen atom between said carbon atom and said nitrogen atom form a 4- to 8-membered heterocycle, which contains the two nitrogen atoms as heteroatoms, and may further contain 1 or 2 heteroatoms which, independently of each other, are selected from N, O, and S, wherein S may be oxidized, and/or wherein the heterocycle may be unsubstituted or may be partially or fully substituted by substituents which, independently of each other, are selected from R1 and/or R1 radicals; R49 is H, d-Ce-alkyl, Ci-C6-alkyl-X, C3-C6-cycloalkyl or C3-C6-cycloalkyl-X, wherein X is selected from O, S, NH or NR', wherein the Ci-C6-alkyl or C3-C6-cycloalkyl may be unsubstituted or may be partially or fully substituted by substituents which, independently of each other, are selected from R1; and
R4f is Ci-C6-alkyl, Ci-C6-alkyl-X, C3-C6-cycloalkyl or C3-C6-cycloalkyl-X, wherein X is selected from O, S, NH or NR', wherein the Ci-C6-alkyl or C3-C6-cycloalkyl may be unsubstituted or may be partially or fully substituted by substituents which, independently of each other, are selected from R1; or
R49 and R4f together with the carbon atom to which they are bonded form a 3- to 8- membered, saturated or unsaturated carbo- or heterocycle, which may contain 1 ,
2, or 3 heteroatoms which, independently of each other, are selected from N, O, and S, wherein S may be oxidized and/or wherein the carbo- or heterocycle may be unsubstituted or may be partially or fully substituted by substituents which, independently of each other, are selected from R1 and/or R1 radicals; and wherein
Ra, Rb, Rc are independently of each other selected from H, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6- cycloalkyl, C3-C6-cycloalkylmethyl, C3-C6-halocycloalkyl, C3-C6-cycloalkenyl, C3-C6- cycloalkenylmethyl, C3-C6-halocycloalkenyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4- alkynyl, Ci-C4-alkoxy-Ci-C4-alkyl, heterocyclyl, heterocyclyl-Ci-C4-alkyl, aryl, hetaryl, ar- yl-Ci-C4-alkyl and hetaryl-Ci-C4-alkyl, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or substituents which, independently of each other, are selected from halogen, CN, NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy; Rd is selected from H, Ci-C4-alkoxy, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6- cycloalkylmethyl, C3-C6-halocycloalkyl, C3-C6-cycloalkenyl, C3-C6-cycloalkenylmethyl, C3- C6-halocycloalkenyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, Ci-C4-alkoxy-Ci-
C4-alkyl, heterocyclyl, heterocyclyl-Ci-C4-alkyl, aryl, hetaryl, aryl-Ci-C4-alkyl and hetaryl- Ci-C4-alkyl, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 substituents which are independently of each other selected from halogen, CN, NO2, Ci- C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy;
Re, Rf are independently of each other selected from H, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6- cycloalkyl, C3-C6-cycloalkylmethyl, C3-C6-halocycloalkyl, C3-C6-cycloalkenyl, C3-C6- cycloalkenylmethyl, C3-C6-halocycloalkenyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4- alkynyl, Ci-C4-alkoxy-Ci-C4-alkyl, Ci-C4-alkylcarbonyl, Ci-C4-haloalkylcarbonyl, C1-C4- alkylsulfonyl, Ci-C4-haloalkylsulfonyl, heterocyclyl, heterocyclyl-Ci-C4-alkyl,
heterocyclylcarbonyl, heterocyclyl-Ci-C4-sulfonyl, aryl, arylcarbonyl, arylsulfonyl, hetaryl, hetarylcarbonyl, hetarylsulfonyl, aryl-Ci-C4-alkyl and hetaryl-Ci-C4-alkyl, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 substituents which, independently of each other, are selected from halogen, CN, NO2, Ci-C4-alkyl, C1-C4- haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy; or
Re and Rf together with the nitrogen atom to which they are bonded form a 5- or 6-membered, saturated or unsaturated heterocycle, which may carry a further heteroatom being selected from O, S and N as a ring member atom, and wherein the heterocycle may be unsubstituted or may carry 1 , 2, 3, 4 or 5 substituents which are independently of each other selected from halogen, CN, NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci- C4-haloalkoxy;
Rh are independently of each other selected from H, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6- cycloalkyl, C3-C6-halocycloalkyl, C3-C6-cycloalkenyl, C3-C6-cycloalkenylmethyl, C3-C6- halocycloalkenyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, Ci-C4-alkoxy-Ci-C4- alkyl, heterocyclyl, heterocyclyl-Ci-C4-alkyl, aryl, hetaryl, aryl-Ci-C4-alkyl and hetaryl-Ci- C4-alkyl, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 substituents which are independently of each other selected from halogen, CN, NO2, Ci- C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy;
is selected from H, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6-cycloalkylmethyl, C3-C6-halocycloalkyl, C3-C6-cycloalkenyl, C3-C6-cycloalkenylmethyl, C3-C6- halocycloalkenyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, Ci-C4-alkoxy-Ci-C4- alkyl, aryl, and aryl-Ci-C4-alkyl, wherein the aryl rings may be unsubstituted or may carry 1 , 2, 3, 4 or 5 substituents which are independently of each other selected from halogen, CN, NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy;
bonded to C is halogen, OH, CN, NO2, Ci-Cio-alkyl, Ci-Cio-haloalkyl, Ci-Cio-alkoxy, Ci- Cio-haloalkoxy, or S(0)mRk, C3-C6-cycloalkyl, or 3- to 6-membered heterocycle, which may contain 1 or 2 heteroatoms selected from N, O, and S, wherein S may be oxidized, which Rj groups are unsubstituted or partially or fully substituted by Rm and/or R' radicals and wherein two groups Rj connected to the same or adjacent ring atoms may together form a 3- to 6-membered carbo- or heterocycle which heterocycle may contain 1 or 2 heteroatoms selected from N, O, and S, wherein S may be oxidised, which cycles may be partially or fully substituted by Rm and/or R' radicals;
is H, Ci-C4-alkyl, Ci-C4-haloalkyl, or C3-C6-cycloalkyl, which cycle may be partially or fully substituted by R';
bonded to N is Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkylcarbonyl, Ci-C4-haloalkylcarbonyl, or Ci-C4-alkoxycarbonyl;
bonded to C is halogen, OH, CN, N02, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, Ci- C4-alkoxy, Ci-C4-haloalkoxy, or S(0)mRk;
bonded to C is halogen, CN, N02, Ci-C2-alkyl, Ci-C4-haloalkyl, C2-C6-alkenyl, C2-C6- alkynyl, C3-C6-cycloalkyl, C3-C6-cycloalkenyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, C1-C4- alkyliden, =0, =S, =NR1°, =NOR1°, =NSR1°, or S(0)mR1°, two adjacent groups Rn may form together with the atoms to which they are bonded a 3- to 8-membered carbo- or heterocycle, which may contain 1 , 2, 3, or 4 heteroatoms selected from N, O, and S, wherein S may be oxidised, which cyclic Rn moieties may be substituted by halogen, R°, and/or R' radicals;
is H, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, Ci-C4-alkoxy;
bonded to C is Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, Ci-C4-alkoxy, C1-C4- alkylcarbonyl, Ci-C4-haloalkylcarbonyl, or Ci-C4-alkoxycarbonyl;
is halogen, CN, NO2, Ci-C2-alkyl, Ci-C2-haloalkyl, C3-C6-cycloalkyl, Ci-C4-alkoxy, or Cr C2-haloalkoxy, or two groups RP can together form a 3- to 6-membered carbo- or hetero- cyclic ring, which heterocycle contains 1 or 2 heteroatoms selected from N, O, and S, wherein S may be oxidised, which carbo- or heterocyclic ring is unsubstituted or partly or fully substituted by groups R^;
Rq is halogen, CN, N02, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, Ci-C4-alkoxy, or Ci- C4-haloalkoxy;
Rr bonded to C is halogen, CN, N02, Ci-C2-alkyl, Ci-C2-haloalkyl, Ci-C4-alkoxy, Ci-C2- haloalkoxy, or S(0)mRk; or two groups Rr can together form a 3- to 6-membered carbo- or heterocyclic ring, which heterocycle contains 1 or 2 heteroatoms selected from N, O, and S, wherein S may be oxidized, and which carbo- or heterocyclic ring is unsubstituted or partially or fully substituted by Rs;
Rs is halogen, CN, N02, Ci-C2-alkyl, Ci-C2-haloalkyl, C3-C6-cycloalkyl, Ci-C4-alkoxy, or Ci- C2-haloalkoxy;
R1 bonded to C is halogen, N02, CN, d-C6-alkyl, Ci-C6-alkoxy, Ci-C6-haloalkyl, Ci-C6- haloalkoxy, C3-C6-cycloalkyl, C3-C6-cycloalkoxy, C3-C6-halocycloalkyl, C3-C6- halocycloalkoxy, C2-C4-alkenyl, C2-C4-alkynyl, S(0)mRw, =0, =S, =NRV, =NORv, or
=NSRV; or two R1 bonded to the same carbon atom or to adjacent carbon atoms together with the carbon atom(s) to which they are bonded form a 3- to 6-membered, saturated or unsaturated carbo- or heterocycle, which may contain 1 or 2 heteroatoms which, independently of each other, are selected from N, O, and S, wherein S may be oxidized, wherein N may be unsubstituted or substituted by R';
Rv is Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, or C3-C6-halocycloalkyl;
Rw is H, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, or C3-C6-halocycloalkyl, Ci-C4-alkoxy, or Ci-C4-haloalkoxy;
Rx is selected from halogen, CN, N02, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4- haloalkoxy, S(0)mRd, S(0)mNReRf, Ci-Cio-alkylcarbonyl, Ci-C4-haloalkylcarbonyl, Ci-C4- alkoxycarbonyl, Ci-C4-haloalkoxycarbonyl, C3-C6-cycloalkyl, 5- to 7-membered heterocyclyl, 5- or 6-membered hetaryl, aryl, C3-C6-cycloalkoxy, 3- to 6-membered heterocyclyloxy and phenoxy, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 radicals Ry; and
Ry is selected from halogen, CN, N02, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, Ci-C4- haloalkoxy, S(0)mRd, S(0)mNReRf, Ci-C4-alkylcarbonyl, Ci-C4-haloalkylcarbonyl, Ci-C4- alkoxycarbonyl, Ci-C4-haloalkoxycarbonyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C2-C4- alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl and Ci-C4-alkoxy-Ci-C4-alkyl;
and wherein
Y is O or S;
m is 0, 1 or 2; and
n is 1 or 2;
and the salts, stereoisomers, tautomers, and N-oxides thereof.
In further aspects, the present invention relates to a composition and to an agricultural compo- sition for combating animal pests comprising at least one compound of formula I. In still further aspects, the present invention relates to a method for combating or controlling invertebrate pests and to a method for protecting growing plants from attack or infestation by invertebrate pests. In another aspect, the present invention relates to seed comprising a compound of for- mula I, and in yet another aspect, the present invention relates to the use of the compounds of formula I for protecting growing plants from attack or infestation by invertebrate pests.
Further embodiments of the present invention can be found in the claims, the description and the examples. It is to be understood that the features mentioned above and those still to be il- lustrated below of the subject matter of the invention can be applied not only in the respective given combination but also in other combinations without leaving the scope of the invention.
In one embodiment, the present invention relates to compounds of formula I, wherein T is O, S or NR1b. These compounds correspond to formula 1.1 , formula 1.2 and formula 1.3, respectively.
Figure imgf000010_0001
Compounds of formula 1.1 are preferred according to the invention.
The compounds according to the invention can be prepared analogously to the synthesis routes described in WO 2009/027393 and WO 2010/034737 according to standard processes of organic chemistry.
Compounds of formula 1.1 , wherein T is O, can be prepared e.g. by reacting activated pyrazole carboxylic acid derivatives of formula II with a 3-aminopyridine or 4-aminopyridazine of formula III (e.g. Houben-Weyl: "Methoden der organ. Chemie" [Methods of Organic Chemistry], Georg- Thieme-Verlag, Stuttgart, New York 1985, Volume E5, pp. 941 -1045), and subsequently alkylating the resulting amides of formula IV.1 using suitable alkylating agents in the presence of ba- ses, wherein the alk lation can be effected under standard conditions known from literature.
Figure imgf000010_0002
IV.1 1.1
Alternatively, compounds of formula 1.1 , wherein T is O, can directly be prepared e.g. by reacting activated pyrazole carboxylic acid derivatives of formula II with suitable 3-aminopyridine or 4-aminopyridazine derivatives of formula Ilia (e.g. Houben-Weyl: "Methoden der organ. Chemie" [Methods of Organic Chemistry], Georg-Thieme-Verlag, Stuttgart, New York 1985, Volume E5, pp. 941 -1045).
Figure imgf000011_0001
II Ilia 1.1
In formulae II, III and IV.1 , the radicals have the meanings mentioned above for formula I and in particular the meanings mentioned as being preferred, X is a suitable leaving group such as halogen, N3, p-nitrophenoxy or pentafluorophenoxy and the like.
Activated pyrazole carboxylic acid derivatives of formula II are preferably halides, activated esters, anhydrides, azides, for example chlorides, fluorides, bromides, para-nitrophenyl esters, pentafluorophenyl esters, N-hydroxysuccinimides, hydroxybenzotriazol-1 -yl esters.
As already indicated above, the activated pyrazole carboxylic acid derivatives of formula II al- ready contain those radicals R2, R3 and R4, which are desired for the pyrazole compound of formula I. Preferably, this also applies to the situation, where R4 in the pyrazole compound of formula I is any one of the following groups
(iiid),
Figure imgf000011_0002
Accordingly, the following activated pyrazole carboxylic acid derivatives of formula II are preferably used in the above described synthesis of the pyrazole compounds of formula 1.1 .
Figure imgf000011_0003
The activated pyrazole carboxylic acid derivatives of formula II including the activated pyrazole carboxylic acid derivatives of formulae ll(iiia), ll(iiib), ll(iiic), ll(iiid) and ll(iva) as well as the compounds of formula III are commercially available or can be prepared by methods known in the literature (cf. WO 05/040169; WO 08/074824; Journal of Fluorine chemistry 132(1 1 ), p. 995 (201 1 )).
As regards the activated pyrazole carboxylic acid derivatives of formula 11 (ivb) and the group (ivb) being present in the pyrazole compounds of formula I, it is noted that the the wavy lines to the substituents R4f and R4^ indicate that R4f and R4^ may be present in both positions at the carbon atom of the carbon-nitrogen double bond, i.e. either in cis configuration or in trans configuration relative to V. Thus, two geometric isomers are in each case covered. For reasons of clarity, it is only referred to one geometric isomer throughout the specification, but its description embraces the disclosure of the other geometric isomer as well.
The activated pyrazole carboxylic acid derivatives of formula ll(ivb) can be prepared by methods known in the art starting from commercially available precursors. For example, the carbon nitrogen double bond of group (ivb) may be established by a reaction, which is analogous to an imine formation, starting from an aldehyde or ketone substituted by R4^ and R4f and a suitable pyrazole carboxylic acid derivative (see WO 2013/072882, J. Org. Chem. 48(20), p. 3531 (1983), and JP 2013/023476, respectively). Alternatively, the V-W-bond of group (ivb) may be established by a substitution reaction, starting from an oxime, thioxime or hydrazone substituted by R49 and R4f and a suitable pyrazole carboxylic acid derivative, which contains a leaving group at the W substituent (see J. Med. Chem, 28(7), p. 896 (1985)). Once the group ll(ivb) is established, the pyrazole carboxylic acid derivative may be converted to an activated pyrazole carboxylic acid derivative of formula 11 (ivb).
Compounds of formula 1.2, wherein T is S, can be prepared e.g. by reacting compounds of formula 1.1 with 2,4-bis(4-methoxyphenyl)-1 ,3,2,4-dithiadiphosphetane-2,4-disulfide or PSs according to the method described in Synthesis 2003, p. 1929.
Compounds of formula 1.3, wherein T is NR1b, can be prepared e.g. via imine formation starting from the compounds of formula 1.1 . In one embodiment, the present invention relates to compounds of formula I, wherein U is CRU, preferably CH, or N. Compounds, wherein U is CH and U is N, correspond to formula I.A and formula I.B, respectively.
Figure imgf000012_0001
Compounds of formula I.B are particularly preferred according to the invention.
The compounds of formula I may be present in two or three isomeric forms depending on the meaning of U. For example, if U is selected to be CH, as in the compounds of formula I.A, two structural isomers ISO-A and ISO-B can be formed.
Figure imgf000012_0002
If U is selected to be N, as in the compounds of formula I.B, three structural isomers ISO-A, ISO-B and ISO-C can be formed.
Figure imgf000013_0001
It is preferred according to the present invention, that the compounds of formula I are present in the form of the structural isomers ISO-A. However, the compounds of formula I may also be present in the form of the structural isomers ISO-B or ISO-C or in the form of mixtures of two or more of the structural isomers ISO-A, ISO-B and ISO-C. For reasons of clarity it is referred to the structural isomer ISO-A only throughout the specification, but its description embraces the disclosure of the other structural isomers as well.
Isomers ISO-C can be obtained by alkylation of amide compounds IV. B. The reaction can be performed by analogy to known N-alkylation of pyridazines. N-Alkylation of pyridazines is known in literature and can be found in e.g.: J. Chem. Soc, Perkin Trans. Vol. 1 , p. 401 (1988), and J. Org. Chem. Vol. 46, p. 2467 (1981 ). For example, the following compound IV.B. may be used as starting material.
Figure imgf000013_0002
In one embodiment, the present invention relates to compounds of formula I, wherein R4 is any one of groups (iiia), (iiib), (iiic), (iiid), (iva) or (ivb). These compounds correspond to formula I.R4(iiia), formula I.R4(iiib), formula I.R4(iiic), formula I.R4(iiid), formula I.R4(iva) and formula I.R4(ivb), respectively.
Figure imgf000013_0003
Figure imgf000014_0001
If R4 is any one of groups (iiia), (iiib), (iiic), (iiid), (iva) or (ivb), the substituent R4 will accordingly be referred to as R4(iiia), R4(iiib), R4(iiic), R4(iiid), R4(iva) or R4(ivb).
As already indicated above, the wavy lines to the substituents R4f and R4^ in the compounds of formula I .R4(ivb) indicate that R4f and R4^ may be present in both positions at the carbon atom of the carbon-nitrogen double bond, i.e. either in cis configuration or in trans configuration relative to V. Thus, two geometric isomers are in each case covered. For reasons of clarity, it is only referred to one geometric isomer throughout the specification, but its description embraces the disclosure of the other geometric isomer as well.
The groups (iiia), (iiib), (iiic), (iiid), (iva) and (ivb) may also result in the formation of tautomers. Such tautomers are also encompassed by the compounds of formula I of the present invention.
In one embodiment, the present invention relates to compounds of formula I , wherein R1 is a substituent according to options the following options (i), (ii), (iii), (iv) or (v):
(i) C3-Cio-cycloalkenyl, C3-Cio-cycloalkenyloxy, C3-Cio-cycloalkenylthio or C3-C10- cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx;
or
(ii) La-C3-Cio-cycloalkenyl, La-C3-Cio-cycloalkenyloxy, La-C3-Cio-cycloalkenylthio or La- C3-Cio-cycloalkenylamino , wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx, and wherein
La is C(Y), C(Y)NR9, S(0)n, Ci-C8-alkylene, C2-C8-alkenylene, C2-C8-alkynylene, C3- C6-cycloalkylene, phenylene, hetarylene, wherein the carbon chains and cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
or
(iii) Lb-La1-C3-Cio-cycloalkenyl, Lb-La1-C3-Cio-cycloalkenyloxy, L -La1-C3-Cio- cycloalkenylthio or Lb-La1-C3-Cio-cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx, and wherein
Lb is d-Ce-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx; and
La1 is C(Y), C(Y)NR9, S(0)n, phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
or (iv) Lc-Ld-C3-Cio-cycloalkenyl, Lc-Ld-C3-Cio-cycloalkenyloxy, Lc-Ld-C3-Cio-cycloalkenylthio or Lc-Ld-C3-Cio-cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx, and wherein
Lc is O, S, NRe, C(Y), C(Y)0, C(Y)NR9, C(Y)NR'NRe, S(0)n, S(0)nNRe, phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx; and
Ld is Ci-Ce-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
or
(v) Lb-Lc-Ld-C3-Cio-cycloalkenyl, Lb-Lc-Ld-C3-Cio-cycloalkenyloxy, L -Lc-Ld-C3-Cio- cycloalkenylthio or Lb-Lc-Ld-C3-Cio-cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals Ry and Rx, and wherein
Lb is Ci-Cs-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2,
3, 4 or 5 identical or different substituents Rx;
Lc is O, S, NRe, C(Y), C(Y)0, C(Y)NR9, C(Y)NR'NRe, S(0)n, S(0)nNRe, phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx; and
Ld is Ci-Cs-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx.
Compounds, wherein R1 is a substituent according to option (i), correspond to formula I.R1(i). Compounds, wherein R1 is a substituent according to option (ii), correspond to formula I.R1(ii). Compounds, wherein R1 is a substituent according to option (iii), correspond to formula I.R1(iii). Compounds, wherein R1 is a substituent according to option (iv), correspond to formula I .R1(iv). Compounds, wherein R1 is a substituent according to option (v), correspond to formula I.R1(v).
Figure imgf000015_0001
If R1 is any one of options (i), (ii), (iii), (iv) or (v), the substituent R1 will accordingly be referred to as R1(i), R1("), R1(i"), R1(iv) or R (v).
If R1 is option (i), the C3-Cio-cycloalkenyl, C3-Cio-cycloalkenyloxy, C3-Cio-cycloalkenylthio or C3-Cio-cycloalkenylamino group as defined above is directly attached to the nitrogen atom of the amide group of the compounds of formula I.R1(i). If R1 is any one of options (ii), (iii), (iv) or (v), La, Lb-La1, Lc-Ld and Lb-Lc-Ld are to be understood as linkers, via which C3-Cio-cycloalkenyl, C3-Cio-cycloalkenyloxy, C3-Cio-cycloalkenylthio or C3- Cio-cycloalkenylamino groups as defined above are attached to the nitrogen atoms of the amide groups of the compounds of formulae I.R1(N). I.R1(iii), I.R1(iv) and I.R1(v), respectively. It is noted that the definition of the C3-Cio-cycloalkenyl, C3-Cio-cycloalkenyloxy, C3-Cio-cycloalkenylthio or C3-Cio-cycloalkenylamino groups for R1 being any one of R1 (ii) , R1(iii), R1(iv) or R1(v) corresponds to the definition of the same groups for R1 being R1(i).
Accordingly, option (ii) may be understood as such that a substituent corresponding to R1(i) is attached to the nitrogen atom of the amide group via a linker La. Therefore, the compounds of formula I.R1(ii) may also be referred to as compounds of formula I.La-R1(i), and R (ii) may also be referred to as La-R1(i). Option (iii) may be understood as such that a substituent corresponding to R1(i) is attached to the nitrogen atom of the amide group via a linker Lb-La1. Therefore, the compounds of formula I.R1(iii) may also be referred to as compounds of formula I.Lb-La1-R1(i), and R1(iii) may also be referred to as Lb-La1-R1(i). Option (iv) may be understood as such that a substituent corresponding to R1(i) is attached to the nitrogen atom of the amide group via a linker Lc-Ld. Therefore, the compounds of formula I.R1(iv) may also be referred to as compounds of formula I.LC-Ld-R1(i), and R1(iv) may also be referred to as Lc-Ld-R1(i). Option (v) may be understood as such that a substituent corresponding to R1(i) is attached to the nitrogen atom of the amide group via a linker Lb-Lc-Ld. Therefore, the compounds of formula I.R1(v) may also be re- ferred to as compounds of formula I.Lb-Lc-Ld-R1(i), and R1(v) may also be referred to as Lb-Lc-Ld- R1(i). The compounds are depicted below.
I.R (iii) = I.L -La -R (i)
Figure imgf000016_0001
I.R (iv) = I.LC-Ld-R (i) I.R1(v) = I.L -Lc-Ld-R (i)
If La, Lb, La1, Lc or Ld represents a non-symmetric moiety, e.g. C(Y)NR9, C(Y)NR'NRe, C(Y)0, S(0)nNRe, the moiety may be present in both possible connectivities with the moieties, to which it is bonded. For example, if La is C(Y)NR9, either the C(Y) group or the NRs group may be attached to the nitrogen atom of the amide group, and if the C(Y) group is attached to the nitrogen atom of the amide group, the NRs group is attached to the substituent corresponding to R1(i), and if the NRe group is attached to the nitrogen atom of the amide group, the C(Y) group is at- tached to the substituent corresponding to R1(i). N-oxides of the compounds of formula I, can be prepared by oxidation of compounds I according to standard methods of preparing heteroaromatic N-oxides, e.g. by the method described in Journal of Organometallic Chemistry 1989, 370, 17-31 .
If individual compounds cannot be prepared via the above-described routes, they can be pre- pared by derivatization of other compounds I or by customary modifications of the synthesis routes described. For example, in individual cases, certain compounds I can advantageously be prepared from other compounds I by ester hydrolysis, amidation, esterification, ether cleavage, olefination, reduction, oxidation and the like.
The reaction mixtures are worked up in the customary manner, for example by mixing with wa- ter, separating the phases, and, if appropriate, purifying the crude products by chromatography, for example on alumina or on silica gel. Some of the intermediates and end products may be obtained in the form of colorless or pale brown viscous oils which are freed or purified from volatile components under reduced pressure and at moderately elevated temperature. If the intermediates and end products are obtained as solids, they may be purified by recrystallization or trituration.
The term "compound(s) according to the invention", or "compounds of formula I" comprises the compound(s) as defined herein as well as a stereoisomer, salt, tautomer or N-oxide thereof. The term "compound(s) of the present invention" is to be understood as equivalent to the term "compound(s) according to the invention", therefore also comprising a stereoisomer, salt, tautomer or N-oxide thereof.
The radicals attached to the backbone of formula I may contain one or more centers of chirali- ty. In this case the compounds of formula I are present in the form of different enantiomers or diastereomers, depending on the substituents. The present invention relates to every possible stereoisomer of the formula I, i.e. to single enantiomers or diastereomers, as well as to mixtures thereof.
As already indicated above, the compounds of formula I may be present in the form of different structural isomers depending on the position of R1. The present invention relates to every possible structural isomer as indicated in the compounds of formula I.A:ISO-A, formula I.A:ISO-B, formula I.B:ISO-A, formula I.B:ISO-B, formula I.B:ISO-C, and mixtures thereof.
As already indicated above, the compounds of formula I may also be present in the form of different tautomers depending e.g. on the selection of the radical R4. The present invention relates to every possible tautomer of the formula I.
As already indicated above, the compounds of formula I may be present in the form of different geometric isomers depending e.g. on the selection of R4. If geometric isomers are possible, the present invention relates to both, the E- and Z-isomers of the compounds of formula I.
The compounds of formula I may be amorphous or may exist in one or more different crystalline states (polymorphs) which may have different macroscopic properties such as stability or show different biological properties such as activities. The present invention relates to amor- phous and crystalline compounds of formula I, mixtures of different crystalline states of the respective compound I, as well as amorphous or crystalline salts thereof.
Salts of the compounds of the formula I are preferably veterinary and/or agriculturally acceptable salts, preferably agriculturally acceptable salts. They can be formed in a customary manner, e.g. by reacting the compound with an acid of the anion in question if the compound of formula I has a basic functionality.
Veterinary and/or agriculturally useful salts of the compounds of formula I encompass especially the acid addition salts of those acids whose cations and anions, respectively, have no ad- verse effect on the pesticidal action of the compounds of formula I.
Anions of useful acid addition salts are primarily chloride, bromide, fluoride, hydrogensulfate, sulfate, dihydrogenphosphate, hydrogenphosphate, phosphate, nitrate, bicarbonate, carbonate, hexafluorosilicate, hexafluorophosphate, benzoate, and the anions of Ci-C4-alkanoic acids, preferably formate, acetate, propionate and butyrate. They can be formed by reacting com- pounds of formula I with an acid of the corresponding anion, preferably of hydrochloric acid, hydrobromic acid, sulfuric acid, phosphoric acid or nitric acid.
The term "N-oxide" includes any compound of formula I which has at least one tertiary nitrogen atom that is oxidized to an N-oxide moiety. The organic moieties mentioned in the above definitions of the variables are - like the term halogen - collective terms for individual listings of the individual group members. The prefix Cn- Cm indicates in each case the possible number of carbon atoms in the group.
The term "halogen" denotes in each case fluorine, bromine, chlorine or iodine, in particular fluorine, chlorine or bromine.
The term "alkyl" as used herein and in the alkyl moieties of alkylamino, alkylcarbonyl, alkylthio, alkylsulfinyl, alkylsulfonyl and alkoxyalkyl denotes in each case a straight-chain or branched alkyl group having usually from 1 to 10 carbon atoms, frequently from 1 to 6 carbon atoms, preferably 1 to 4 carbon atoms, more preferably from 1 to 3 carbon atoms. Examples of an alkyl group are methyl, ethyl, n-propyl, iso-propyl, n-butyl, 2-butyl, iso-butyl, tert-butyl, n-pentyl, 1 - methylbutyl, 2-methylbutyl, 3-methylbutyl, 2,2-dimethylpropyl, 1 -ethyl propyl, n-hexyl, 1 ,1 - dimethylpropyl, 1 ,2-dimethylpropyl, 1 -methylpentyl, 2-methylpentyl, 3-methylpentyl, 4- methylpentyl, 1 ,1 -dimethylbutyl, 1 ,2-dimethylbutyl, 1 ,3-dimethylbutyl, 2,2-dimethylbutyl, 2,3- dimethylbutyl, 3,3-dimethylbutyl, 1 -ethylbutyl, 2-ethylbutyl, 1 ,1 ,2-trimethylpropyl, 1 ,2,2- trimethylpropyl, 1 -ethyl-1 -methylpropyl, and 1 -ethyl-2-methyl propyl.
The term "haloalkyl" as used herein and in the haloalkyl moieties of haloalkylcarbonyl, haloalkoxycarbonyl, haloalkylthio, haloalkylsulfonyl, haloalkylsulfinyl, haloalkoxy and
haloalkoxyalkyl, denotes in each case a straight-chain or branched alkyl group having usually from 1 to 10 carbon atoms, frequently from 1 to 6 carbon atoms, preferably from 1 to 4 carbon atoms, wherein the hydrogen atoms of this group are partially or totally replaced with halogen atoms. Preferred haloalkyl moieties are selected from Ci-C4-haloalkyl, more preferably from Ci- C3-haloalkyl or Ci-C2-haloalkyl, in particular from Ci-C2-fluoroalkyl such as fluoromethyl, difluoromethyl, trifluoromethyl, 1 -fluoroethyl, 2-fluoroethyl, 2,2-difluoroethyl, 2,2,2-trifluoroethyl, pentafluoroethyl, and the like.
The term "alkoxy" as used herein denotes in each case a straight-chain or branched alkyl group which is bonded via an oxygen atom and has usually from 1 to 10 carbon atoms, frequently from 1 to 6 carbon atoms, preferably 1 to 4 carbon atoms. Examples of an alkoxy group are methoxy, ethoxy, n-propoxy, iso-propoxy, n-butyloxy, 2-butyloxy, iso-butyloxy, tert.-butyloxy, and the like. The term "alkoxyalkyl" as used herein refers to alkyl usually comprising 1 to 10, frequently 1 to 4, preferably 1 to 2 carbon atoms, wherein 1 carbon atom carries an alkoxy radical usually comprising 1 to 4, preferably 1 or 2 carbon atoms as defined above. Examples are CH2OCH3, CH2-OC2H5, 2-(methoxy)ethyl, and 2-(ethoxy)ethyl.
The term "haloalkoxy" as used herein denotes in each case a straight-chain or branched alkoxy group having from 1 to 10 carbon atoms, frequently from 1 to 6 carbon atoms, preferably 1 to 4 carbon atoms, wherein the hydrogen atoms of this group are partially or totally replaced with halogen atoms, in particular fluorine atoms. Preferred haloalkoxy moieties include C1-C4- haloalkoxy, in particular Ci-C2-fluoroalkoxy, such as fluoromethoxy, difluoromethoxy, trifluoromethoxy, 1 -fluoroethoxy, 2-fluoroethoxy, 2,2-difluoroethoxy, 2,2,2-trifluoroethoxy, 2- chloro-2-fluoroethoxy, 2-chloro-2,2-difluoro-ethoxy, 2,2dichloro-2-fluorethoxy, 2,2,2- trichloroethoxy, pentafluoroethoxy and the like.
The term "alkylthio "( alkylsulfanyl: alkyl-S-)" as used herein refers to a straight-chain or branched saturated alkyl group having 1 to 10 carbon atoms, preferably 1 to 4 carbon atoms (= Ci-C4-alkylthio), more preferably 1 to 3 carbon atoms, which is attached via a sulfur atom.
The term "haloalkylthio" as used herein refers to an alkylthio group as mentioned above wherein the hydrogen atoms are partially or fully substituted by fluorine, chlorine, bromine and/or iodine.
The term "alkylsulfinyl" (alkylsulfoxyl: Ci-C6-alkyl-S(=0)-), as used herein refers to a straight- chain or branched saturated alkyl group (as mentioned above) having 1 to 10 carbon atoms, preferably 1 to 4 carbon atoms (= Ci-C4-alkylsulfinyl), more preferably 1 to 3 carbon atoms bonded through the sulfur atom of the sulfinyl group at any position in the alkyl group.
The term "haloalkylsulfinyl" as used herein refers to an alkylsulfinyl group as mentioned above wherein the hydrogen atoms are partially or fully substituted by fluorine, chlorine, bromine and/or iodine.
The term "alkylsulfonyl" (alkyl-S(=0)2-) as used herein refers to a straight-chain or branched saturated alkyl group having 1 to 10 carbon atoms, preferably 1 to 4 carbon atoms (= C1-C4- alkylsulfonyl), preferably 1 to 3 carbon atoms, which is bonded via the sulfur atom of the sulfonyl group at any position in the alkyl group.
The term "haloalkylsulfonyl" as used herein refers to an alkylsulfonyl group as mentioned above wherein the hydrogen atoms are partially or fully substituted by fluorine, chlorine, bromine and/or iodine.
The term "alkylcarbonyl" refers to an alkyl group as defined above, which is bonded via the carbon atom of a carbonyl group (C=0) to the remainder of the molecule.
The term "haloalkylcarbonyl" refers to an alkylcarbonyl group as mentioned above, wherein the hydrogen atoms are partially or fully substituted by fluorine, chlorine, bromine and/or iodine.
The term "alkoxycarbonyl" refers to an alkylcarbonyl group as defined above, which is bonded via an oxygen atom to the remainder of the molecule.
The term "haloalkoxycarbonyl" refers to an alkoxycarbonyl group as mentioned above, where- in the hydrogen atoms are partially or fully substituted by fluorine, chlorine, bromine and/or iodine.
The term "alkenyl" as used herein denotes in each case a singly unsaturated hydrocarbon radical having usually 2 to 10, frequently 2 to 6, preferably 2 to 4 carbon atoms, e.g. vinyl, allyl (2- propen-1 -yl), 1 -propen-1 -yl, 2-propen-2-yl, methallyl (2-methylprop-2-en-1 -yl), 2-buten-1 -yl, 3- buten-1 -yl, 2-penten-1 -yl, 3-penten-1 -yl, 4-penten-1 -yl, 1 -methylbut-2-en-1 -yl, 2-ethylprop-2-en- 1 -yl and the like.
The term "haloalkenyl" as used herein refers to an alkenyl group as defined above, wherein the hydrogen atoms are partially or totally replaced with halogen atoms.
The term "alkynyl" as used herein denotes in each case a singly unsaturated hydrocarbon radical having usually 2 to 10, frequently 2 to 6, preferably 2 to 4 carbon atoms, e.g. ethynyl, propargyl (2-propyn-1 -yl), 1 -propyn-1 -yl, 1 -methylprop-2-yn-1 -yl), 2-butyn-1 -yl, 3-butyn-1 -yl, 1 - pentyn-1 -yl, 3-pentyn-1 -yl, 4-pentyn-1 -yl, 1 -methylbut-2-yn-1 -yl, 1 -ethylprop-2-yn-1 -yl and the like.
The term "haloalkynyl" as used herein refers to an alkynyl group as defined above, wherein the hydrogen atoms are partially or totally replaced with halogen atoms.
The term "cycloalkyi" as used herein and in the cycloalkyi moieties of cycloalkylalkyl, cycloalkoxy and cycloalkylthio denotes in each case a monocyclic cycloaliphatic radical having usually from 3 to 10 or from 3 to 6 carbon atoms, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl and cyclodecyl or cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
The term "halocycloalkyl" as used herein and in the halocycloalkyl moieties of halocycloalkoxy and halocycloalkylthio denotes in each case a monocyclic cycloaliphatic radical having usually from 3 to 10 C atoms or 3 to 6 C atoms, wherein at least one, e.g. 1 , 2, 3, 4 or 5 of the hydrogen atoms, are replaced by halogen, in particular by fluorine or chlorine. Examples are 1 - and 2- fluorocyclopropyl, 1 ,2-, 2,2- and 2,3-difluorocyclopropyl, 1 ,2,2-trifluorocyclopropyl, 2,2,3,3- tetrafluorocycl propyl, 1 - and 2-chlorocyclopropyl, 1 ,2-, 2,2- and 2,3-dichlorocyclopropyl, 1 ,2,2- trichlorocyclopropyl, 2,2,3,3-tetrachlorocyclpropyl, 1 -,2- and 3-fluorocyclopentyl, 1 ,2-, 2,2-, 2,3-, 3,3-, 3,4-, 2,5-difluorocyclopentyl, 1 -,2- and 3-chlorocyclopentyl, 1 ,2-, 2,2-, 2,3-, 3,3-, 3,4-, 2,5- dichlorocyclopentyl and the like.
The term "cycloalkoxy" refers to a cycloalkyi group as defined above, which is bonded via an oxygen atom to the remainder of the molecule.
The term "halocycloalkoxy" refers to a halocycloalkyl group as defined above, which is bonded via an oxygen atom to the remainder of the molecule.
The term "cycloalkylthio" refers to a cycloalkyi group as defined above, which is bonded via a sulfur atom to the remainder of the molecule.
The term "halocycloalkylthio" refers to a halocycloalkyl group as defined above, which is bonded via a sulfur atom to the remainder of the molecule.
The term "cycloalkylalkyl" refers to a cycloalkyi group as defined above which is bonded via an alkyl group, such as a Ci-Cs-alkyl group or a Ci-C4-alkyl group, in particular a methyl group (= cycloalkylmethyl), to the remainder of the molecule.
The term "cycloalkenyl" as used herein and in the cycloalkenyl moieties of cycloalkenylalkyl, cycloalkenyloxy, cycloalkenylthio and cycloalkenylamino denotes in each case a monocyclic singly unsaturated non-aromatic radical having usually from 3 to 10, e.g. 3 or 4 or from 5 to 10 carbon atoms, preferably from 3 to 8 carbon atoms, more preferably from 3 to 6 carbon atoms. The cycloalkenyl group may be bonded to the remainder of the molecule via a carbon atom, which forms the double bond, or via a carbon atom, which forms a single bond, preferably via a carbon atom, which forms a double bond. Exemplary cycloalkenyl groups include cyclopropen- 1 -yl, cyclohexen-1 -yl, cyclohepten-1 -yl or cycloocten-1 -yl.
The term "halocycloalkenyl" as used herein and in the halocycloalkenyl moieties of halo- cycloalkenyloxy, halocycloalkenylthio and halocycloalkenylamino denotes in each case a mono- cyclic singly unsaturated non-aromatic radical having usually from 3 to 10, e.g. 3 or 4 or from 5 to 10 carbon atoms, preferably from 3 to 8 carbon atoms, more preferably from 3 to 6 carbon atoms, wherein at least one, e.g. 1 , 2, 3, 4 or 5 of the hydrogen atoms, are replaced by halogen, in particular by fluorine or chlorine. The halocycloalkenyl group may be bonded to the remainder of the molecule via a carbon atom, which forms the double bond, or via a carbon atom, which forms a single bond, preferably via a carbon atom, which forms a double bond. Examples are 3,3,-difluorocyclopropen-1 -yl and 3,3-dichlorocyclopropen-1 -yl.
The term "cycloalkenyloxy" refers to a cycloalkenyl group as defined above, which is bonded via an oxygen atom to the remainder of the molecule.
The term "halocycloalkenyloxy" refers to a halocycloalkenyl group as defined above, which is bonded via an oxygen atom to the remainder of the molecule.
The term "cycloalkenylthio" refers to a cycloalkenyl group as defined above, which is bonded via a sulfur atom to the remainder of the molecule.
The term "halocycloalkenylthio" refers to a halocycloalkenyl group as defined above, which is bonded via a sulfur atom to the remainder of the molecule.
The term "cycloalkenylamino" refers to a cycloalkenyl group as defined above, which is bonded via a nitrogen atom to the remainder of the molecule. The nitrogen atom may carry one further substituent Re as defined above, so that a cycloalkenylamino group corresponds to a cycloalkenyl-NRe- group. Preferably, Re is hydrogen, so that the cycloalkenylamino group corresponds to a cycloalkenyl-NH- group.
The term "halocycloalkenylamino" refers to a halocycloalkenyl group as defined above, which is bonded via a nitrogen atom to the remainder of the molecule. The nitrogen atom may carry one further substituent Re as defined above, so that a halocycloalkenylamino group corresponds to a halocycloalkenyl-NRe- group. Preferably, Re is hydrogen, so that the halocycloalkenylamino group corresponds to a halocycloalkenyl-NH- group.
The term "cycloalkenylalkyl" refers to a cycloalkenyl group as defined above which is bonded via an alkyl group, such as a Ci-Cs-alkyl group or a Ci-C4-alkyl group, in particular a methyl group (= cycloalkenylmethyl), to the remainder of the molecule.
The term "carbocycle" or "carbocyclyl" includes in general a 3- to 12-membered, preferably a 3- to 8-membered or a 5- to 8-membered, more preferably a 5- or 6-membered mono-cyclic, non-aromatic ring comprising 3 to 12, preferably 3 to 8 or 5 to 8, more preferably 5 or 6 carbon atoms. Preferably, the term "carbocycle" covers cycloalkyl and cycloalkenyl groups as defined above.
The term "heterocycloalkyl" includes in general 3- to 8-membered, in particular 6-membered monocyclic saturated heterocyclic non-aromatic radicals. The heterocyclic non-aromatic radicals usually comprise 1 , 2, or 3 heteroatoms selected from N, O and S as ring members, where S- atoms as ring members may be present as S, SO or SO2.
The term "heterocycloalkenyl" includes in general 3- to 8-membered, in particular 6-membered monocyclic singly unsaturated heterocyclic non-aromatic radicals. The heterocyclic non- aromatic radicals usually comprise 1 , 2, or 3 heteroatoms selected from N, O and S as ring members, where S-atoms as ring members may be present as S, SO or SO2.
The term "heterocycle" or "heterocyclyl" includes in general 3- to 12-membered, preferably 3- to 8-membered or 5- to 8-membered, more preferably 5- or 6-membered, in particular 6- membered monocyclic heterocyclic non-aromatic radicals. The heterocyclic non-aromatic radicals usually comprise 1 , 2, 3, 4 or 5, preferably 1 , 2 or 3 heteroatoms selected from N, O and S as ring members, where S-atoms as ring members may be present as S, SO or SO2. Examples of 5- or 6-membered heterocyclic radicals comprise saturated or unsaturated, non-aromatic heterocyclic rings, such as oxiranyl, oxetanyl, thietanyl, thietanyl-S-oxid (S-oxothietanyl), thietanyl-S-dioxid (S-dioxothiethanyl), pyrrolidinyl, pyrrolinyl, pyrazolinyl, tetrahydrofuranyl, dihy- drofuranyl, 1 ,3-dioxolanyl, thiolanyl, S-oxothiolanyl, S-dioxothiolanyl, dihydrothienyl, S- oxodihydrothienyl, S-dioxodihydrothienyl, oxazolidinyl, oxazolinyl, thiazolinyl, oxathiolanyl, piperidinyl, piperazinyl, pyranyl, dihydropyranyl, tetrahydropyranyl, 1 ,3- and 1 ,4-dioxanyl, thiopyranyl, S.oxothiopyranyl, S-dioxothiopyranyl, dihydrothiopyranyl, S-oxodihydrothiopyranyl, S-dioxodihydrothiopyranyl, tetrahydrothiopyranyl, S-oxotetrahydrothiopyranyl, S- dioxotetrahydrothiopyranyl, morpholinyl, thiomorpholinyl, S-oxothiomorpholinyl, S- dioxothiomorpholinyl, thiazinyl and the like. Examples for heterocyclic ring also comprising 1 or 2 carbonyl groups as ring members comprise pyrrolidin-2-onyl, pyrrolidin-2,5-dionyl, imida- zolidin-2-onyl, oxazolidin-2-onyl, thiazolidin-2-onyl and the like.
The term "aryl" includes mono-, bi- or tricyclic aromatic radicals having usually from 6 to 14, preferably 6, 10 or 14 carbon atoms. Exemplary aryl groups include phenyl, naphthyl and anthracenyl. Phenyl is preferred as aryl group.
The term "hetaryl" includes monocyclic 5- or 6-membered heteroaromatic radicals comprising as ring members 1 , 2, 3 or 4 heteroatoms selected from N, O and S. Examples of 5- or
6-membered heteroaromatic radicals include pyridyl, i.e. 2-, 3-, or 4-pyridyl, pyrimidinyl, i.e. 2-, 4- or 5-pyrimidinyl, pyrazinyl, pyridazinyl, i.e. 3- or 4-pyridazinyl, thienyl, i.e. 2- or 3-thienyl, furyl, i.e. 2-or 3-furyl, pyrrolyl, i.e. 2- or 3-pyrrolyl, oxazolyl, i.e. 2-, 3- or 5-oxazolyl, isoxazolyl, i.e. 3-, 4- or 5-isoxazolyl, thiazolyl, i.e. 2-, 3- or 5-thiazolyl, isothiazolyl, i.e. 3-, 4- or
5-isothiazolyl, pyrazolyl, i.e. 1 -, 3-, 4- or 5-pyrazolyl, i.e. 1 -, 2-, 4- or 5-imidazolyl, oxadiazolyl, e.g. 2- or 5-[1 ,3,4]oxadiazolyl, 4- or 5-(1 ,2,3-oxadiazol)yl, 3- or 5-(1 ,2,4-oxadiazol)yl, 2- or
5-(1 ,3,4-thiadiazol)yl, thiadiazolyl, e.g. 2- or 5-(1 ,3,4-thiadiazol)yl, 4- or 5-(1 ,2,3-thiadiazol)yl, 3- or 5-(1 ,2,4-thiadiazol)yl, triazolyl, e.g. 1 H-, 2H- or 3H-1 ,2,3-triazol-4-yl, 2H-triazol-3-yl, 1 H-, 2H-, or 4H-1 ,2,4-triazolyl and tetrazolyl, i.e. 1 H- or 2H-tetrazolyl. The term "hetaryl" also includes bicyclic 8 to 10-membered heteroaromatic radicals comprising as ring members 1 , 2 or 3 het- eroatoms selected from N, O and S, wherein a 5- or 6-membered heteroaromatic ring is fused to a phenyl ring or to a 5- or 6-membered heteroaromatic radical. Examples of a 5- or 6- membered heteroaromatic ring fused to a phenyl ring or to a 5- or 6-membered heteroaromatic radical include benzofuranyl, benzothienyl, indolyl, indazolyl, benzimidazolyl, benzoxathiazolyl, benzoxadiazolyl, benzothiadiazolyl, benzoxazinyl, chinolinyl, isochinolinyl, purinyl, 1 ,8- naphthyridyl, pteridyl, pyrido[3,2-d]pyrimidyl or pyridoimidazolyl and the like. These fused hetaryl radicals may be bonded to the remainder of the molecule via any ring atom of 5- or 6- membered heteroaromatic ring or via a carbon atom of the fused phenyl moiety. The terms "heterocyclyloxy", "hetaryloxy", "aryloxy" and "phenoxy" refer to heterocyclyl, hetaryl and aryl as defined above and phenyl, which are bonded via an oxygen atom to the remainder of the molecule.
The terms "heterocyclylsulfonyl", "hetarylsulfonyl", "arylsulfonyl", and "phenylsulfonyl" refer to heterocycly, hetaryl and aryl as defined above, and phenyl, respectively, which are bonded via the sulfur atom of a sulfonyl group to the remainder of the molecule.
The terms "heterocyclylcarbonyl", "hetarylcarbonyl", "arylcarbonyl", and "phenylcarbonyl" refer to heterocyclyl, hetaryl and aryl as defined above, and phenyl, respectively, which are bonded via the carbon atom of a carbonyl group (C=0) to the remainder of the molecule.
The terms "heterocyclylalkyl" and "hetarylalkyl" refer to heterocyclyl or hetaryl, respectively, as defined above which are bonded via a Ci-Cs-alkyl group or a Ci-C4-alkyl group, in particular a methyl group (= heterocyclyl methyl or hetarylmethyl, respectively), to the remainder of the molecule.
The term "arylalkyl" and "phenylalkyl" refer to aryl as defined above and phenyl, respectively, which are bonded via Ci-Cs-alkyl group or a Ci-C4-alkyl group, in particular a methyl group (= arylmethyl or phenylmethyl), to the remainder of the molecule, examples including benzyl, 1 - phenylethyl, 2-phenylethyl, 2-phenoxyethyl etc.
The terms "alkylene", "cycloalkylene", "heterocycloalkylene", "alkenylene", "cycloalkenylene", "heterocycloalkenylene" and "alkynylene" refer to alkyl, cycloalkyl, heterocycloalkyl, alkenyl, cycloalkenyl, heterocycloalkenyl and alkynyl as defined above, respectively, which are bonded to the remainder of the molecule, via two atoms, preferably via two carbon atoms, of the respective group, so that they represent a linker between two moieties of the molecule.
The term "cyclic moiety" can refer to any cyclic groups, which are present in the compounds of formula I, and which are defined above, e.g. cycloalkyl, cycloalkenyl, carbocycle,
heterocycloalkyl, heterocycloalkenyl, heterocycle, aryl, hetaryl and the like.
With respect to the variables, the particularly preferred embodiments of the intermediates correspond to those of the compounds of the formula I.
In a particular embodiment, the variables of the compounds of the formula I have the following meanings, these meanings, both on their own and in combination with one another, being particular embodiments of the compounds of the formula I:
In a preferred embodiment, the invention relates to compounds of formula I, wherein T is O, i.e. compounds of formula 1.1 as depicted above.
In another preferred embodiment, the invention relates to compounds of formula I, wherein U is CH or N, i.e. compounds of formula I.A or I.B as depicted above. Compounds of formula I, wherein U is N, i.e. compounds of formula I.B, are particularly preferred according to the invention.
In another preferred embodiment of the compounds of formula I, RP1, RP2 and RP3 are H.
These compounds correspond to formula I*.
Figure imgf000024_0001
In another preferred embodiment, the invention relates to compounds of formula I, wherein R4 is any one of groups (iiia), (iiib), (iiic), (iiid), (iva) or (ivb), i.e. to compounds of formula I.R4(iiia), I.R4(iiib), I.R4(iiic), I.R4(iiid), I.R4(iva) or I.R4(ivb) as depicted above. The groups groups (iiia), (iiib), (iiic), (iiid), (iva) or (ivb) are again depicted below.
(iiid),
Figure imgf000024_0002
R4a, R4b, R4c, R4d, R4e, R4f, R49, A, D, E, G, M, Q, V, W and m are as defined above.
It is particularly preferred that in group (iiia)
R4a is CN, C2-C6-alkyl, Ci-C2-haloalkyl, Ci-C2-alkoxy-Ci-C2-alkyl, or C3-C6-cycloalkyl, wherein the C-atoms may be substituted as indicated above;
R4b is Ci-C4-alkyl, Ci-C4-haloalkyl, or C3-C6-cycloalkyl, wherein the C-atoms may be substituted as indicated above; and
R4c is H or CH3.
Further, it is particularly preferred that in group (iiib)
R4a is H, F, CN, Ci-C2-alkyl, or halomethyl; and
A is a cycloalkyl ring, preferably a cyclohexyl, a cyclopentyl or a cyclobutyl ring, or a
tetrahydropyrane or tetrahydrofuran ring, which rings may be substituted as indicated above.
Further, it is particularly preferred that in group (iiic)
R4a is CN, Ci-C2-alkyl, Ci-C2-haloalkyl, or cyclopropyl;
R4b is H, CN, Ci-C2-alkyl, or Ci-C2-haloalkyl;
D is a direct bond or Ci-C4-alkylene; and
E is a saturated or unsaturated heterocyclic group, wherein the heterocycle may be sub- stituted as indicated above, and wherein a phenyl group may optionally be annealed to the ring.
Further, it is particularly preferred that in group (iiid)
G is a-branched C2-C3-alkylene, preferably CH(CH3) or CH(CH3)CH2,
m is 0 or 1 ; and
R4d is Ci-C2-haloalkyl or C-C3H5, wherein the carbon atoms may be halogenated.
Further, it is particularly preferred that in group (iva)
Q is an a-branched or straight-chain d-Cs-alkylene, C2-Cs-alkenylene or C2-Cs- alkynylene, which carbon chains can be partially or fully substituted as indicated above, or a direct bond; and
R4e is H or CH3; or Q and R4e together form a 4- to 6-membered carbocyclic ring or a 4- to 6-membered heterocyclic ring, which contains O or S as heteroatom, and which groups may be substituted as indicated above; and
M is O, S, NOCHs or NSCHs; or
Q and M together form a 4- to 6-membered unsaturated, non-aromatic N-containing heterocyclic ring as defined above.
Further, it is particularly preferred that in group (ivb)
W is an a-branched or straight-chain d-Cs-alkylene, Cs-Cs-cycloalkylene or C3-C8- heterocycloalkylene, wherein the groups W may be substituted as indicated above; V is O or S;
R49 is H, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl or C3-C6-cycloalkylmethyl, wherein the alkyl or cycloalkyl groups may be substituted as indicated above; and R4f is Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl or C3-C6-cycloalkylmethyl, wherein the alkyl or cycloalkyl groups may be substituted as indicated above.
It is particularly preferred according to the present invention that the compounds of formula I are compounds of formula I .R4(iiia), compounds of formula I.R4(iiib) or compounds of formula I .R4(iiic), i.e. compounds of formula I , wherein R4 is any one of options (iiia), (iiib) or (iiic) as defined above.
In another preferred embodiment, the invention relates to compounds of formula I , wherein R2 and R3 are independently of each other selected from H, halogen, CN, Ci-C4-alkyl, C1-C4- haloalkyl, C3-C4-cycloalkyl, C3-C4-halocycloalkyl, ORa, and SRa, wherein Ra is Ci-C4-alkyl, Ci- C4-haloalkyl, C3-C4-cycloalkyl, or C3-C4-halocycloalkyl. For R2, it is preferred that R2 is C1-C2- alkyl, Ci-C2-haloalkyl, C3-cycloalkyl, or C3-halocycloalkyl, and more preferred that R2 is CH3 or fluoromethyl, e.g. CF2H or CF3. For R3, it is preferred that R3 is H.
In another preferred embodiment, the invention relates to compounds of formula I, wherein R1 is any one of options (i), (ii), (iii), (iv) or (v) as defined above, i.e. to compounds of formula I .R1(i), I . 1(ii). I .R1(iii). I R (iv) or I .R1(v) as depicted above.
For R1 being any one of options (i), (ii), (iii), (iv) and (v), it is preferred that R1 is
(i) C3-Cio-cycloalkenyl, C3-Cio-cycloalkenyloxy, C3-Cio-cycloalkenylthio or C3-C10- cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx;
or
(ii) La-C3-Cio-cycloalkenyl, La-C3-Cio-cycloalkenyloxy, La-C3-Cio-cycloalkenylthio or La- C3-Cio-cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx, and wherein
La is C(Y), S(0)n, d-Cs-alkylene, C2-C8-alkenylene, C2-C8-alkynylene, C3-C6- cycloalkylene, phenylene, hetarylene, wherein the carbon chains and cyclic moie- ties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
or (iii) Lb-La1-C3-Cio-cycloalkenyl, Lb-La1-C3-Cio-cycloalkenyloxy, L -La1-C3-Cio- cycloalkenylthio or Lb-La1-C3-Cio-cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx, and wherein
Lb is d-Ce-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2,
3, 4 or 5 identical or different substituents Rx; and
La1 is C(Y), S(0)n, phenylene or hetarylene, wherein the cyclic moieties may be
unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx; or
(iv) Lc-Ld-C3-Cio-cycloalkenyl, Lc-Ld-C3-Cio-cycloalkenyloxy, Lc-Ld-C3-Cio-cycloalkenylthio or Lc-Ld-C3-Cio-cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx, and wherein
Lc is O, S, NRe, C(Y), S(0)n, phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx; and
Ld is Ci-Ce-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
or
(v) L -Lc-Ld-C3-Cio-cycloalkenyl, L -Lc-Ld-C3-Cio-cycloalkenyloxy, L -Lc-Ld-C3-Cio- cycloalkenylthio or Lb-Lc-Ld-C3-Cio-cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx, and wherein
Lb is Ci-Cs-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
Lc is O, S, NRe, C(Y), S(0)n, phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx; and
Ld is Ci-Cs-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx.
ore preferred that R1 is
(i) C3-C6-cycloalkenyl, C3-C6-cycloalkenyloxy or C3-C6-cycloalkenylthio, wherein the cycloalkenyl rings may be unsubstituted, or may be partially or fully halogenated;
or
(ii) La-C3-C6-cycloalkenyl, La-C3-C6-cycloalkenyloxy or La-C3-C6-cycloalkenylthio, wherein the cycloalkenyl rings may be unsubstituted, or may be partially or fully halogenated, and wherein
La is Ci-Cs-alkylene, phenylene, hetarylene, wherein the carbon chain and the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
or (iii) Lb-La1-C3-C6-cycloalkenyl, Lb-La1-C3-C6-cycloalkenyloxy or L -La1-C3-C6- cycloalkenylthio, wherein the cycloalkenyl rings may be unsubstituted, or may be partially or fully halogenated, and wherein
Lb is Ci-C2-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 or 2 identical or different substituents Rx; and
La1 is phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
or
(iv) Lc-Ld-C3-C6-cycloalkenyl, Lc-Ld-C3-C6-cycloalkenyloxy or Lc-Ld-C3-C6- cycloalkenylthio, wherein the cycloalkenyl rings may be unsubstituted, or may be partially or fully halogenated, and wherein
Lc is phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx; and Ld is Ci-C2-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 or 2 identical or different substituents Rx;
or
(v) L -Lc-Ld-C3-C6-cycloalkenyl, L -Lc-Ld-C3-C6-cycloalkenyloxy or L -Lc-Ld-C3-C6- cycloalkenylthio, wherein the cycloalkenyl rings may be unsubstituted, or may be partially or fully halogenated, and wherein
Lb is Ci-C2-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 or 2 identical or different substituents Rx;
Lc is phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx; and Ld is Ci-C2-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 or 2 identical or different substituents Rx.
It is most preferred that R1 is
(i) C3-C6-cycloalkenyl, wherein the cycloalkenyl ring may be unsubstituted, or may be partially or fully halogenated;
or
(ii) La-C3-C6-cycloalkenyl, wherein the cycloalkenyl ring may be unsubstituted, or may be partially or fully halogenated, and wherein
La is Ci-C2-alkylene.
In view of the above, it is particularly preferred according to the present invention that the compounds of formula I are compounds of formula I.R (i) or compounds of formula I.R1(N). i.e. compounds of formula I, wherein R1 is R1(i) or R1 (ii), i.e. any one of options (i) or (ii) as defined above. In other words and in view of the definition of compounds of formula I.La-R1(i) provided above , it is particularly preferred according to the present invention that the compounds of formula I are compounds of formula I.R (i) or compounds of formula I.La-R1(i), i.e. compounds of formula I, wherein R1 is R1(i) or La-R1(i), wherein La and R1(i) are as defined above.
In view of the above, the invention preferably relates to compounds of formula I,
• wherein T is O, U is CH, RP1, RP2 and RP3 are H and R1 is R1(i), i.e. compounds of formula IM .A.R (i); • wherein T is O, U is CH, RP1, RP2 and RP3 are H and R1 is R1 (ii), i.e. compounds of formula IM .A.R (ii).
Furthermore, the invention preferably relates to compounds of formula I
• wherein T is O, U is N, RP1, RP2 and RP3 are H and R1 is R1(i), i.e. compounds of formu- la IM .B.R (i);
wherein T is O, U is N, RP1, RP2 and RP3 are H and R1 is R1 (ii), i.e. compounds of formula IM .B.R (ii).
Figure imgf000028_0001
In view of the above definition that R (ii) may also be referred to as La-R1(i), the compounds of formulae l*.1 .A.R1(ii) and l*.1 .B.R1(ii) may also be represented by compounds of formulae l*.1 .A.La-R1(i) and l*.1.B.La-R1(i) as depicted below.
Figure imgf000028_0002
In particular with a view to their use, preference is given to the compounds of the formula I compiled in the tables below, which compounds correspond to the formula 1.1 , in particular compounds of formulae IM .A.R1(i), l*.1.B.R1(i), l*.1.A.R1(N), and IM .B.R (ii), respectively (tables 1 to 6 cover compounds of formula .1 .A.R1(i) and formula .1 .B. R1(i), tables 7 to 18 cover compounds of formula l*.1 .A.R1(ii) and formula .1 .B.R1(ii), which correspond to compounds of formula .1 .A.La-R1(i) and formula .1 .B.La-R1(i), respectively). Each of the groups mentioned for a substituent in the tables is furthermore per se, independently of the combination in which it is mentioned, a particularly preferred aspect of the substituent in question.
Table 1
Compounds of the formula IM .A.R1(i), in which R2 is CH3, R3 is H, and the combination of R1(i) and R4 for a compound corresponds in each case to one row of Table A
Table 2
Compounds of the formula IM .A. R1(i), in which R2 is CF2H, R3 is H, and the combination of R1(i) and R4 for a compound corresponds in each case to one row of Table A
Table 3
Compounds of the formula IM .A. R1(i), in which R2 is CF3, R3 is H, and the combination of R1(i) and R4 for a compound corresponds in each case to one row of Table A
Table 4
Compounds of the formula IM .B. R1(i), in which R2 is CH3, R3 is H and the combination of R1(i) and R4 for a compound corresponds in each case to one row of Table A Table 5
Compounds of the formula IM .B. R1(i), in which R2 is CF2H, R3 is H, and the combination of R1(i) and R4 for a compound corresponds in each case to one row of Table A
Table 6
Compounds of the formula IM .B. R1(i), in which R2 is CF3, R3 is H, and the combination of R1(i) and R4 for a compound corresponds in each case to one row of Table A
Table 7
Compounds of the formula IM .A.R1(ii), in which R1(ii) is La-R1(i), R2 is CH3, R3 is H, La is CH2, and the combination of R1(i) and R4 for a compound corresponds in each case to one row of Table A
Table 8
Compounds of the formula IM .A. R1(ii), in which R1(ii) is La-R1(i), R2 is CF2H, R3 is H, La is CH2, and the combination of R1(i) and R4 for a compound corresponds in each case to one row of Table A
Table 9
Compounds of the formula IM .A. R1(ii), in which R1(ii) is La-R1(i), R2 is CF3, R3 is H, La is CH2, and the combination of R1(i) and R4 for a compound corresponds in each case to one row of Table A
Table 10
Compounds of the formula IM .B. R1(ii), in which R1(ii) is La-R1(i), R2 is CH3, R3 is H, La is CH2, and the combination of R1(i) and R4 for a compound corresponds in each case to one row of Table A
Table 1 1
Compounds of the formula IM .B. R1(ii), in which R1(ii) is La-R1(i), R2 is CF2H, R3 is H, La is CH2, and the combination of R1(i) and R4 for a compound corresponds in each case to one row of Table A
Table 12
Compounds of the formula IM .B. R1(ii), in which R1(ii) is La-R1(i), R2 is CF3, R3 is H, La is CH2, and the combination of R1(i) and R4 for a compound corresponds in each case to one row of Table A
Table 13
Compounds of the formula IM .A.R1(ii), in which R1(ii) is La-R1(i), R2 is CH3, R3 is H, La is CH2CH2, and the combination of R1(i) and R4 for a compound corresponds in each case to one row of Table A
Table 14
Compounds of the formula IM .A. R1(ii), in which R1(ii) is La-R1(i), R2 is CF2H, R3 is H, La is CH2CH2, and the combination of R1(i) and R4 for a compound corresponds in each case to one row of Table A
Table 15
Compounds of the formula IM .A. R1(ii), in which R1(ii) is La-R1(i), R2 is CF3, R3 is H, La is
CH2CH2, and the combination of R1(i) and R4 for a compound corresponds in each case to one row of Table A Table 16
Compounds of the formula l*.1.B. R1(ii), in which R1(ii) is La-R1(i), R2 is CH3, R3 is H, La is CH2CH2, and the combination of R1(i) and R4 for a compound corresponds in each case to one row of Table A
Table 17
Compounds of the formula l*.1.B. R1(ii), in which R1(ii) is La-R1(i), R2 is CF2H, R3 is H, La is CH2CH2, and the combination of R1(i) and R4 for a compound corresponds in each case to one row of Table A
Table 18
Compounds of the formula l*.1.B. R1(ii), in which R1(ii) is La-R1(i), R2 is CF3, R3 is H, La is
CH2CH2, and the combination of R1(i) and R4 for a compound corresponds in each case to one row of Table A
Table A
No. R (i) R4 No. R (i) R4
A-1 R (i)-1 R4-1 A-28 R1(i)-3 R4-6
A-2 R (i)-2 R4-1 A-29 R (i)-4 R4-6
A-3 R1(i)-3 R4-1 A-30 R1(i)-5 R4-6
A-4 R (i)-4 R4-1 A-31 R (i)-1 R4-7
A-5 R1(i)-5 R4-1 A-32 R (i)-2 R4-7
A-6 R (i)-1 R4-2 A-33 R1(i)-3 R4-7
A-7 R (i)-2 R4-2 A-34 R (i)-4 R4-7
A-8 R1(i)-3 R4-2 A-35 R1(i)-5 R4-7
A-9 R (i)-4 R4-2 A-36 R (i)-1 R4-8
A-10 R1(i)-5 R4-2 A-37 R (i)-2 R4-8
A-11 R (i)-1 R4-3 A-38 R1(i)-3 R4-8
A-12 R (i)-2 R4-3 A-39 R (i)-4 R4-8
A-13 R1(i)-3 R4-3 A-40 R1(i)-5 R4-8
A-14 R (i)-4 R4-3 A-41 R (i)-1 R4-9 (m=0)
A-15 R1(i)-5 R4-3 A-42 R (i)-2 R4-9 (m=0)
A-16 R (i)-1 R4-4 A-43 R1(i)-3 R4-9 (m=0)
A-17 R (i)-2 R4-4 A-44 R (i)-4 R4-9 (m=0)
A-18 R1(i)-3 R4-4 A-45 R1(i)-5 R4-9 (m=0)
A-19 R (i)-4 R4-4 A-46 R (i)-1 R4-9 (m=1)
A-20 R1(i)-5 R4-4 A-47 R (i)-2 R4-9 (m=1)
A-21 R (i)-1 R4-5 A-48 R1(i)-3 R4-9 (m=1)
A-22 R (i)-2 R4-5 A-49 R (i)-4 R4-9 (m=1)
A-23 R1(i)-3 R4-5 A-50 R1(i)-5 R4-9 (m=1)
A-24 R (i)-4 R4-5 A-51 R (i)-1 R4-9 (m=2)
A-25 R1(i)-5 R4-5 A-52 R (i)-2 R4-9 (m=2)
A-26 R (i)-1 R4-6 A-53 R1(i)-3 R4-9 (m=2)
A-27 R (i)-2 R4-6 A-54 R (i)-4 R4-9 (m=2)
Figure imgf000031_0001
Figure imgf000032_0001
Figure imgf000033_0001
wherein the groups mentioned for R1(i) have the following meanings
R1(i)-3,
Figure imgf000033_0002
wherein, for the compounds of formula .1 .Α. R1(i) and the compounds of formula .1 .Β. R1(i), § designates the bond to the nitrogen atom to which R1(i) is attached, and
wherein, for the compounds of formula .1 .Α. R1(ii) and the compounds of formula .1 .Β. R1 (ii), which correspond to compounds of formula l*.1.A.La-R1(i) and compounds of formula l*.1.B.La- R1(i), respectively, § designates the bond to La via which R1(i) is attached to the nitrogen atom; and wherein the groups mentioned for R4 have the following meanings
Figure imgf000034_0001
wherein #, in each case, designates the bond to the pyrazole moiety. The present invention also relates to a mixture of at least one compound of the present invention with at least one mixing partner as defined herein after. Preferred are binary mixtures of one compound of the present invention as component I with one mixing partner as defined herein after as component II. Preferred weight ratios for such binary mixtures are from 5000:1 to 1 :5000, preferably from 1000:1 to 1 :1000, more preferably from 100:1 to 1 :100, particularly preferably from 10:1 to 1 :10. In such binary mixtures, components I and II may be used in equal amounts, or an excess of component I, or an excess of component II may be used.
Mixing partners can be selected from pesticides, in particular insecticides, nematicides, and acaricides, fungicides, herbicides, plant growth regulators, fertilizers, and the like. Preferred mixing partners are insecticides, nematicides and fungicides.
The following list M of pesticides, grouped and numbered according the Mode of Action Classification of the Insecticide Resistance Action Committee (IRAC), together with which the compounds of the present invention can be used and with which potential synergistic effects might be produced, is intended to illustrate the possible combinations, but not to impose any limitation: M.1 Acetylcholine esterase (AChE) inhibitors from the class of: M.1A carbamates, for example aldicarb, alanycarb, bendiocarb, benfuracarb, butocarboxim, butoxycarboxim, carbaryl, carbofu- ran, carbosulfan, ethiofencarb, fenobucarb, formetanate, furathiocarb, isoprocarb, methiocarb, methomyl, metolcarb, oxamyl, pirimicarb, propoxur, thiodicarb, thiofanox, trimethacarb, XMC, xylylcarb and triazamate; or from the class of M.1 B organophosphates, for example acephate, azamethiphos, azinphos-ethyl, azinphosmethyl, cadusafos, chlorethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos/ DDVP, dicrotophos, dimethoate, dimethylvinphos, disulfoton, EPN, ethion, ethoprophos, famphur, fenamiphos, fenitrothion, fenthion, fosthiazate, heptenophos, imicyafos, isofenphos, isopropyl O- (methoxyaminothio-phosphoryl) salicylate, isoxathion, malathion, me- carbam, methamidophos, methidathion, mevinphos, monocrotophos, naled, omethoate, oxyde- meton-methyl, parathion, parathion-methyl, phenthoate, phorate, phosalone, phosmet, phos- phamidon, phoxim, pirimiphos- methyl, profenofos, propetamphos, prothiofos, pyraclofos, pyri- daphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiome- ton, triazophos, trichlorfon and vamidothion;
M.2. GABA-gated chloride channel antagonists such as: M.2A cyclodiene organochlorine compounds, as for example endosulfan or chlordane; or M.2B fiproles (phenylpyrazoles), as for example ethiprole, fipronil, flufiprole, pyrafluprole and pyriprole;
M.3 Sodium channel modulators from the class of M.3A pyrethroids, for example acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin S- cylclopentenyl, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda- cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, theta- cypermethrin, zeta-cypermethrin, cyphenothrin, deltamethrin, empenthrin, esfenvalerate, eto- fenprox, fenpropathrin, fenvalerate, flucythrinate, flumethrin, tau-fluvalinate, halfenprox, hepta- fluthrin, imiprothrin, meperfluthrin,metofluthrin, momfluorothrin, permethrin, phenothrin, pral- lethrin, profluthrin, pyrethrin (pyrethrum), resmethrin, silafluofen, tefluthrin, tetramethylfluthrin, tetramethrin, tralomethrin and transfluthrin; or M.3B sodium channel modulators such as DDT or methoxychlor; M.4 Nicotinic acetylcholine receptor agonists (nAChR) from the class of M.4A neonicotinoids, for example acetamiprid, clothianidin, cycloxaprid, dinotefuran, imidacloprid, nitenpyram, thia- cloprid and thiamethoxam; or the compounds M.4A.2: (2E-)-1 -[(6-Chloropyridin-3-yl)methyl]-N'- nitro-2-pentylidenehydrazinecarboximidamide; or M4.A.3: 1 -[(6-Chloropyridin-3-yl)methyl]-7- methyl-8-nitro-5-propoxy-1 ,2,3,5,6,7-hexahydroimidazo[1 ,2-a]pyridine; or from the class M.4B nicotine;
M.5 Nicotinic acetylcholine receptor allosteric activators from the class of spinosyns, for example spinosad or spinetoram;
M.6 Chloride channel activators from the class of avermectins and milbemycins, for example abamectin, emamectin benzoate, ivermectin, lepimectin or milbemectin;
M.7 Juvenile hormone mimics, such as M.7A juvenile hormone analogues as hydroprene, ki- noprene and methoprene; or others as M.7B fenoxycarb or M.7C pyriproxyfen;
M.8 miscellaneous non-specific (multi-site) inhibitors, for example M.8A alkyl halides as methyl bromide and other alkyl halides, or M.8B chloropicrin, or M.8C sulfuryl fluoride, or M.8D borax, or M.8E tartar emetic;
M.9 Selective homopteran feeding blockers, for example M.9B pymetrozine, or M.9C floni- camid;
M.10 Mite growth inhibitors, for example M.10A clofentezine, hexythiazox and diflovidazin, or M.10B etoxazole;
M.1 1 Microbial disruptors of insect midgut membranes, for example bacillus thuringiensis or bacillus sphaericus and the insecticdal proteins they produce such as bacillus thuringiensis subsp. israelensis, bacillus sphaericus, bacillus thuringiensis subsp. aizawai, bacillus thuringiensis subsp. kurstaki and bacillus thuringiensis subsp. tenebrionis, or the Bt crop proteins: CrylAb, CrylAc, Cryl Fa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb and Cry34/35Ab1 ;
M.12 Inhibitors of mitochondrial ATP synthase, for example M.12A diafenthiuron, or M.12B or- ganotin miticides such as azocyclotin, cyhexatin or fenbutatin oxide, or M.12C propargite, or M.12D tetrad if on;
M.13 Uncouplers of oxidative phosphorylation via disruption of the proton gradient, for example chlorfenapyr, DNOC or sulfluramid;
M.14 Nicotinic acetylcholine receptor (nAChR) channel blockers, for example nereistoxin analogues as bensultap, cartap hydrochloride, thiocyclam or thiosultap sodium;
M.15 Inhibitors of the chitin biosynthesis type 0, such as benzoylureas as for example bistrifluron, chlorfluazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron or triflumuron;
M.16 Inhibitors of the chitin biosynthesis type 1 , as for example buprofezin;
M.17 Moulting disruptors, Dipteran, as for example cyromazine;
M.18 Ecdyson receptor agonists such as diacylhydrazines, for example methoxyfenozide, te- bufenozide, halofenozide, fufenozide or chromafenozide;
M.19 Octopamin receptor agonists, as for example amitraz;
M.20 Mitochondrial complex III electron transport inhibitors, for example M.20A hydramethyl- non, or M.20B acequinocyl, or M.20C fluacrypyrim; M.21 Mitochondrial complex I electron transport inhibitors, for example M.21 A METI acaricides and insecticides such as fenazaquin, fenpyroximate, pyrimidifen, pyridaben, tebufenpyrad or tolfenpyrad, or M.21 B rotenone;
M.22 Voltage-dependent sodium channel blockers, for example M.22A indoxacarb, or M.22B metaflumizone, or M.22B.1 : 2-[2-(4-Cyanophenyl)-1 -[3-(trifluoromethyl)phenyl]ethylidene]-N-[4- (difluoromethoxy)phenyl]-hydrazinecarboxamide or M.22B.2: N-(3-Chloro-2-methylphenyl)-2-[(4- chlorophenyl)[4-[methyl(methylsulfonyl)amino]phenyl]methylene]-hydrazinecarboxamide;
M.23 Inhibitors of the of acetyl CoA carboxylase, such as Tetronic and Tetramic acid derivatives, for example spirodiclofen, spiromesifen or spirotetramat;
M.24 Mitochondrial complex IV electron transport inhibitors, for example M.24A phosphine such as aluminium phosphide, calcium phosphide, phosphine or zinc phosphide, or M.24B cyanide;
M.25 Mitochondrial complex II electron transport inhibitors, such as beta-ketonitrile derivatives, for example cyenopyrafen or cyflumetofen;
M.28 Ryanodine receptor-modulators from the class of diamides, as for example flubendia- mide, chlorantraniliprole (rynaxypyr®), cyantraniliprole (cyazypyr®), tetraniliprole, or the phtha- lamide compounds M.28.1 : (R)-3-Chlor-N1 -{2-methyl-4-[1 ,2,2,2 -tetrafluor-1 - (trifluormethyl)ethyl]phenyl}-N2-(1 -methyl-2-methylsulfonylethyl)phthalamid and M.28.2: (S)-3- Chlor-N1 -{2-methyl-4-[1 ,2,2,2 -tetrafluor-1 -(trifluormethyl)ethyl]phenyl}-N2-(1 -methyl-2- methylsulfonylethyl)phthalamid, or the compound M.28.3: 3-bromo-N-{2-bromo-4-chloro-6-[(1 - cyclopropylethyl)carbamoyl]phenyl}-1 -(3-chlorpyridin-2-yl)-1 H-pyrazole-5-carboxamide (proposed ISO name: cyclaniliprole), or the compound M.28.4: methyl-2-[3,5-dibromo-2-({[3-bromo- 1 -(3-chlorpyridin-2-yl)-1 H-pyrazol-5-yl]carbonyl}amino)benzoyl]-1 ,2- dimethylhydrazinecarboxylate; or a compound selected from M.28.5a) to M.28.5d) and M.28.5h) to M.28.5I): M.28.5a) N-[4,6-dichloro-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2- (3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; M.28.5b) N-[4-chloro-2-[(diethyl- lambda-4-sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5- (trifluoromethyl)pyrazole-3-carboxamide; M.28.5c) N-[4-chloro-2-[(di-2-propyl-lambda-4- sulfanylidene)carbamoyl]-6-methyl-phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3- carboxamide; M.28.5d) N-[4,6-dichloro-2-[(di-2-propyl-lambda-4-sulfanylidene)carbamoyl]- phenyl]-2-(3-chloro-2-pyridyl)-5-(trifluoromethyl)pyrazole-3-carboxamide; M.28.5h) N-[4,6- dibromo-2-[(diethyl-lambda-4-sulfanylidene)carbamoyl]-phenyl]-2-(3-chloro-2-pyridyl)-5- (trifluoromethyl)pyrazole-3-carboxamide; M.28.5i) N-[2-(5-Amino-1 ,3,4-thiadiazol-2-yl)-4-chloro- 6-methylphenyl]-3-bromo-1 -(3-chloro-2-pyridinyl)-1 H-pyrazole-5-carboxamide; M.28.5j) 3- Chloro-1 -(3-chloro-2-pyridinyl)-N-[2,4-dichloro-6-[[(1 -cyano-1 - methylethyl)amino]carbonyl]phenyl]-1 H-pyrazole-5-carboxamide; M.28.5k) 3-Bromo-N-[2,4- dichloro-6-(methylcarbamoyl)phenyl]-1 -(3,5-dichloro-2-pyridyl)-1 H-pyrazole-5-carboxamide; M.28.5I) N-[4-Chloro-2-[[(1 ,1 -dimethylethyl)amino]carbonyl]-6-methylphenyl]-1 -(3-chloro-2- pyridinyl)-3-(fluoromethoxy)-1 H-pyrazole-5-carboxamide; or a compound selected from M.28.6: N-(2-cyanopropan-2-yl)-N-(2,4-dimethylphenyl)-3-iodobenzene-1 ,2-dicarboxamide; or M.28.7: 3-Chloro-N-(2-cyanopropan-2-yl)-N-(2,4-dimethylphenyl)-benzene-1 ,2-dicarboxamide;
M.29. insecticidal active compounds of unknown or uncertain mode of action, as for example afidopyropen, afoxolaner, azadirachtin, amidoflumet, benzoximate, bifenazate, broflanilide, bromopropylate, chinomethionat, cryolite, dicloromezotiaz, dicofol, flufenerim, flometoquin, flu- ensulfone, fluhexafon, fluopyram, flupyradifurone, fluralaner, metoxadiazone, piperonyl butox- ide, pyflubumide, pyridalyl, pyrifluquinazon, sulfoxaflor, tioxazafen, triflumezopyrim, or the compounds
M.29.3: 1 1 -(4-chloro-2,6-dimethylphenyl)-12-hydroxy-1 ,4-dioxa-9-azadispiro[4.2.4.2]-tetradec- 1 1 -en-10-one, or the compound
M.29.4: 3-(4'-fluoro-2,4-dimethylbiphenyl-3-yl)-4-hydroxy-8-oxa-1 -azaspiro[4.5]dec-3-en-2-one, or the compound
M.29.5: 1 -[2-fluoro-4-methyl-5-[(2,2,2-trifluoroethyl)sulfinyl]phenyl]-3-(trifluoromethyl)-1 H-1 ,2,4- triazole-5-amine, or actives on basis of bacillus firmus (Votivo, 1-1582); or
a compound selected from the group of M.29.6, wherein the compound is selected from M.29.6a) to M.29.6k): M.29.6a) (E/Z)-N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2- trifluoro-acetamide; M.29.6b) (E/Z)-N-[1 -[(6-chloro-5-fluoro-3-pyridyl)methyl]-2-pyridylidene]- 2,2,2-trifluoro-acetamide; M.29.6c) (E/Z)-2,2,2-trifluoro-N-[1 -[(6-fluoro-3-pyridyl)methyl]-2- pyridylidene]acetamide; M.29.6d) (E/Z)-N-[1 -[(6-bromo-3-pyridyl)methyl]-2-pyridylidene]-2,2,2- trifluoro-acetamide; M.29.6e) (E/Z)-N-[1 -[1 -(6-chloro-3-pyridyl)ethyl]-2-pyridylidene]-2,2,2- trifluoro-acetamide; M.29.6f) (E/Z)-N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro- acetamide; M.29.6g) (E/Z)-2-chloro-N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2-difluoro- acetamide; M.29.6h) (E/Z)-N-[1 -[(2-chloropyrimidin-5-yl)methyl]-2-pyridylidene]-2,2,2-trifluoro- acetamide; M.29.6i) (E/Z)-N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,3,3,3-pentafluoro- propanamide.); M.29.6j) N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro- thioacetamide; or M.29.6k) N-[1 -[(6-chloro-3-pyridyl)methyl]-2-pyridylidene]-2,2,2-trifluoro-N'- isopropyl-acetamidine; or the compounds
M.29.8: 8-chloro-N-[2-chloro-5-methoxyphenyl)sulfonyl]-6-trifluoromethyl)-imidazo[1 ,2- a]pyridine-2-carboxamide; or the compounds
M.29.9.a): 4-[5-(3,5-dichlorophenyl)-5-(trifluoromethyl)-4H-isoxazol-3-yl]-2-methyl-N-(1 - oxothietan-3-yl)benzamide; or M.29.9.b): 4-[5-(3,5-Dichlorophenyl)-5-trifluoromethyl-4,5- dihydroisoxazol-3-yl]-N-[(methoxyimino)methyl]-2-methylbenzamide; or
M.29.10: 5-[3-[2,6-dichloro-4-(3,3-dichloroallyloxy)phenoxy]propoxy]-1 H-pyrazole; or a compound selected from the group of M.29.1 1 , wherein the compound is selected from M.29.1 1 b) to M.29.1 1 p): M.29.1 1.b) 3-(benzoylmethylamino)-N-[2-bromo-4-[1 , 2,2,3,3,3- hexafluoro-1 -(trifluoromethyl)propyl]-6-(trifluoromethyl)phenyl]-2-fluoro-benzamide; M.29.1 1.c)
3- (benzoylmethylamino)-2-fluoro-N-[2-iodo-4-[1 ,2,2,2-tetrafluoro-1 -(trifluoromethyl)ethyl]-6- (trifluoromethyl)phenyl]-benzamide; M.29.1 1 .d) N-[3-[[[2-iodo-4-[1 ,2,2,2-tetrafluoro-1 - (trifluoromethyl)ethyl]-6-(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide; M.29.1 1 .e) N-[3-[[[2-bromo-4-[1 ,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]-6- (trifluoromethyl)phenyl]amino]carbonyl]-2-fluorophenyl]-4-fluoro-N-methyl-benzamide; M.29.1 1 .f)
4- fluoro-N-[2-fluoro-3-[[[2-iodo-4-[1 ,2,2,2-tetrafluoro-1 -(trifluoromethyl)ethyl]-6- (trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide; M.29.1 1 .g) 3-fluoro-N-[2- fluoro-3-[[[2-iodo-4-[1 ,2,2,2-tetrafluoro-1 -(trifluoromethyl)ethyl]-6-
(trifluoromethyl)phenyl]amino]carbonyl]phenyl]-N-methyl-benzamide; M.29.1 1 .h) 2-chloro-N-[3- [[[2-iodo-4-[1 ,2,2,2-tetrafluoro-1 -(trifluoromethyl)ethyl]-6-
(trifluoromethyl)phenyl]amino]carbonyl]phenyl]- 3-pyridinecarboxamide; M.29.1 1 .i) 4-cyano-N- [2-cyano-5-[[2,6-dibromo-4-[1 ,2,2,3,3,3-hexafluoro-1 -(trifluoromethyl)- propyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide; M.29.1 1 .j) 4-cyano-3-[(4-cyano-2-methyl- benzoyl)amino]-N-[2,6-dichloro-4-[1 ,2,2,3,3,3-hexafluoro-1 -(trifluoromethyl)propyl]phenyl]-2- fluoro-benzamide; M.29.1 1.k) N-[5-[[2-chloro-6-cyano-4-[1 ,2,2,3,3,3-hexafluoro-1 - (trifluoromethyl)propyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide;
M.29.1 1 .1) N-[5-[[2-bromo-6-chloro-4-[2,2,2-trifluoro-1 -hydroxy-1 - (trifluoromethyl)ethyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide;
M.29.1 1 .m) N-[5-[[2-bromo-6-chloro-4-[1 ,2,2,3,3,3-hexafluoro-1 -(trifluoromethyl)- propyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; M.29.1 1 .n) 4-cyano-N- [2-cyano-5-[[2,6-dichloro-4-[1 ,2,2,3,3,3-hexafluoro-1 -(trifluoromethyl)- propyl]phenyl]carbamoyl]phenyl]-2-methyl-benzamide; M.29.1 1.o) 4-cyano-N-[2-cyano-5-[[2,6- dichloro-4-[1 ,2,2,2-tetrafluoro-1 -(trifluoromethyl)ethy^
benzamide; M.29.1 1 .p) N-[5-[[2-bromo-6-chloro-4-[1 ,2,2,2-tetrafluoro-1 -
(trifluoromethyl)ethyl]phenyl]carbamoyl]-2-cyano-phenyl]-4-cyano-2-methyl-benzamide; or a compound selected from the group of M.29.12, wherein the compound is selected from M.29.12a) to M.29.12m): M.29.12.a) 2-(1 ,3-Dioxan-2-yl)-6-[2-(3-pyridinyl)-5-thiazolyl]-pyridine; M.29.12. b) 2-[6-[2-(5-Fluoro-3-pyridinyl)-5-thiazolyl]-2-pyridinyl]-pyrimidine; M.29.12. c) 2-[6-[2- (3-Pyridinyl)-5-thiazolyl]-2-pyridinyl]-pyrimidine; M.29.12.d) N-Methylsulfonyl-6-[2-(3- pyridyl)thiazol-5-yl]pyridine-2-carboxamide; M.29.12. e) N-Methylsulfonyl-6-[2-(3-pyridyl)thiazol- 5-yl]pyridine-2-carboxamide; M.29.12.f) N-Ethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3- methylthio-propanamide; M.29.12. g) N-Methyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3- methylthio-propanamide; M.29.12. h) N,2-Dimethyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3- methylthio-propanamide; M.29.12. i) N-Ethyl-2-methyl-N-[4-methyl-2-(3-pyridyl)thiazol-5-yl]-3- methylthio-propanamide; M.29.12J) N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-ethyl-2-methyl-3- methylthio-propanamide; M.29.12. k) N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N,2-dimethyl-3- methylthio-propanamide; M.29.12.1) N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-methyl-3-methylthio- propanamide; M.29.12. m) N-[4-Chloro-2-(3-pyridyl)thiazol-5-yl]-N-ethyl-3-methylthio- propanamide; or the compounds
M.29.14a) 1 -[(6-Chloro-3-pyridinyl)methyl]-1 ,2,3,5, 6,7-hexahydro-5-methoxy-7-methyl-8-nitro- imidazo[1 ,2-a]pyridine; or M.29.14b) 1 -[(6-Chloropyridin-3-yl)methyl]-7-methyl-8-nitro- 1 ,2,3,5,6,7-hexahydroimidazo[1 ,2-a]pyridin-5-ol; or the compounds
M.29.16a) 1 -isopropyl-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; or M.29.16b) 1 - (1 ,2-dimethylpropyl)-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide; M.29.16c) N,5- dimethyl-N-pyridazin-4-yl-1 -(2,2,2-trifluoro-1 -methyl-ethyl)pyrazole-4-carboxamide; M.29.16d) 1 - [1 -(1 -cyanocyclopropyl)ethyl]-N-ethyl-5-methyl-N-pyridazin-4-yl-pyrazole-4-carboxamide;
M.29.16e) N-ethyl-1 -(2-fluoro-1 -methyl-propyl)-5-methyl-N-pyridazin-4-yl-pyrazole-4- carboxamide; M.29.16f) 1 -(1 ,2-dimethylpropyl)-N,5-dimethyl-N-pyridazin-4-yl-pyrazole-4- carboxamide; M.29.16g) 1 -[1 -(1 -cyanocyclopropyl)ethyl]-N,5-dimethyl-N-pyridazin-4-yl-pyrazole- 4-carboxamide; M.29.16h) N-methyl-1 -(2-fluoro-1-methyl-propyl]-5-methyl-N-pyridazin-4-yl- pyrazole-4-carboxamide; M.29.16i) 1 -(4,4-difluorocyclohexyl)-N-ethyl-5-methyl-N-pyridazin-4-yl- pyrazole-4-carboxamide; or M.29.16j) 1 -(4,4-difluorocyclohexyl)-N,5-dimethyl-N-pyridazin-4-yl- pyrazole-4-carboxamide. The commercially available compounds of the group M listed above may be found in The Pesticide Manual, 16th Edition, C. MacBean, British Crop Protection Council (2013) among other publications. The online Pesticide Manual is updated regularly and is accessible through http://bcpcdata.com/pesticide-manual.html.
Another online data base for pesticides providing the ISO common names is
http://www.alanwood.net/pesticides.
The M.4 neonicotinoid cycloxaprid is known from WO2010/069266 and WO201 1/069456, the neonicotinoid M.4A.2, sometimes also to be named as guadipyr, is known from
WO2013/003977, and the neonicotinoid M.4A.3 (approved as paichongding in China) is known from WO2007/101369. The metaflumizone analogue M.22B.1 is described in CN 10171577 and the analogue M.22B.2 in CN102126994. The phthalamides M.28.1 and M.28.2 are both known from WO2007/101540. The anthranilamide M.28.3 is described in WO2005/077934. The hydrazide compound M.28.4 is described in WO2007/043677. The anthranilamides M.28.5a) to M.28.5d) and M.28.5h) are described in WO 2007/006670, WO2013/024009 and
WO2013/024010, the anthranilamide Μ.28.5Ϊ) is described in WO201 1/085575, M.28.5j) in WO2008/134969, M.28.5k) in US201 1/046186 and M.28.5I) in WO2012/034403. The diamide compounds M.28.6 and M.28.7 can be found in CN102613183. The spiroketal-substituted cyclic ketoenol derivative M.29.3 is known from WO2006/089633 and the biphenyl-substituted spirocyclic ketoenol derivative M.29.4 from WO2008/06791 1. The triazoylphenylsulfide M.29.5 is described in WO2006/043635, and biological control agents on the basis of bacillus firmus are described in WO2009/124707. The compounds M.29.6a) to Μ.29.6Ϊ) listed under M.29.6 are described in WO2012/029672, and M.29.6j) and M.29.6k) in WO2013/129688. The nematicide M.29.8 is known from WO2013/055584. The isoxazoline M.29.9.a) is described in
WO2013/050317. The isoxazoline M.29.9.b) is described in WO2014/126208. The pyridalyl- type analogue M.29.10 is known from WO2010/060379. The carboxamides broflanilide and
M.29.1 1.b) to M.29.1 1 .h) are described in WO2010/018714, and the carboxamides M.29.1 1 i) to M.29.1 1 .P) in WO2010/127926. The pyridylthiazoles M.29.12.a) to M.29.12.C) are known from WO2010/006713, M.29.12.d) and M.29.12.e) are known from WO2012/000896, and M.29.12.†) to M.29.12.m) from WO2010/129497. The compounds M.29.14a) and M.29.14b) are known from WO2007/101369. The pyrazoles M.29.16.a) to M.29.16h) are described in
WO2010/034737, WO2012/084670, and WO2012/143317, respectively, and the pyrazoles Μ.29.16Ϊ) and M.29.16j) are described in US 61/891437.
The following list of fungicides, in conjunction with which the compounds of the present invention can be used, is intended to illustrate the possible combinations but does not limit them: A) Respiration inhibitors
Inhibitors of complex III at Q0 site (e. g. strobilurins): azoxystrobin (A.1 .1 ), coumethoxy- strobin (A.1.2), coumoxystrobin (A.1 .3), dimoxystrobin (A.1.4), enestroburin (A.1 .5),
fenaminstrobin (A.1.6), fenoxystrobin/flufenoxystrobin (A.1 .7), fluoxastrobin (A.1 .8), kresoxim- methyl (A.1 .9), mandestrobin (A.1.10), metominostrobin (A.1.1 1 ), orysastrobin (A.1.12), picoxy- .strobin (A.1.13), pyraclostrobin (A.1 .14), pyrametostrobin (A.1 .15), pyraoxystrobin (A.1 .16), trifloxystrobin (A.1.17), 2-(2-(3-(2,6-dichlorophenyl)-1 -methyl-allylideneaminooxymethyl)- phenyl)-2-methoxyimino-N-methyl-acetamide (A.1.18), pyribencarb (A.1.19),
triclopyricarb/chlorodincarb (A.1.20), famoxadone (A.1.21 ), fenamidone (A.1.21 ), methyl-A/-[2- [(1 ,4-dimethyl-5-phenyl-pyrazol-3-yl)oxylmethyl]phenyl]-N-methoxy-carbamate (A.1 .22), 1 -[3- chloro-2-[[1 -(4-chlorophenyl)-1 H-pyrazol-3-yl]oxymethyl]phenyl]-4-methyl-tetrazol-5-one
(A.1.23), 1 -[3-bromo-2-[[1 -(4-chlorophenyl)pyrazol-3-yl]oxymethyl]phenyl]-4-methyl-tetrazol-5- one (A.1.24), 1 -[2-[[1 -(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-methyl-phenyl]-4-methyl- tetrazol-5-one (A.1 .25), 1 -[2-[[1 -(4-chlorophenyl)pyrazol-3-yl]oxymethyl]-3-fluoro-phenyl]-4- methyl-tetrazol-5-one (A.1 .26), 1 -[2-[[1 -(2,4-dichlorophenyl)pyrazol-3-yl]oxymethyl]-3-fluoro- phenyl]-4-methyl-tetrazol-5-one (A.1 .27), 1 -[2-[[4-(4-chlorophenyl)thiazol-2-yl]oxymethyl]-3- methyl-phenyl]-4-methyl-tetrazol-5-one (A.1.28), 1-[3-chloro-2-[[4-(p-tolyl)thiazol-2- yl]oxymethyl]phenyl]-4-methyl-tetrazol-5-one (A.1 .29), 1 -[3-cyclopropyl-2-[[2-methyl-4-(1 - methylpyrazol-3-yl)phenoxy]methyl]phenyl]-4-methyl-tetrazol-5-one (A.1 .30), 1 -[3-
(difluoromethoxy)-2-[[2-methyl-4-(1 -methylpyrazol-3-yl)phenoxy]methyl]phenyl]-4-methyl- tetrazol-5-one (A.1 .31 ), 1 -methyl-4-[3-methyl-2-[[2-methyl-4-(1 -methylpyrazol-3- yl)phenoxy]methyl]phenyl]tetrazol-5-one (A.1 .32), 1 -methyl-4-[3-methyl-2-[[1 -[3- (trifluoromethyl)phenyl]-ethylideneamino]oxymethyl]phenyl]tetrazol-5-one (A.1 .33), (Z,2E)-5-[1 - (2,4-dichlorophenyl)pyrazol-3-yl]-oxy-2-methoxyimino-A/,3-dimethyl-pent-3-enamide (A.1.34), (Z,2E)-5-[1 -(4-chlorophenyl)pyrazol-3-yl]oxy-2-methoxyimino-A/,3-dimethyl-pent-3-enam^ (A.1.35), (Z,2E)-5-[1 -(4-chloro-2-fluoro-phenyl)pyrazol-3-yl]oxy-2-methoxyimino-A/,3-dimethyl- pent-3-enamide (A.1.36),
inhibitors of complex III at Qi site: cyazofamid (A.2.1 ), amisulbrom (A.2.2), [(3S,6S,7R,8R)- 8-benzyl-3-[(3-acetoxy-4-methoxy-pyridine-2-carbonyl)amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan- 7-yl] 2-methylpropanoate (A.2.3), [(3S,6S,7R,8R)-8-benzyl-3-[[3-(acetoxymethoxy)-4-methoxy- pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate (A.2.4), [(3S,6S,7R,8R)-8-benzyl-3-[(3-isobutoxycarbonyloxy-4-methoxy-pyridine-2-carbonyl)amino]-6- methyl-4,9-dioxo-1 ,5-dioxonan-7-yl] 2-methylpropanoate (A.2.5), [(3S,6S,7R,8R)-8-benzyl-3-[[3- (1 ,3-benzodioxol-5-ylmethoxy)-4-methoxy-pyridine-2-carbonyl]amino]-6-methyl-4,9-dioxo-1 ,5- dioxonan-7-yl] 2-methylpropanoate (A.2.6); (3S,6S,7R,8R)-3-[[(3-hydroxy-4-methoxy-2- pyridinyl)carbonyl]amino]-6-methyl-4,9-dioxo-8-(phenylmethyl)-1 ,5-dioxonan-7-yl 2- methylpropanoate (A.2.7), (3S,6S,7R,8R)-8-benzyl-3-[3-[(isobutyryloxy)methoxy]-4- methoxypicolinamido]-6-methyl-4,9-dioxo-1 ,5-dioxonan-7-yl isobutyrate (A.2.8);
- inhibitors of complex II (e. g. carboxamides): benodanil (A.3.1 ), benzovindiflupyr (A.3.2), bixafen (A.3.3), boscalid (A.3.4), carboxin (A.3.5), fenfuram (A.3.6), fluopyram (A.3.7), flutolanil (A.3.8), fluxapyroxad (A.3.9), furametpyr (A.3.10), isofetamid (A.3.1 1 ), isopyrazam (A.3.12), mepronil (A.3.13), oxycarboxin (A.3.14), penflufen (A.3.14), penthiopyrad (A.3.15), sedaxane (A.3.16), tecloftalam (A.3.17), thifluzamide (A.3.18), N-(4'-trifluoromethylthiobiphenyl-2-yl)- 3-difluoromethyl-1 -methyl-1 H-pyrazole-4-carboxamide (A.3.19), N-(2-(1 ,3,3-trimethyl-butyl)- phenyl)-1 ,3-dimethyl-5-fluoro-1 H-pyrazole-4-carboxamide (A.3.20), 3-(difluoromethyl)-1 -methyl- N-(1 ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide (A.3.21 ), 3-(trifluoromethyl)-1 -methyl-Nil ,1 ,3-trimethylindan-4-yl)pyrazole-4-carboxamide (A.3.22), 1 ,3-dimethyl-N-(1 ,1 ,3- trimethylindan-4-yl)pyrazole-4-carboxamide (A.3.23), 3-(trifluoromethyl)-1 ,5-dimethyl-N-(1 ,1 ,3- trimethylindan-4-yl)pyrazole-4-carboxamide (A.3.24), 1 ,3,5-trimethyl-N-(1 ,1 ,3-trimethylindan-4- yl)pyrazole-4-carboxamide (A.3.25), N-(7-fluoro-1 ,1 ,3-trimethyl-indan-4-yl)-1 ,3-dimethyl- pyrazole-4-carboxamide (A.3.26), N-[2-(2,4-dichlorophenyl)-2-methoxy-1 -methyl-ethyl]-3- (difluoromethyl)-l -methyl-pyrazole-4-carboxamide (A.3.27); other respiration inhibitors (e. g. complex I, uncouplers): diflumetorim (A.4.1 ), (5,8-difluoro- quinazolin-4-yl)-{2-[2-fluoro-4-(4-trifluoromethylpyridin-2-yloxy)-phenyl]-ethyl}-amine (A.4.2); nitrophenyl derivates: binapacryl (A.4.3), dinobuton (A.4.4), dinocap (A.4.5), fluazinam (A.4.6); ferimzone (A.4.7); organometal compounds: fentin salts, such as fentin-acetate (A.4.8), fentin chloride (A.4.9) or fentin hydroxide (A.4.10); ametoctradin (A.4.1 1 ); and silthiofam (A.4.12);
B) Sterol biosynthesis inhibitors (SBI fungicides)
C14 demethylase inhibitors (DMI fungicides): triazoles: azaconazole (B.1.1 ), bitertanol (B.1.2), bromuconazole (B.1.3), cyproconazole (B.1 .4), difenoconazole (B.1 .5), diniconazole (B.1.6), diniconazole-M (B.1 .7), epoxiconazole (B.1.8), fenbuconazole (B.1.9), fluquinconazole (B.1.10), flusilazole (B.1 .1 1 ), flutriafol (B.1 .12), hexaconazole (B.1.13), imibenconazole (B.1.14), ipconazole (B.1 .15), metconazole (B.1.17), myclobutanil (B.1.18), oxpoconazole (B.1.19), paclobutrazole (B.1.20), penconazole (B.1 .21 ), propiconazole (B.1.22), prothioconazole
(B.1.23), simeconazole (B.1 .24), tebuconazole (B.1.25), tetraconazole (B.1 .26), triadimefon (B.1.27), triadimenol (B.1 .28), triticonazole (B.1 .29), uniconazole (B.1 .30), 1 -[re/-(2S;3R)-3-(2- chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-5-thiocyanato-1 H-[1 ,2,4]triazolo (B.1 .31 ), 2- [re/-(2S;3R)-3-(2-chlorophenyl)-2-(2,4-difluorophenyl)-oxiranylmethyl]-2H-[1 ,2,4]triazole-3-thiol (B.1.32), 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pentan-2-ol (B.1 .33) , 1 -[4- (4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -cyclopropyl-2-(1 ,2,4-triazol-1 -yl)ethanol (B.1.34), 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 -yl)butan-2-ol (B.1.35), 2-[2-chloro-4-(4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)butan-2-ol (B.1.36), 2-[4-(4-chloro- phenoxy)-2-(trifluoromethyl)phenyl]-3-methyl-1 -(1 ,2,4-triazol-1 -yl)butan-2-ol (B.1 .37), 2-[4-(4- chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 -yl)propan-2-ol (B.1 .38), 2-[2-chloro- 4-(4-chlorophenoxy)phenyl]-3-methyl-1 -(1 ,2,4-triazol-1 -yl)butan-2-ol (B.1 .39), 2-[4-(4- chlorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pentan-2-ol (B.1.40), 2-[4-(4- fluorophenoxy)-2-(trifluoromethyl)phenyl]-1 -(1 ,2,4-triazol-1 -yl)propan-2-ol (B.1 .41 ), 2-[2-chloro-
4- (4-chlorophenoxy)phenyl]-1 -(1 ,2,4-triazol-1 -yl)pent-3-yn-2-ol (B.1.51 ); imidazoles: imazalil (B.1.42), pefurazoate (B.1 .43), prochloraz (B.1.44), triflumizol (B.1 .45); pyrimidines, pyridines and piperazines: fenarimol (B.1 .46), nuarimol (B.1 .47), pyrifenox (B.1 .48), triforine (B.1 .49), [3- (4-chloro-2-fluoro-phenyl)-5-(2,4-difluorophenyl)isoxazol-4-yl]-(3-pyridyl)methanol (B.1 .50); - Delta14-reductase inhibitors: aldimorph (B.2.1 ), dodemorph (B.2.2), dodemorph-acetate (B.2.3), fenpropimorph (B.2.4), tridemorph (B.2.5), fenpropidin (B.2.6), piperalin (B.2.7), spiroxamine (B.2.8);
Inhibitors of 3-keto reductase: fenhexamid (B.3.1 );
C) Nucleic acid synthesis inhibitors
- phenylamides or acyl amino acid fungicides: benalaxyl (C.1.1 ), benalaxyl-M (C.1 .2), kiralaxyl (C.1.3), metalaxyl (C.1.4), metalaxyl-M (mefenoxam, C.1 .5), ofurace (C.1.6), oxadixyl (C.1.7);
others: hymexazole (C.2.1 ), octhilinone (C.2.2), oxolinic acid (C.2.3), bupirimate (C.2.4),
5- fluorocytosine (C.2.5), 5-fluoro-2-(p-tolylmethoxy)pyrimidin-4-amine (C.2.6), 5-fluoro-2-(4- fluorophenylmethoxy)pyrimidin-4-amine (C.2.7);
D) Inhibitors of cell division and cytoskeleton
tubulin inhibitors, such as benzimidazoles, thiophanates: benomyl (D1.1 ), carbendazim (D1 .2), fuberidazole (D1.3), thiabendazole (D1 .4), thiophanate-methyl (D1.5); triazolopyrimidines: 5-chloro-7-(4-methylpipendin-1 -yl)-6-(2,4,6-trifluorophenyl)-[1 ,2,4]tri- azolo[1 ,5-a]pyrimidine (D1 .6);
other cell division inhibitors: diethofencarb (D2.1 ), ethaboxam (D2.2), pencycuron (D2.3), fluopicolide (D2.4), zoxamide (D2.5), metrafenone (D2.6), pyriofenone (D2.7);
E) Inhibitors of amino acid and protein synthesis
methionine synthesis inhibitors (anilino-pyrimidines): cyprodinil (E.1 .1 ), mepanipyrim (E.1.2), pyrimethanil (E.1 .3);
protein synthesis inhibitors: blasticidin-S (E.2.1 ), kasugamycin (E.2.2), kasugamycin hy- drochloride-hydrate (E.2.3), mildiomycin (E.2.4), streptomycin (E.2.5), oxytetracyclin (E.2.6), polyoxine (E.2.7), validamycin A (E.2.8);
F) Signal transduction inhibitors
MAP / histidine kinase inhibitors: fluoroimid (F.1 .1 ), iprodione (F.1 .2), procymidone (F.1 .3), vinclozolin (F.1.4), fenpiclonil (F.1.5), fludioxonil (F.1 .6);
G protein inhibitors: quinoxyfen (F.2.1 );
G) Lipid and membrane synthesis inhibitors
Phospholipid biosynthesis inhibitors: edifenphos (G.1.1 ), iprobenfos (G.1 .2), pyrazophos (G.1.3), isoprothiolane (G.1 .4);
lipid peroxidation: dicloran (G.2.1 ), quintozene (G.2.2), tecnazene (G.2.3), tolclofos-methyl (G.2.4), biphenyl (G.2.5), chloroneb (G.2.6), etridiazole (G.2.7);
- phospholipid biosynthesis and cell wall deposition: dimethomorph (G.3.1 ), flumorph
(G.3.2), mandipropamid (G.3.3), pyrimorph (G.3.4), benthiavalicarb (G.3.5), iprovalicarb (G.3.6), valifenalate (G.3.7) and N-(1 -(1 -(4-cyano-phenyl)ethanesulfonyl)-but-2-yl) carbamic acid-(4- fluorophenyl) ester (G.3.8);
compounds affecting cell membrane permeability and fatty acides: propamocarb (G.4.1 ); - fatty acid amide hydrolase inhibitors: oxathiapiprolin (G.5.1 ), 2-{3-[2-(1 -{[3,5-bis(di- fluoromethyl-1 H-pyrazol-1 -yl]acetyl}piperidin-4-yl)-1 ,3-thiazol-4-yl]-4,5-dihydro-1 ,2-oxazol-5- yl}phenyl methanesulfonate (G.5.2), 2-{3-[2-(1 -{[3, 5-bis(difluoromethyl)-1 H-pyrazol-1 - yl]acetyl}piperidin-4-yl) 1 ,3-thiazol-4-yl]-4,5-dihydro-1 ,2-oxazol-5-yl}-3-chlorophenyl
methanesulfonate (G.5.3);
H) Inhibitors with Multi Site Action
inorganic active substances: Bordeaux mixture (H.1.1 ), copper acetate (H.1 .2), copper hydroxide (H.1.3), copper oxychloride (H.1 .4), basic copper sulfate (H.1 .5), sulfur (H.1.6);
thio- and dithiocarbamates: ferbam (H.2.1 ), mancozeb (H.2.2), maneb (H.2.3), metam (H.2.4), metiram (H.2.5), propineb (H.2.6), thiram (H.2.7), zineb (H.2.8), ziram (H.2.9);
- organochlorine compounds (e. g. phthalimides, sulfamides, chloronitriles): anilazine (H.3.1 ), chlorothalonil (H.3.2), captafol (H.3.3), captan (H.3.4), folpet (H.3.5), dichlofluanid (H.3.6), dichlorophen (H.3.7), hexachlorobenzene (H.3.8), pentachlorphenole (H.3.9) and its salts, phthalide (H.3.10), tolylfluanid (H.3.1 1 ), N-(4-chloro-2-nitro-phenyl)-N-ethyl-4-methyl- benzenesulfonamide (H.3.12);
- guanidines and others: guanidine (H.4.1 ), dodine (H.4.2), dodine free base (H.4.3), guazatine (H.4.4), guazatine-acetate (H.4.5), iminoctadine (H.4.6), iminoctadine-triacetate (H.4.7), iminoctadine-tris(albesilate) (H.4.8), dithianon (H.4.9), 2,6-dimethyl-1 H,5H- [1 ,4]dithiino[2,3-c:5,6-c']dipyrrole-1 ,3,5,7(2H,6H)-tetraone (H.4.10); I) Cell wall synthesis inhibitors
inhibitors of glucan synthesis: validamycin (1.1.1 ), polyoxin B (1.1 .2);
melanin synthesis inhibitors: pyroquilon (1.2.1 ), tricyclazole (I.2.2), carpropamid (1.2.3), dicyclomet (1.2.4), fenoxanil (1.2.5);
J) Plant defence inducers
acibenzolar-S-methyl (J.1.1 ), probenazole (J.1 .2), isotianil (J.1 .3), tiadinil (J.1.4), prohexadione-calcium (J.1.5); phosphonates: fosetyl (J.1 .6), fosetyl-aluminum (J.1.7), phosphorous acid and its salts (J.1 .8), potassium or sodium bicarbonate (J.1 .9);
K) Unknown mode of action
- bronopol (K.1.1 ), chinomethionat (K.1.2), cyflufenamid (K.1 .3), cymoxanil (K.1.4), dazomet (K.1.5), debacarb (K.1.6), diclomezine (K.1 .7), difenzoquat (K.1 .8), difenzoquat-methylsulfate (K.1 .9), diphenylamin (K.1.10), fenpyrazamine (K.1 .1 1 ), flumetover (K.1 .12), flusulfamide (K.1.13), flutianil (K.1.14), methasulfocarb (K.1 .15), nitrapyrin (K.1 .16), nitrothal-isopropyl (K.1.18), oxathiapiprolin (K.1 .19), tolprocarb (K.1 .20), oxin-copper (K.1.21 ), proquinazid
(K.1.22), tebufloquin (K.1 .23), tecloftalam (K.1.24), triazoxide (K.1 .25), 2-butoxy-6-iodo-
3-propylchromen-4-one (K.1.26), 2-[3,5-bis(difluoromethyl)-1 H-pyrazol-1 -yl]-1 -[4-(4-{5-[2-(prop- 2-yn-1 -yloxy)phenyl]-4,5-dihydro-1 ,2-oxazol-3-yl}-1 ,3-thiazol-2-yl)piperidin-1 -yl]ethanone (K.1.27), 2-[3,5-bis(difluoromethyl)-1 H-pyrazol-1 -yl]-1 -[4-(4-{5-[2-fluoro-6-(prop-2-yn-1 -yl- oxy)phenyl]-4,5-dihydro-1 ,2-oxazol-3-yl}-1 ,3-thiazol-2-yl)piperidin-1 -yl]ethanone (K.1 .28), 2-[3,5- bis(difluoromethyl)-1 H-pyrazol-1 -yl]-1 -[4-(4-{5-[2-chloro-6-(prop-2-yn-1 -yloxy)phenyl]-4,5- dihydro-1 ,2-oxazol-3-yl}-1 ,3-thiazol-2-yl)piperidin-1 -yl]ethanone (K.1.29), N-(cyclo- propylmethoxyimino-(6-difluoro-methoxy-2,3-difluoro-phenyl)-methyl)-2-phenyl acetamide (K.1.30), N'-(4-(4-chloro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N-methyl formamidine (K.1.31 ), N'-(4-(4-fluoro-3-trifluoromethyl-phenoxy)-2,5-dimethyl-phenyl)-N-ethyl-N- methyl formamidine (K.1.32), N'-(2-methyl-5-trifluoromethyl-4-(3-trimethylsilanyl-propoxy)- phenyl)-N-ethyl-N-methyl formamidine (K.1.33), N'-(5-difluoromethyl-2-methyl-4-(3-tri- methylsilanyl-propoxy)-phenyl)-N-ethyl-N-methyl formamidine (K.1.34), methoxy-acetic acid 6- tert-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester (K.1 .35), 3-[5-(4-methylphenyl)-2,3-dimethyl- isoxazolidin-3-yl]-pyridine (K.1 .36), 3-[5-(4-chloro-phenyl)-2,3-dimethyl-isoxazolidin-3-yl]- pyridine (pyrisoxazole) (K.1.37), N-(6-methoxy-pyridin-3-yl) cyclopropanecarboxylic acid amide (K.1.38), 5-chloro-1 -(4,6-dimethoxy-pyrimidin-2-yl)-2-methyl-1 H-benzoimidazole (K.1 .39), 2-(4- chloro-phenyl)-N-[4-(3,4-dimethoxy-phenyl)-isoxazol-5-yl]-2-prop-2-ynyloxy-acetamide, ethyl (Z)-3-amino-2-cyano-3-phenyl-prop-2-enoate (K.1.40), picarbutrazox (K.1.41 ), pentyl N-[6-[[(Z)- [(1 -methyltetrazol-5-yl)-phenyl-methylene]amino]oxymethyl]-2-pyridyl]carbamate (K.1 .42), 2-[2- [(7,8-difluoro-2-methyl-3-quinolyl)oxy]-6-fluoro-phenyl]propan-2-ol (K.1 .43), 2-[2-fluoro-6-[(8- fluoro-2-methyl-3-quinolyl)oxy]phen-yl]propan-2-ol (K.1 .44), 3-(5-fluoro-3,3,4,4-tetramethyl-3,4- dihydroisoquinolin-1 -yl)quinoline (K.1 .45), 3-(4,4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1 - yl)quinoline (K.1.46), 3-(4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1 -yl)quinoline
(K.1.47), 9-fluoro-2,2-dimethyl-5-(3-quinolyl)-3H-1 ,4-benzoxazepine (K.1.48).
The fungicides described by common names, their preparation and their activity e.g. against harmful fungi is known (cf.: http://www.alanwood.net/pesticides/); these substances are commercially available.
The fungicides described by lUPAC nomenclature, their preparation and their pesticidal activi- ty is also known (cf. Can. J. Plant Sci. 48(6), 587-94, 1968; EP-A 141 317; EP-A 152 031 ; EP-A 226 917; EP-A 243 970; EP-A 256 503; EP-A 428 941 ; EP-A 532 022; EP-A 1 028 125; EP-A 1 035 122; EP-A 1 201 648; EP-A 1 122 244, JP 2002316902; DE 19650197; DE 10021412; DE 102005009458; US 3,296,272; US 3,325,503; WO 98/46608; WO 99/14187; WO 99/24413; WO 99/27783; WO 00/29404; WO 00/46148; WO 00/65913; WO 01/54501 ; WO 01/56358; WO 02/22583; WO 02/40431 ; WO 03/10149; WO 03/1 1853; WO 03/14103; WO 03/16286; WO 03/53145; WO 03/61388; WO 03/66609; WO 03/74491 ; WO 04/49804; WO 04/83193; WO 05/120234; WO 05/123689; WO 05/123690; WO 05/63721 ; WO 05/87772; WO 05/87773; WO 06/15866; WO 06/87325; WO 06/87343; WO 07/82098; WO 07/90624, WO 1 1/028657, WO2012/168188, WO 2007/006670, WO 201 1/77514; WO13/047749, WO 10/069882, WO 13/047441 , WO 03/16303, WO 09/90181 , WO 13/007767, WO 13/010862, WO 13/127704, WO 13/024009, WO 13/024010 and WO 13/047441 , WO 13/162072, WO 13/092224, WO 1 1/135833).
Suitable mixing partners for the compounds of the present invention also include biopesticides. Biopesticides have been defined as a form of pesticides based on micro-organisms (bacteria, fungi, viruses, nematodes, etc.) or natural products (compounds, such as metabolites, proteins, or extracts from biological or other natural sources) (U.S. Environmental Protection Agency: http://www.epa.gov/pesticides/biopesticides/). Biopesticides fall into two major classes, microbial and biochemical pesticides:
(1 ) Microbial pesticides consist of bacteria, fungi or viruses (and often include the metabolites that bacteria and fungi produce). Entomopathogenic nematodes are also classified as microbial pesticides, even though they are multi-cellular.
(2) Biochemical pesticides are naturally occurring substances or or structurally-similar and functionally identical to a naturally-occurring substance and extracts from biological sources that control pests or provide other crop protection uses as defined below, but have non-toxic mode of actions (such as growth or developmental regulation, attractents, repellents or defence activators (e.g. induced resistance) and are relatively non-toxic to mammals.
Biopesticides for use against crop diseases have already established themselves on a variety of crops. For example, biopesticides already play an important role in controlling downy mildew diseases. Their benefits include: a 0-Day Pre-Harvest Interval, the ability to use under moderate to severe disease pressure, and the ability to use in mixture or in a rotational program with other registered pesticides.
A major growth area for biopesticides is in the area of seed treatments and soil amendments. Biopesticidal seed treatments are e.g. used to control soil borne fungal pathogens that cause seed rots, damping-off, root rot and seedling blights. They can also be used to control internal seed borne fungal pathogens as well as fungal pathogens that are on the surface of the seed. Many biopesticidal products also show capacities to stimulate plant host defenses and other physiological processes that can make treated crops more resistant to a variety of biotic and abiotic stresses or can regulate plant growth. Many biopesticidal products also show capacities to stimulate plant health, plant growth and/or yield enhancing activity.
The following list of biopesticides, in conjunction with which the compounds of the present invention can be used, is intended to illustrate the possible combinations but does not limit them:
L) Biopesticides L1 ) Microbial pesticides with fungicidal, bactericidal, viricidal and/or plant defense activator activity: Ampelomyces quisqualis, Aspergillus flavus, Aureobasidium pullulans, Bacillus altitudinis, B. amyloliquefaciens, B. megaterium, B. mojavensis, B. mycoides, B. pumilus, B. simplex, B. solisalsi, B. subtilis, B. subtilis var. amyloliquefaciens, Candida oleophila, C. saitoana,
Clavibacter michiganensis (bacteriophages), Coniothyrium minitans, Cryphonectria parasitica, Cryptococcus albidus, Dilophosphora alopecuri, Fusarium oxysporum, Clonostachys rosea f . catenulate (also named Gliocladium catenulatum), Gliocladium roseum, Lysobacter antibioticus, L. enzymogenes, Metschnikowia fructicola, Microdochium dimerum, Microsphaeropsis ochracea, Muscodor albus, Paenibacillus alvei, Paenibacillus polymyxa, Pantoea vagans, Penicillium bilaiae, Phlebiopsis gigantea, Pseudomonas sp., Pseudomonas chloraphis,
Pseudozyma flocculosa, Pichia anomala, Pythium oligandrum, Sphaerodes mycoparasitica, Streptomyces griseoviridis, S. lydicus, S. violaceusniger, Talaromyces flavus, Trichoderma asperelloides, T. asperellum, T. atroviride, T. fertile, T. gamsii, T. harmatum, T. harzianum, T. polysporum, T. stromaticum, T. virens, T. viride, Typhula phacorrhiza, Ulocladium oudemansii, Verticillium dahlia, zucchini yellow mosaic virus (avirulent strain);
L2) Biochemical pesticides with fungicidal, bactericidal, viricidal and/or plant defense activator activity: harpin protein, Reynoutria sachalinensis extract;
L3) Microbial pesticides with insecticidal, acaricidal, molluscidal and/or nematicidal activity: Agrobacterium radiobacter, Bacillus cereus, B. firmus, B. thuringiensis, B. thuringiensis ssp. aizawai, B. t. ssp. israelensis, B. t. ssp. galleriae, B. t. ssp. kurstaki, B. t. ssp. tenebrionis, Beauveria bassiana, B. brongniartii, Burkholderia spp., Chromobacterium subtsugae, Cydia pomonella granulovirus (CpGV), Cryptophlebia leucotreta granulovirus (CrleGV),
Flavobacterium spp., Helicoverpa armigera nucleopolyhedrovirus (HearNPV), Helicoverpa zea nucleopolyhedrovirus (HzNPV), Helicoverpa zea single capsid nucleopolyhedrovirus (HzSNPV), Heterorhabditis bacteriophora, Isaria fumosorosea, Lecanicillium longisporum, L. muscarium, Metarhizium anisopliae, Metarhizium anisopliae var. anisopliae, M. anisopliae var. acridum, Nomuraea rileyi, Paecilomyces fumosoroseus, P. lilacinus, Paenibacillus popilliae, Pasteuria spp., P. nishizawae, P. penetrans, P. ramosa, P. thornea, P. usgae, Pseudomonas fluorescens, Spodoptera littoralis nucleopolyhedrovirus (SpliNPV), Steinernema carpocapsae, S. feltiae, S. kraussei, Streptomyces galbus, S. microflavus;
L4) Biochemical pesticides with insecticidal, acaricidal, molluscidal, pheromone and/or nematicidal activity: L-carvone, citral, (E,Z)-7,9-dodecadien-1 -yl acetate, ethyl formate, (E,Z)- 2,4-ethyl decadienoate (pear ester), (Z,Z,E)-7,1 1 ,13-hexadecatrienal, heptyl butyrate, isopropyl myristate, lavanulyl senecioate, cis-jasmone, 2-methyl 1 -butanol, methyl eugenol, methyl jasmonate, (E,Z)-2,13-octadecadien-1 -ol, (E,Z)-2,13-octadecadien-1 -ol acetate, (E,Z)-3,13- octadecadien-1 -ol, R-1 -octen-3-ol, pentatermanone, (E,Z,Z)-3,8,1 1 -tetradecatrienyl acetate, (Z,E)-9,12-tetradecadien-1 -yl acetate, Z-7-tetradecen-2-one, Z-9-tetradecen-1 -yl acetate, Z-1 1 - tetradecenal, Z-1 1 -tetradecen-1 -ol, extract of Chenopodium ambrosiodes, Neem oil, Quillay extract;
L5) Microbial pesticides with plant stress reducing, plant growth regulator, plant growth promoting and/or yield enhancing activity: Azospirillum amazonense, A. brasilense, A. Iipoferum, A. irakense, A. halopraeferens, Bradyrhizobium spp., B. elkanii, B. japonicum, B. liaoningense, B. lupini, Delftia acidovorans, Glomus intraradices, Mesorhizobium spp., Rhizobium leguminosarum bv. phaseoli, R. I. bv. trifolii, R. I. bv. viciae, R. tropici, Sinorhizobium meliloti.
The biopesticides from group L1 ) and/or L2) may also have insecticidal, acaricidal,
molluscidal, pheromone, nematicidal, plant stress reducing, plant growth regulator, plant growth promoting and/or yield enhancing activity. The biopesticides from group L3) and/or L4) may also have fungicidal, bactericidal, viricidal, plant defense activator, plant stress reducing, plant growth regulator, plant growth promoting and/or yield enhancing activity. The biopesticides from group L5) may also have fungicidal, bactericidal, viricidal, plant defense activator, insecticidal, acaricidal, molluscidal, pheromone and/or nematicidal activity.
Many of these biopesticides have been deposited under deposition numbers mentioned herein (the prefices such as ATCC or DSM refer to the acronym of the respective culture collection, for details see e. g. here: http://www. wfcc.info/ccinfo/collection/by_acronym/), are referred to in literature, registered and/or are commercially available: mixtures of Aureobasidium pullulans DSM 14940 and DSM 14941 isolated in 1989 in Konstanz, Germany (e. g. blastospores in Blossom Protect® from bio-ferm GmbH, Austria), Azospirillum brasilense Sp245 originally isolat- ed in wheat reagion of South Brazil (Passo Fundo) at least prior to 1980 (BR 1 1005; e. g.
GELFIX® Gramineas from BASF Agricultural Specialties Ltd., Brazil), A. brasilense strains Ab- V5 and Ab-V6 (e. g. in AzoMax from Novozymes BioAg Produtos papra Agricultura Ltda., Quat- tro Barras, Brazil or Simbiose-Maiz® from Simbiose-Agro, Brazil; Plant Soil 331 , 413-425, 2010), Bacillus amyloliquefaciens strain AP-188 (NRRL B-50615 and B-50331 ; US 8,445,255); B. amyloliquefaciens spp. plantarum D747 isolated from air in Kikugawa-shi, Japan
(US 20130236522 A1 ; FERM BP-8234; e. g. Double Nickel™ 55 WDG from Certis LLC, USA), B. amyloliquefaciens spp. plantarum FZB24 isolated from soil in Brandenburg, Germany (also called SB3615; DSM 96-2; J. Plant Dis. Prot. 105, 181-197, 1998; e. g. Taegro® from
Novozyme Biologicals, Inc., USA), B. amyloliquefaciens ssp. plantarum FZB42 isolated from soil in Brandenburg, Germany (DSM 231 17; J. Plant Dis. Prot. 105, 181-197, 1998; e. g.
RhizoVital® 42 from AbiTEP GmbH, Germany), B. amyloliquefaciens ssp. plantarum MBI600 isolated from faba bean in Sutton Bonington, Nottinghamshire, U.K. at least before 1988 (also called 1430; NRRL B-50595; US 2012/0149571 A1 ; e. g. Integral® from BASF Corp., USA), B. amyloliquefaciens spp. plantarum QST-713 isolated from peach orchard in 1995 in California, U.S.A. (NRRL B-21661 ; e. g. Serenade® MAX from Bayer Crop Science LP, USA), B.
amyloliquefaciens spp. plantarum TJ 1000 isolated in 1992 in South Dakoda, U.S.A. (also called 1 BE; ATCC BAA-390; CA 2471555 A1 ; e. g. QuickRoots™ from TJ Technologies, Watertown, SD, USA), B. firmus CNCM 1-1582, a variant of parental strain EIP-N1 (CNCM 1-1556) isolated from soil of central plain area of Israel (WO 2009/126473, US 6,406,690; e. g. Votivo® from Bayer CropScience LP, USA), B. pumilus GHA 180 isolated from apple tree rhizosphere in Mexico (IDAC 260707-01 ; e. g. PRO-MIX® BX from Premier Horticulture, Quebec, Canada), B. pumilus INR-7 otherwise referred to as BU-F22 and BU-F33 isolated at least before 1993 from cucumber infested by Erwinia tracheiphila (NRRL B-50185, NRRL B-50153; US 8,445,255), B. pumilus KFP9F isolated from the rhizosphere of grasses in South Africa at least before 2008 (NRRL B-50754; WO 2014/029697; e. g. BAC-UP or FUSION-P from BASF Agricultural Specialities (Pty) Ltd., South Africa), B. pumilus QST 2808 was isolated from soil collected in
Pohnpei, Federated States of Micronesia, in 1998 (NRRL B-30087; e. g. Sonata® or Ballad® Plus from Bayer Crop Science LP, USA), B. simplex ABU 288 (NRRL B-50304; US 8,445,255), B. subtilis FB17 also called UD 1022 or UD10-22 isolated from red beet roots in North America (ATCC PTA-1 1857; System. Appl. Microbiol. 27, 372-379, 2004; US 2010/0260735;
WO 201 1/109395); B. thuringiensis ssp. aizawai ABTS-1857 isolated from soil taken from a lawn in Ephraim, Wisconsin, U.S.A., in 1987 (also called ABG-6346; ATCC SD-1372; e. g. XenTari® from BioFa AG, Munsingen, Germany), B. t. ssp. /a/rsfa/ /' ABTS-351 identical to HD-1 isolated in 1967 from diseased Pink Bollworm black larvae in Brownsville, Texas, U.S.A. (ATCC SD-1275; e. g. Dipel® DF from Valent Biosciences, IL, USA), B. t. ssp. kurstaki SB4 isolated from E. saccharina larval cadavers (NRRL B-50753; e. g. Beta Pro® from BASF Agricultural Specialities (Pty) Ltd., South Africa), B. t. ssp. tenebrionis NB-176-1 , a mutant of strain NB-125, a wild type strain isolated in 1982 from a dead pupa of the beetle Tenebrio molitor (DSM 5480; EP 585 215 B1 ; e. g. Novodor® from Valent Biosciences, Switzerland), Beauveria bassiana GHA (ATCC 74250; e. g. BotaniGard® 22WGP from Laverlam Int. Corp., USA), B. bassiana JW-1 (ATCC 74040; e. g. Naturalis® from CBC (Europe) S.r.l., Italy), B. bassiana PPRI 5339 isolated from the larva of the tortoise beetle Conchyloctenia punctata (NRRL 50757; e. g.
BroadBand® from BASF Agricultural Specialities (Pty) Ltd., South Africa), Bradyrhizobium elkanii strains SEMIA 5019 (also called 29W) isolated in Rio de Janeiro, Brazil and SEMIA 587 isolated in 1967 in the State of Rio Grande do Sul, from an area previously inoculated with a North American isolate, and used in commercial inoculants since 1968 (Appl. Environ.
Microbiol. 73(8), 2635, 2007; e. g. GELFIX 5 from BASF Agricultural Specialties Ltd., Brazil), B. japonicum 532c isolated from Wisconsin field in U.S.A. (Nitragin 61A152; Can. J. Plant. Sci. 70, 661 -666, 1990; e. g. in Rhizoflo®, Histick®, Hicoat® Super from BASF Agricultural Specialties Ltd., Canada), B. japonicum E-109 variant of strain USDA 138 (INTA E109, SEMIA 5085; Eur. J. Soil Biol. 45, 28-35, 2009; Biol. Fertil. Soils 47, 81-89, 201 1 ); B. japonicum strains deposited at SEMIA known from Appl. Environ. Microbiol. 73(8), 2635, 2007: SEMIA 5079 isolated from soil in Cerrados region, Brazil by Embrapa-Cerrados used in commercial inoculants since 1992 (CPAC 15; e. g. GELFIX 5 or ADHERE 60 from BASF Agricultural Specialties Ltd., Brazil), B. japonicum SEMIA 5080 obtained under lab condtions by Embrapa-Cerrados in Brazil and used in commercial inoculants since 1992, being a natural variant of SEMIA 586 (CB1809) originally isolated in U.S.A. (CPAC 7; e. g. GELFIX 5 or ADHERE 60 from BASF Agricultural Specialties Ltd., Brazil); Burkholderia sp. A396 isolated from soil in Nikko, Japan, in 2008 (NRRL B-50319; WO 2013/032693; Marrone Bio Innovations, Inc., USA), Coniothyrium minitans CON/M/91 -08 isolated from oilseed rape (WO 1996/021358; DSM 9660; e. g. Contans® WG, Intercept® WG from Bayer CropScience AG, Germany), harpin (alpha-beta) protein (Science 257, 85-88, 1992; e. g. Messenger™ or HARP-N-Tek from Plant Health Care pic, U.K.), Helicoverpa armigera nucleopolyhedrovirus (HearNPV) (J. Invertebrate Pathol. 107, 1 12-126, 201 1 ; e. g. Helicovex® from Adermatt Biocontrol, Switzerland; Diplomata® from Koppert, Brazil; Vivus® Max from AgBiTech Pty Ltd., Queensland, Australia), Helicoverpa zea single capsid nucleopolyhedrovirus (HzSNPV) (e. g. Gemstar® from Certis LLC, USA), Helicoverpa zea nucleopolyhedrovirus ABA- NPV-U (e. g. Heligen® from AgBiTech Pty Ltd., Queensland, Australia), Heterorhabditis bacteriophora (e. g. Nemasys® G from BASF Agricultural Specialities Limited, UK), Isaria fumosorosea Apopka-97 isolated from mealy bug on gynura in Apopka, Florida, U.S.A. (ATCC 20874; Biocontrol Science Technol. 22(7), 747-761 , 2012; e. g. PFR-97™ or PreFeRal® from Certis LLC, USA), Metarhizium anisopliae var. anisopliae F52 also called 275 or V275 isolated from codling moth in Austria (DSM 3884, ATCC 90448; e. g. Met52® Novozymes Biologicals BioAg Group, Canada), Metschnikowia fructicola 277 isolated from grapes in the central part of Israel (US 6,994,849; NRRL Y-30752; e. g. formerly Shemer® from Agrogreen, Israel),
Paecilomyces ilacinus 251 isolated from infected nematode eggs in the Philippines (AGAL 89/030550; W01991/02051 ; Crop Protection 27, 352-361 , 2008; e. g. BioAct®from Bayer
CropScience AG, Germany and MeloCon® from Certis, USA), Paenibacillus a/ve/ NAS6G6 isolated from the rhizosphere of grasses in South Africa at least before 2008 (WO 2014/029697; NRRL B-50755; e.g. BAC-UP from BASF Agricultural Specialities (Pty) Ltd., South Africa), Pasteuria nishizawae Pn1 isolated from a soybean field in the mid-2000s in Illinois, U.S.A.
(ATCC SD-5833; Federal Register 76(22), 5808, February 2, 201 1 ; e.g. Clariva™ PN from Syn- genta Crop Protection, LLC, USA), Penicillium bilaiae (also called P. bilaii) strains ATCC 18309 (= ATCC 74319), ATCC 20851 and/or ATCC 22348 (= ATCC 74318) originally isolated from soil in Alberta, Canada (Fertilizer Res. 39, 97-103, 1994; Can. J. Plant Sci. 78(1 ), 91 -102, 1998; US 5,026,417, WO 1995/017806; e. g. Jump Start®, Provide® from Novozymes Biologicals BioAg Group, Canada), Reynoutria sachalinensis extract (EP 0307510 B1 ; e. g. Regalia® SC from Marrone Biolnnovations, Davis, CA, USA or Milsana® from BioFa AG, Germany),
Steinernema carpocapsae (e. g. Millenium® from BASF Agricultural Specialities Limited, UK), S. feltiae (e. g. Nemashield® from BioWorks, Inc., USA; Nemasys® from BASF Agricultural Specialities Limited, UK), Streptomyces microflavus NRRL B-50550 (WO 2014/124369; Bayer CropScience, Germany), Trichoderma asperelloides JM41 R isolated in South Africa (NRRL 50759; also referred to as T. fertile; e. g. Trichoplus® from BASF Agricultural Specialities (Pty) Ltd., South Africa), T. harzianum J-22 also called KRL-AG2 (ATCC 20847; BioControl 57, 687- 696, 2012; e. g. Plantshield® from BioWorks Inc., USA or SabrEx™ from Advanced Biological Marketing Inc., Van Wert, OH, USA).
According to the invention, the solid material (dry matter) of the biopesticides (with the exception of oils such as Neem oil) are considered as active components (e.g. to be obtained after drying or evaporation of the extraction or suspension medium in case of liquid formulations of the microbial pesticides).
In accordance with the present invention, the weight ratios and percentages used herein for a biological extract such as Quillay extract are based on the total weight of the dry content (solid material) of the respective extract(s).
The total weight ratios of compositions comprising at least one microbial pesticide in the form of viable microbial cells including dormant forms, can be determined using the amount of CFU of the respective microorganism to calclulate the total weight of the respective active component with the following equation that 1 x 1010 CFU equals one gram of total weight of the respective active component. Colony forming unit is measure of viable microbial cells, in particular fungal and bacterial cells. In addition, here "CFU" may also be understood as the number of (juvenile) individual nematodes in case of (entomopathogenic) nematode biopesticides, such as
Steinernema feltiae.
When mixtures comprising microbial pesticides are employed in crop protection, the application rates preferably range from about 1 x 106 to 5 x 1015 (or more) CFU/ha, preferably from about 1 x 108 to about 1 x 1013 CFU/ha, and even more preferably from about 1 x 109 to about 1 x 1012 CFU/ha. In the case of (entomopathogenic) nematodes as microbial pesticides (e. g. Steinernema feltiae), the application rates preferably range inform about 1 x 105 to 1 x 1012 (or more), more preferably from 1 x 108 to 1 x 101 1 , even more preferably from 5 x 108 to 1 x 1010 individuals (e. g. in the form of eggs, juvenile or any other live stages, preferably in an infetive juvenile stage) per ha.
When mixtures comprising microbial pesticides are employed in seed treatment, the application rates with respect to plant propagation material preferably range from about 1 x 106 to 1 x 1012 (or more) CFU/seed. Preferably, the concentration is about 1 x 106 to about 1 x 109 CFU/seed. In the case of the microbial pesticides II, the application rates with respect to plant propagation material also preferably range from about 1 x 107 to 1 x 1014 (or more) CFU per 100 kg of seed, preferably from 1 x 109 to about 1 x 1012 CFU per 100 kg of seed.
The invention also relates to agrochemical compositions comprising an auxiliary and at least one compound of the present invention or a mixture thereof.
An agrochemical composition comprises a pesticidally effective amount of a compound of the present invention or a mixture thereof. The term "pesticidally effective amount" is defined below.
The compounds of the present invention or the mixtures thereof can be converted into customary types of agro-chemical compositions, e. g. solutions, emulsions, suspensions, dusts, powders, pastes, granules, pressings, capsules, and mixtures thereof. Examples for composition types are suspensions (e.g. SC, OD, FS), emulsifiable concentrates (e.g. EC), emulsions (e.g. EW, EO, ES, ME), capsules (e.g. CS, ZC), pastes, pastilles, wettable powders or dusts
(e.g. WP, SP, WS, DP, DS), pressings (e.g. BR, TB, DT), granules (e.g. WG, SG, GR, FG, GG, MG), insecticidal articles (e.g. LN), as well as gel formulations for the treatment of plant propagation materials such as seeds (e.g. GF). These and further compositions types are defined in the "Catalogue of pesticide formulation types and international coding system", Technical Mono- graph No. 2, 6th Ed. May 2008, CropLife International.
The compositions are prepared in a known manner, such as described by Mollet and Grube- mann, Formulation technology, Wiley VCH, Weinheim, 2001 ; or Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005.
Examples for suitable auxiliaries are solvents, liquid carriers, solid carriers or fillers, surfac- tants, dispersants, emulsifiers, wetters, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feeding stimulants, compatibilizers, bactericides, anti-freezing agents, anti-foaming agents, colorants, tackifi- ers and binders.
Suitable solvents and liquid carriers are water and organic solvents, such as mineral oil frac- tions of medium to high boiling point, e.g. kerosene, diesel oil; oils of vegetable or animal origin; aliphatic, cyclic and aromatic hydrocarbons, e. g. toluene, paraffin, tetrahydronaphthalene, alkylated naphthalenes; alcohols, e.g. ethanol, propanol, butanol, benzylalcohol, cyclo^hexanol; glycols; DMSO; ketones, e.g. cyclohexanone; esters, e.g. lactates, carbonates, fatty acid esters, gamma-butyrolactone; fatty acids; phosphonates; amines; amides, e.g. N-methylpyrrolidone, fatty acid dimethylamides; and mixtures thereof.
Suitable solid carriers or fillers are mineral earths, e.g. silicates, silica gels, talc, kaolins, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharide powders, e.g. cellulose, starch; fertilizers, e.g. am- monium sulfate, ammonium phosphate, ammonium nitrate, ureas; products of vegetable origin, e.g. cereal meal, tree bark meal, wood meal, nutshell meal, and mixtures thereof.
Suitable surfactants are surface-active compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and mixtures thereof. Such surfactants can be used as emusifier, dispersant, solubilizer, wetter, penetration enhancer, protective colloid, or adjuvant. Examples of surfactants are listed in McCutcheon's, Vol.1 : Emulsifiers & Detergents, McCutcheon's Directories, Glen Rock, USA, 2008 (International Ed. or North American Ed.).
Suitable anionic surfactants are alkali, alkaline earth or ammonium salts of sulfonates, sul- fates, phosphates, carboxylates, and mixtures thereof. Examples of sulfonates are alkylaryl- sulfonates, diphenylsulfonates, alpha-olefin sulfonates, lignine sulfonates, sulfonates of fatty acids and oils, sulfonates of ethoxylated alkylphenols, sulfonates of alkoxylated arylphenols, sulfonates of condensed naphthalenes, sulfonates of dodecyl- and tridecylbenzenes, sulfonates of naphthalenes and alkyhnaphthalenes, sulfosuccinates or sulfosuccinamates. Examples of sulfates are sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols, or of fatty acid esters. Examples of phosphates are phosphate esters. Examples of carboxylates are alkyl carboxylates, and carboxylated alcohol or alkylphenol eth- oxylates.
Suitable nonionic surfactants are alkoxylates, N-subsituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof. Examples of alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids or fatty acid esters which have been alkoxylated with 1 to 50 equivalents. Ethylene oxide and/or propylene oxide may be employed for the alkoxylation, preferably ethylene oxide. Examples of N-subsititued fatty acid amides are fatty acid glucamides or fatty acid alkanolamides. Examples of esters are fatty acid esters, glycerol esters or monoglycerides. Examples of sugar- based surfactants are sorbitans, ethoxylated sorbitans, sucrose and glucose esters or alkylpolyglucosides. Examples of polymeric surfactants are homo- or copolymers of
vinylpyrrolidone, vinylalcohols, or vinylacetate.
Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or salts of long-chain primary amines. Suitable amphoteric surfactants are alkylbetains and imidazolines. Suitable block polymers are block polymers of the A-B or A-B-A type comprising blocks of polyethylene oxide and polypropylene oxide, or of the A-B-C type comprising alkanol, polyethylene oxide and polypropylene oxide. Suitable polyelectrolytes are polyacids or polybases. Examples of polyacids are alkali salts of polyacrylic acid or polyacid comb polymers. Examples of polybases are polyvinylamines or polyethyleneamines.
Suitable adjuvants are compounds, which have a neglectable or even no pesticidal activity themselves, and which improve the biological performance of the compounds of the present invention on the target. Examples are surfactants, mineral or vegetable oils, and other auxilaries. Further examples are listed by Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5.
Suitable thickeners are polysaccharides (e.g. xanthan gum, carboxymethylcellulose), anorganic clays (organically modified or unmodified), polycarboxylates, and silicates. Suitable bactericides are bronopol and isothiazolinone derivatives such as alkylisothiazoli- nones and benzisothiazolinones.
Suitable anti-freezing agents are ethylene glycol, propylene glycol, urea and glycerin.
Suitable anti-foaming agents are silicones, long chain alcohols, and salts of fatty acids.
Suitable colorants (e.g. in red, blue, or green) are pigments of low water solubility and water- soluble dyes. Examples are inorganic colorants (e.g. iron oxide, titan oxide, iron hexacyanofer- rate) and organic colorants (e.g. alizarin-, azo- and phthalocyanine colorants).
Suitable tackifiers or binders are polyvinylpyrrolidone, polyvinylacetates, polyvinyl alcohols, polyacrylates, biological or synthetic waxes, and cellulose ethers.
The agrochemical compositions generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, and most preferably between 0.5 and 75%, by weight of active sub-stance. The active substances are employed in a purity of from 90% to 100%, preferably from 95% to 100% (according to NMR spectrum).
Various types of oils, wetters, adjuvants, fertilizer, or micronutrients, and other pesticides (e.g. herbicides, insecticides, fungicides, growth regulators, safeners) may be added to the active substances or the compositions cormprising them as premix or, if appropriate not until immediately prior to use (tank mix). These agents can be admixed with the compositions according to the invention in a weight ratio of 1 :100 to 100:1 , preferably 1 :10 to 10:1.
The user applies the composition according to the invention usually from a predosage de-vice, a knapsack sprayer, a spray tank, a spray plane, or an irrigation system. Usually, the agrochemical composition is made up with water, buffer, and/or further auxiliaries to the desired application concentration and the ready-to-use spray liquor or the agrochemical composition according to the invention is thus obtained. Usually, 20 to 2000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of agricultural useful area.
According to one embodiment, individual components of the composition according to the invention such as parts of a kit or parts of a binary or ternary mixture may be mixed by the user himself in a spray tank and further auxiliaries may be added, if appropriate.
In a further embodiment, either individual components of the composition according to the invention or partially premixed components, e. g. components comprising compounds of the pre- sent invention and/or mixing partners as defined above, may be mixed by the user in a spray tank and further auxiliaries and additives may be added, if appropriate.
In a further embodiment, either individual components of the composition according to the invention or partially premixed components, e. g. components comprising compounds of the present invention and/or mixing partners as defined above, can be applied jointly (e.g. after tank mix) or consecutively.
The compounds of the present invention are suitable for use in protecting crops, plants, plant propagation materials, such as seeds, or soil or water, in which the plants are growing, from attack or infestation by animal pests. Therefore, the present invention also relates to a plant protection method, which comprises contacting crops, plants, plant propagation materials, such as seeds, or soil or water, in which the plants are growing, to be protected from attack or infestation by animal pests, with a pesticidally effective amount of a compound of the present invention. The compounds of the present invention are also suitable for use in combating or controlling animal pests. Therefore, the present invention also relates to a method of combating or controlling animal pests, which comprises contacting the animal pests, their habitat, breeding ground, or food supply, or the crops, plants, plant propagation materials, such as seeds, or soil, or the area, material or environment in which the animal pests are growing or may grow, with a pesticidally effective amount of a compound of the present invention.
The compounds of the present invention are effective through both contact and ingestion. Furthermore, the compounds of the present invention can be applied to any and all developmental stages, such as egg, larva, pupa, and adult.
The compounds of the present invention can be applied as such or in form of compositions comprising them as defined above. Furthermore, the compounds of the present invention can be applied together with a mixing partner as defined above or in form of compositions comprising said mixtures as defined above. The components of said mixture can be applied simultaneously, jointly or separately, or in succession, that is immediately one after another and thereby creating the mixture "in situ" on the desired location, e.g. the plant, the sequence, in the case of separate application, generally not having any effect on the result of the control measures.
The application can be carried out both before and after the infestation of the crops, plants, plant propagation materials, such as seeds, soil, or the area, material or environment by the pests.
Suitable application methods include inter alia soil treatment, seed treatment, in furrow application, and foliar application. Soil treatment methods include drenching the soil, drip irrigation (drip application onto the soil), dipping roots, tubers or bulbs, or soil injection. Seed treatment techniques include seed dressing, seed coating, seed dusting, seed soaking, and seed pelleting. In furrow applications typically include the steps of making a furrow in cultivated land, seed- ing the furrow with seeds, applying the pesticidally active compound to the furrow, and closing the furrow. Foliar application refers to the application of the pesticidally active compound to plant foliage, e.g. through spray equipment. For foliar applications, it can be advantageous to modify the behavior of the pests by use of pheromones in combination with the compounds of the present invention. Suitable pheromones for specific crops and pests are known to a skilled person and publicly available from databases of pheromones and semiochemicals, such as http://www.pherobase.com.
As used herein, the term "contacting" includes both direct contact (applying the compounds/compositions directly on the animal pest or plant - typically to the foliage, stem or roots of the plant) and indirect contact (applying the compounds/compositions to the locus, i.e. habi- tat, breeding ground, plant, seed, soil, area, material or environment in which a pest is growing or may grow, of the animal pest or plant).
The term "animal pest" includes arthropods, gastropods, and nematodes. Preferred animal pests according to the invention are arthropods, preferably insects and arachnids, in particular insects. Insects, which are of particular relevance for crops, are typically referred to as crop in- sect pests.
The term "crop" refers to both, growing and harvested crops.
The term "plant" includes cereals, e.g. durum and other wheat, rye, barley, triticale, oats, rice, or maize (fodder maize and sugar maize / sweet and field corn); beet, e.g. sugar beet or fodder beet; fruits, such as pomes, stone fruits or soft fruits, e.g. apples, pears, plums, peaches, nectarines, almonds, cherries, papayas, strawberries, raspberries, blackberries or gooseberries; leguminous plants, such as beans, lentils, peas, alfalfa or soybeans; oil plants, such as rape- seed (oilseed rape), turnip rape, mustard, olives, sunflowers, coconut, cocoa beans, castor oil plants, oil palms, ground nuts or soybeans; cucurbits, such as squashes, pumpkins, cucumber or melons; fiber plants, such as cotton, flax, hemp or jute; citrus fruit, such as oranges, lemons, grapefruits or mandarins; vegetables, such as eggplant, spinach, lettuce (e.g. iceberg lettuce), chicory, cabbage, asparagus, cabbages, carrots, onions, garlic, leeks, tomatoes, potatoes, cucurbits or sweet peppers; lauraceous plants, such as avocados, cinnamon or camphor; energy and raw material plants, such as corn, soybean, rapeseed, sugar cane or oil palm; tobacco; nuts, e.g. walnuts; pistachios; coffee; tea; bananas; vines (table grapes and grape juice grape vines); hop; sweet leaf (also called Stevia); natural rubber plants or ornamental and forestry plants, such as flowers (e.g. carnation, petunias, geranium/pelargoniums, pansies and impa- tiens), shrubs, broad-leaved trees (e.g. poplar) or evergreens, e.g. conifers; eucalyptus; turf; lawn; grass such as grass for animal feed or ornamental uses. Preferred plants include potatoes sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rapeseed, legumes, sunflowers, coffee or sugar cane; fruits; vines; ornamentals; or vegetables, such as cucumbers, tomatoes, beans or squashes.
The term "plant" is to be understood as including wild type plants and plants, which have been modified by either conventional breeding, or mutagenesis or genetic engineering, or by a combination thereof.
Plants, which have been modified by mutagenesis or genetic engineering, and are of particular commercial importance, include alfalfa, rapeseed (e.g. oilseed rape), bean, carnation, chicory, cotton, eggplant, eucalyptus, flax, lentil, maize, melon, papaya, petunia, plum, poplar, potato, rice, soybean, squash, sugar beet, sugarcane, sunflower, sweet pepper, tobacco, tomato, and cereals (e.g. wheat), in particular maize, soybean, cotton, wheat, and rice. In plants, which have been modified by mutagenesis or genetic engineering, one or more genes have been mutagen- ized or integrated into the genetic material of the plant. The one or more mutagenized or integrated genes are preferably selected from pat, epsps, crylAb, bar, cry1 Fa2, crylAc, cry34Ab1 , cry35AB1 , cry3A, cryF, cry1 F, mcry3a, cry2Ab2, cry3Bb1 , cry1A.105, dfr, barnase, vip3Aa20, barstar, als, bxn, bp40, asnl , and ppo5. The mutagenesis or integration of the one or more genes is performed in order to improve certain properties of the plant. Such properties, also known as traits, include abiotic stress tolerance, altered growth/yield, disease resistance, herbicide tolerance, insect resistance, modified product quality, and pollination control. Of these properties, herbicide tolerance, e.g. imidazolinone tolerance, glyphosate tolerance, or glufosinate tolerance, is of particular importance. Several plants have been rendered tolerant to herbicides by mutagenesis, for example Clearfield® oilseed rape being tolerant to
imidazolinones, e.g. imazamox. Alternatively, genetic engineering methods have been used to render plants, such as soybean, cotton, corn, beets and oil seed rape, tolerant to herbicides, such as glyphosate and glufosinate, some of which are commercially available under the trade names RoundupReady® (glyphosate) and LibertyLink® (glufosinate). Furthermore, insect resistance is of importance, in particular lepidopteran insect resistance and coleopteran insect resistance. Insect resistance is typically achieved by modifying plants by integrating cry and/or vip genes, which were isolated from Bacillus thuringiensis (Bt), and code for the respective Bt toxins. Genetically modified plants with insect resistance are commercially available under trade names including WideStrike®, Bollgard®, Agrisure®, Herculex®, YieldGard®, Genuity®, and Intacta®. Plants may be modified by mutagenesis or genetic engineering either in terms of one property (singular traits) or in terms of a combination of properties (stacked traits). Stacked traits, e.g. the combination of herbicide tolerance and insect resistance, are of increasing importance. In general, all relevant modified plants in connection with singular or stacked traits as well as detailed information as to the mutagenized or integrated genes and the respective events are available from websites of the organizations "International Service for the Acquisition of Agri-biotech Applications (ISAAA)" (http://www.isaaa.org/gmapprovaldatabase) and "Center for Environmental Risk Assessment (CERA)" (http://cera-gmc.org/GMCropDatabase).
It has surprisingly been found that the pesticidal activity of the compounds of the present invention may be enhanced by the insecticidal trait of a modified plant. Furthermore, it has been found that the compounds of the present invention are suitable for preventing insects to become resistant to the insecticidal trait or for combating pests, which already have become resistant to the insecticidal trait of a modified plant. Moreover, the compounds of the present invention are suitable for combating pests, against which the insecticidal trait is not effective, so that a complementary insecticidal activity can advantageously be used.
The term "plant propagation material" refers to all the generative parts of the plant such as seeds and vegetative plant material such as cuttings and tubers (e.g. potatoes), which can be used for the multiplication of the plant. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, shoots, sprouts and other parts of plants. Seedlings and young plants, which are to be transplanted after germination or after emergence from soil, may also be included. These plant propagation materials may be treated prophylactically with a plant protection compound either at or before planting or transplanting.
The term "seed" embraces seeds and plant propagules of all kinds including but not limited to true seeds, seed pieces, suckers, corms, bulbs, fruit, tubers, grains, cuttings, cut shoots and the like, and means in a preferred embodiment true seeds.
In general, "pesticidally effective amount" means the amount of active ingredient needed to achieve an observable effect on growth, including the effects of necrosis, death, retardation, prevention, and removal, destruction, or otherwise diminishing the occurrence and activity of the target organism. The pesticidally effective amount can vary for the various compounds/compositions used in the invention. A pesticidally effective amount of the compositions will also vary according to the prevailing conditions such as desired pesticidal effect and dura- tion, weather, target species, locus, mode of application, and the like.
In the case of soil treatment, in furrow application or of application to the pests dwelling place or nest, the quantity of active ingredient ranges from 0.0001 to 500 g per 100 m2, preferably from 0.001 to 20 g per 100 m2.
For use in treating crop plants, e.g. by foliar application, the rate of application of the active in- gredients of this invention may be in the range of 0.0001 g to 4000 g per hectare, e.g. from 1 g to 2 kg per hectare or from 1 g to 750 g per hectare, desirably from 1 g to 100 g per hectare, more desirably from 10 g to 50 g per hectare, e.g., 10 to 20 g per hectare, 20 to 30 g per hectare, 30 to 40 g per hectare, or 40 to 50 g per hectare. The compounds of the present invention are particularly suitable for use in the treatment of seeds in order to protect the seeds from insect pests, in particular from soil-living insect pests, and the resulting seedling's roots and shoots against soil pests and foliar insects. The present invention therefore also relates to a method for the protection of seeds from insects, in particular from soil insects, and of the seedling's roots and shoots from insects, in particular from soil and foliar insects, said method comprising treating the seeds before sowing and/or after pregermina- tion with a compound of the present invention. The protection of the seedling's roots and shoots is preferred. More preferred is the protection of seedling's shoots from piercing and sucking in- sects, chewing insects and nematodes.
The term "seed treatment" comprises all suitable seed treatment techniques known in the art, such as seed dressing, seed coating, seed dusting, seed soaking, seed pelleting, and in-furrow application methods. Preferably, the seed treatment application of the active compound is carried out by spraying or by dusting the seeds before sowing of the plants and before emergence of the plants.
The present invention also comprises seeds coated with or containing the active compound. The term "coated with and/or containing" generally signifies that the active ingredient is for the most part on the surface of the propagation product at the time of application, although a greater or lesser part of the ingredient may penetrate into the propagation product, depending on the method of application. When the said propagation product is (re)planted, it may absorb the active ingredient.
Suitable seed is for example seed of cereals, root crops, oil crops, vegetables, spices, ornamentals, for example seed of durum and other wheat, barley, oats, rye, maize (fodder maize and sugar maize / sweet and field corn), soybeans, oil crops, crucifers, cotton, sunflowers, ba- nanas, rice, oilseed rape, turnip rape, sugarbeet, fodder beet, eggplants, potatoes, grass, lawn, turf, fodder grass, tomatoes, leeks, pumpkin/squash, cabbage, iceberg lettuce, pepper, cucumbers, melons, Brassica species, melons, beans, peas, garlic, onions, carrots, tuberous plants such as potatoes, sugar cane, tobacco, grapes, petunias, geranium/pelargoniums, pansies and impatiens.
In addition, the active compound may also be used for the treatment of seeds from plants, which have been modified by mutagenisis or genetic engineering, and which e.g. tolerate the action of herbicides or fungicides or insecticides. Such modified plants have been described in detail above.
Conventional seed treatment formulations include for example flowable concentrates FS, solu- tions LS, suspoemulsions (SE), powders for dry treatment DS, water dispersible powders for slurry treatment WS, water-soluble powders SS and emulsion ES and EC and gel formulation GF. These formulations can be applied to the seed diluted or undiluted. Application to the seeds is carried out before sowing, either directly on the seeds or after having pregerminated the latter. Preferably, the formulations are applied such that germination is not included.
The active substance concentrations in ready-to-use formulations, which may be obtained after two-to-tenfold dilution, are preferably from 0.01 to 60% by weight, more preferably from 0.1 to 40 % by weight. In a preferred embodiment a FS formulation is used for seed treatment. Typically, a FS formulation may comprise 1 -800 g/l of active ingredient, 1 -200 g/l Surfactant, 0 to 200 g/l antifreezing agent, 0 to 400 g/l of binder, 0 to 200 g/l of a pigment and up to 1 liter of a solvent, preferably water.
Especially preferred FS formulations of the compounds of the present invention for seed treatment usually comprise from 0.1 to 80% by weight (1 to 800 g/l) of the active ingredient, from 0.1 to 20 % by weight (1 to 200 g/l) of at least one surfactant, e.g. 0.05 to 5 % by weight of a wetter and from 0.5 to 15 % by weight of a dispersing agent, up to 20 % by weight, e.g. from 5 to 20 % of an anti-freeze agent, from 0 to 15 % by weight, e.g. 1 to 15 % by weight of a pigment and/or a dye, from 0 to 40 % by weight, e.g. 1 to 40 % by weight of a binder (sticker /adhesion agent), optionally up to 5 % by weight, e.g. from 0.1 to 5 % by weight of a thickener, optionally from 0.1 to 2 % of an anti-foam agent, and optionally a preservative such as a biocide, antioxidant or the like, e.g. in an amount from 0.01 to 1 % by weight and a filler/vehicle up to 100 % by weight.
In the treatment of seed, the application rates of the compounds of the invention are generally from 0.1 g to 10 kg per 100 kg of seed, preferably from 1 g to 5 kg per 100 kg of seed, more preferably from 1 g to 1000 g per 100 kg of seed and in particular from 1 g to 200 g per 100 kg of seed, e.g. from 1 g to 100 g or from 5 g to 100 g per 100 kg of seed.
The invention therefore also relates to seed comprising a compound of the present invention, or an agriculturally useful salt thereof, as defined herein. The amount of the compound of the present invention or the agriculturally useful salt thereof will in general vary from 0.1 g to 10 kg per 100 kg of seed, preferably from 1 g to 5 kg per 100 kg of seed, in particular from 1 g to 1000 g per 100 kg of seed. For specific crops such as lettuce the rate can be higher. The compounds of the present invention may also be used for improving the health of a plant. Therefore, the present invention also relates to a method for improving plant health by treating a plant, plant propagation material and/or the locus where the plant is growing or is to grow with an effective and non-phytotoxic amount of a compound of the present invention.
As used herein "an effective and non-phytotoxic amount" means that the compound is used in a quantity which allows to obtain the desired effect but which does not give rise to any phyto- toxic symptom on the treated plant or on the plant grown from the treated propagule or treated soil.
The terms "plant" and "plant propagation material" are defined above.
"Plant health" is defined as a condition of the plant and/or its products which is determined by several aspects alone or in combination with each other such as yield (for example increased biomass and/or increased content of valuable ingredients), quality (for example improved content or composition of certain ingredients or shelf life), plant vigour (for example improved plant growth and/or greener leaves ("greening effect"), tolerance to abiotic (for example drought) and/or biotic stress (for example disease) and production efficiency (for example, harvesting efficiency, processability).
The above identified indicators for the health condition of a plant may be interdependent and may result from each other. Each indicator is defined in the art and can be determined by methods known to a skilled person. The compounds of the invention are also suitable for use against non-crop insect pests. For use against said non-crop pests, compounds of the present invention can be used as bait composition, gel, general insect spray, aerosol, as ultra-low volume application and bed net (im- pregnated or surface applied). Furthermore, drenching and rodding methods can be used.
As used herein, the term "non-crop insect pest" refers to pests, which are particularly relevant for non-crop targets, such as ants, termites, wasps, flies, ticks, mosquitos, crickets, or cockroaches.
The bait can be a liquid, a solid or a semisolid preparation (e.g. a gel). The bait employed in the composition is a product, which is sufficiently attractive to incite insects such as ants, termites, wasps, flies, mosquitos, crickets etc. or cockroaches to eat it. The attractiveness can be manipulated by using feeding stimulants or sex pheromones. Food stimulants are chosen, for example, but not exclusively, from animal and/or plant proteins (meat-, fish- or blood meal, insect parts, egg yolk), from fats and oils of animal and/or plant origin, or mono-, oligo- or polyorganosaccharides, especially from sucrose, lactose, fructose, dextrose, glucose, starch, pectin or even molasses or honey. Fresh or decaying parts of fruits, crops, plants, animals, insects or specific parts thereof can also serve as a feeding stimulant. Sex pheromones are known to be more insect specific. Specific pheromones are described in the literature (e.g.
http://www.pherobase.com), and are known to those skilled in the art.
For use in bait compositions, the typical content of active ingredient is from 0.001 weight % to 15 weight %, desirably from 0.001 weight % to 5% weight % of active compound.
Formulations of the compounds of the present invention as aerosols (e.g in spray cans), oil sprays or pump sprays are highly suitable for the non-professional user for controlling pests such as flies, fleas, ticks, mosquitos or cockroaches. Aerosol recipes are preferably composed of the active compound, solvents, furthermore auxiliaries such as emulsifiers, perfume oils, if appropriate stabilizers, and, if required, propellants.
The oil spray formulations differ from the aerosol recipes in that no propellants are used.
For use in spray compositions, the content of active ingredient is from 0.001 to 80 weights %, preferably from 0.01 to 50 weight % and most preferably from 0.01 to 15 weight %.
The compounds of the present invention and its respective compositions can also be used in mosquito and fumigating coils, smoke cartridges, vaporizer plates or long-term vaporizers and also in moth papers, moth pads or other heat-independent vaporizer systems.
Methods to control infectious diseases transmitted by insects (e.g. malaria, dengue and yellow fever, lymphatic filariasis, and leishmaniasis) with compounds of the present invention and its respective compositions also comprise treating surfaces of huts and houses, air spraying and impregnation of curtains, tents, clothing items, bed nets, tsetse-fly trap or the like. Insecticidal compositions for application to fibers, fabric, knitgoods, nonwovens, netting material or foils and tarpaulins preferably comprise a mixture including the insecticide, optionally a repellent and at least one binder.
The compounds of the present invention and its compositions can be used for protecting wooden materials such as trees, board fences, sleepers, frames, artistic artifacts, etc. and buildings, but also construction materials, furniture, leathers, fibers, vinyl articles, electric wires and cables etc. from ants and/or termites, and for controlling ants and termites from doing harm to crops or human being (e.g. when the pests invade into houses and public facilities).
Customary application rates in the protection of materials are, for example, from 0.001 g to 2000 g or from 0.01 g to 1000 g of active compound per m2 treated material, desirably from 0.1 g to 50 g per m2.
Insecticidal compositions for use in the impregnation of materials typically contain from 0.001 to 95 weight %, preferably from 0.1 to 45 weight %, and more preferably from 1 to 25 weight % of at least one repellent and/or insecticide. The compounds of the the present invention are especially suitable for efficiently combating animal pests such as arthropods, gastropods and nematodes including but not limited to:
insects from the order of Lepidoptera, for example Achroia grisella, Acleris spp. such as A fimbriana, A. gloverana, A. variana; Acrolepiopsis assectella, Acronicta major, Adoxophyes spp. such as A. cyrtosema, A. orana; Aedia leucomelas, Agrotis spp. such as A. exclamationis, A. fucosa, A. ipsilon, A. orthogoma, A. segetum, A. subterranea; Alabama argillacea, Aleurodicus dispersus, Alsophila pometaria, Ampelophaga rubiginosa, Amyelois transitella, Anacampsis sarcitella, Anagasta kuehniella, Anarsia lineatella, Anisota senatoria, Antheraea pernyi, Anticarsia (=Thermesia) spp. such as A. gemmatalis; Apamea spp., Aproaerema modicella, Archips spp. such as A. argyrospila, A. fuscocupreanus, A. rosana, A. xyloseanus; Argyresthia conjugella, Argyroploce spp., Argyrotaenia spp. such as A. velutinana; Athetis mindara, Austroasca viridigrisea, Autographa gamma, Autographa nigrisigna, Barathra brassicae, Bedellia spp., Bonagota salubricola, Borbo cinnara, Bucculatrix thurberiella, Bupalus piniarius, Busseola spp., Cacoecia spp. such as C. murinana, C. podana; Cactoblastis cactorum, Cadra cautella, Calingo braziliensis, Caloptilis theivora, Capua reticulana, Carposina spp. such as C. niponensis, C. sasakii; Cephus spp., Chaetocnema aridula, Cheimatobia brumata, Chilo spp. such as C. Indicus, C. suppressalis, C. partellus; Choreutis pariana, Choristoneura spp. such as C. conflictana, C. fumiferana, C. longicellana, C. murinana, C. occidentalis, C. rosaceana; Chrysodeixis (=Pseudoplusia) spp. such as C. eriosoma, C. includens; Cirphis unipuncta, Clysia ambiguella, Cnaphalocerus spp., Cnaphalocrocis medinalis, Cnephasia spp., Cochylis hospes, Coleophora spp., Colias eurytheme, Conopomorpha spp., Conotrachelus spp., Copitarsia spp., Corcyra cephalonica, Crambus caliginosellus, Crambus teterrellus, Crocidosema (=Epinotia) a pore ma, Cydalima (=Diaphania) perspectalis, Cydia (=Carpocapsa) spp. such as C. pomonella, C. latiferreana; Dalaca noctuides, Datana integerrima, Dasychira pinicola, Dendrolimus spp. such as D. pini, D. spectabilis, D. sibiricus; Desmia funeralis, Diaphania spp. such as D. nitidalis, D. hyalinata; Diatraea grandiosella, Diatraea saccharalis, Diphthera festiva, Earias spp. such as E. insulana, E. vittella; Ecdytolopha aurantianu, Egira (=Xylomyges) curialis, Elasmopalpus lignosellus, Eldana saccharina, Endopiza viteana, Ennomos subsignaria, Eoreuma loftini, Ephestia spp. such as E. cautella, E. elutella, E. kuehniella; Epinotia aporema, Epiphyas postvittana, Erannis tiliaria, Erionota thrax, Etiella spp., Eulia spp., Eupoecilia ambiguella, Euproctis chrysorrhoea, Euxoa spp., Evetria bouliana, Faronta albilinea, Feltia spp. such as F. subterranean; Galleria mellonella, Gracillaria spp., Grapholita spp. such as G. funebrana, G. molesta, G. inopinata; Halysidota spp., Harrisina americana, Hedylepta spp., Helicoverpa spp. such as H. armigera (=Heliothis armigera), H. zea (=Heliothis zea); Heliothis spp. such as H. assulta, H. subflexa, H. virescens; Hellula spp. such as H. undalis, H. rogatalis; Helocoverpa gelotopoeon, Hemileuca oliviae, Herpetogramma licarsisalis, Hibernia defoliaria, Hofmannophila pseudospretella, Homoeosoma electellum, Homona magnanima, Hypena scabra, Hyphantria cunea, Hyponomeuta padella, Hyponomeuta malinellus, Kakivoria flavofasciata, Keiferia lycopersicella, Lambdina fiscellaria fiscellaria, Lambdina fiscellaria lugubrosa, Lamprosema indicata, Laspeyresia molesta, Leguminivora glycinivorella, Lerodea eufala, Leucinodes orbonalis, Leucoma salicis, Leucoptera spp. such as L. coffeella, L. scitella; Leuminivora lycinivorella, Lithocolletis blancardella, Lithophane antennata, Llattia octo (=Amyna axis), Lobesia botrana, Lophocampa spp., Loxagrotis albicosta, Loxostege spp. such as L. sticticalis, L. cereralis; Lymantria spp. such as L. dispar, L. monacha; Lyonetia clerkella, Lyonetia prunifoliella, Malacosoma spp. such as M. americanum, M. californicum, M. constrictum, M. neustria; Mamestra spp. such as M. brassicae, M. configurata; Mamstra brassicae, Manduca spp. such as M. quinquemaculata, M. sexta; Marasmia spp, Marmara spp., Maruca testulalis, Megalopyge lanata, Melanchra picta, Melanitis leda, Mocis spp. such as M. lapites, M. repanda; Mocis latipes, Monochroa fragariae, Mythimna separata, Nemapogon cloacella, Neoleucinodes elegantalis, Nepytia spp., Nymphula spp., Oiketicus spp., Omiodes indicata, Omphisa anastomosalis, Operophtera brumata, Orgyia pseudotsugata, Oria spp., Orthaga thyrisalis, Ostrinia spp. such as O. nubilalis; Oulema oryzae, Paleacrita vernata, Panolis flammea, Parnara spp., Papaipema nebris, Papilio cresphontes, Paramyelois transitella, Paranthrene regalis, Paysandisia archon, Pectinophora spp. such as P. gossypiella; Peridroma saucia, Perileucoptera spp., such as P. coffeella; Phalera bucephala, Phryganidia calif ornica, Phthorimaea spp. such as P. operculella; Phyllocnistis citrella, Phyllonorycter spp. such as P. blancardella, P. crataegella, P. issikii, P. ringoniella; Pieris spp. such as P. brassicae, P. rapae, P. napi; Pilocrocis tripunctata, Plathypena scabra, Platynota spp. such as P. flavedana, P. idaeusalis, P. stultana; Platyptilia carduidactyla, Plebejus argus, Plodia interpunctella, Plusia spp, Plutella maculipennis, Plutella xylostella, Pontia protodica, Prays spp., Prodenia spp., Proxenus lepigone, Pseudaletia spp. such as P. sequax, P. unipuncta; Pyrausta nubilalis, Rachiplusia nu, Richia albicosta, Rhizobius ventralis, Rhyacionia frustrana, Sabulodes aegrotata, Schizura concinna, Schoenobius spp., Schreckensteinia festaliella, Scirpophaga spp. such as S. incertulas, S. innotata; Scotia segetum, Sesamia spp. such as S. inferens, Seudyra subflava, Sitotroga cerealella, Sparganothis pilleriana, Spilonota lechriaspis, S. ocellana, Spodoptera (=Lamphygma) spp. such as S. eridania, S. exigua, S. frugiperda, S. latisfascia, S. littoralis, S. litura, S. omithogalli; Stigmella spp., Stomopteryx subsecivella, Strymon bazochii, Sylepta derogata, Synanthedon spp. such as S. exitiosa, Tecia solanivora, Telehin licus, Thaumatopoea pityocampa, Thaumatotibia (=Cryptophlebia) leucotreta, Thaumetopoea pityocampa, Thecla spp., Theresimima ampelophaga, Thyrinteina spp, Tildenia inconspicuella, Tinea spp. such as T. cloacella, T. pellionella; Tineola bisselliella, Tortrix spp. such as T. viridana; Trichophaga tapetzella, Trichoplusia spp. such as T. ni; Tuta (=Scrobipalpula) absoluta, Udea spp. such as U. rubigalis, U. rubigalis; Virachola spp., Yponomeuta padella, and Zeiraphera canadensis;
insects from the order of Coleoptera, for example Acalymma vittatum, Acanthoscehdes obtectus, Adoretus spp., Agelastica alni, Agrilus spp. such as A. anxius, A. planipennis, A. sinuatus; Agriotes spp. such as A. fuscicollis, A. lineatus, A. obscurus; Alphitobius diaperinus, Amphimallus solstitialis, Anisandrus dispar, Anisoplia austriaca, Anobium punctatum, Anomala corpulenta, Anomala rufocuprea, Anoplophora spp. such as A. glabripennis; Anthonomus spp. such as A. eugenii, A. grandis, A. pomorum; Anthrenus spp., Aphthona euphoridae, Apion spp., Apogonia spp., Athous haemorrhoidalis, Atomaria spp. such as A. linearis; Attagenus spp., Aulacophora femoralis, Blastophagus piniperda, Blitophaga undata, Bruchidius obtectus, Bruchus spp. such as B. lentis, B. pisorum, B. rufimanus; Byctiscus betulae, Callidiellum rufipenne, Callopistria floridensis, Callosobruchus chinensis, Cameraria ohridella, Cassida nebulosa, Cerotoma trifurcata, Cetonia aurata, Ceuthorhynchus spp. such as C. assimilis, C. napi; Chaetocnema tibialis, Cleonus mendicus, Conoderus spp. such as C. vespertinus; Conotrachelus nenuphar, Cosmopolites spp., Costelytra zealandica, Crioceris asparagi, Cryptolestes ferrugineus, Cryptorhynchus lapathi, Ctenicera spp. such as C. destructor, Curcu- lio spp., Cylindrocopturus spp., Cyclocephala spp., Dactylispa balyi, Dectes texanus, Dermestes spp., Diabrotica spp. such as D. undecimpunctata, D. speciosa, D. longicornis, D. semipunctata, D. virgifera; Diaprepes abbreviates, Dichocrocis spp., Dicladispa armigera, Diloboderus abderus, Diocalandra frumenti (Diocalandra stigmaticollis), Enaphalodes rufulus, Epilachna spp. such as E. varivestis, E. vigintioctomaculata; Epitrix spp. such as E. hirtipennis, E. similaris; Eutheola humilis, Eutinobothrus brasiliensis, Faustinus cubae, Gibbium psylloides, Gnathocerus cornutus, Hellula undalis, Heteronychus arator, Hylamorpha elegans, Hylobius abietis, Hylotrupes bajulus, Hypera spp. such as H. brunneipennis, H. postica; Hypomeces squamosus, Hypothenemus spp., Ips typographus, Lachnosterna consanguinea, Lasioderma serricorne, Latheticus oryzae, Lathridius spp., Lema spp. such as L. bilineata, L. melanopus; Leptinotarsa spp. such as L. decemlineata; Leptispa pygmaea, Limonius californicus, Lissorhoptrus oryzophilus, Lixus spp., Luperodes spp., Lyctus spp. such as L. bruneus; Liogenys fuscus, Macrodactylus spp. such as M. subspinosus; Maladera matrida, Megaplatypus mutates, Megascelis spp., Melanotus communis, Meligethes spp. such as M. aeneus; Melolontha spp. such as M. hippocastani, M. melolontha; Metamasius hemipterus, Microtheca spp., Migdolus spp. such as M. fryanus, Monochamus spp. such as M. alternatus; Naupactus xanthographus, Niptus hololeucus, Oberia brevis, Oemona hirta, Oryctes rhinoceros, Oryzaephilus surinamensis, Oryzaphagus oryzae, Otiorrhynchus sulcatus, Otiorrhynchus ovatus, Otiorrhynchus sulcatus, Oulema melanopus, Oulema oryzae, Oxycetonia jucunda, Phaedon spp. such as P. brassicae, P. cochleariae; Phoracantha recurva, Phyllobius pyri, Phyllopertha horticola, Phyllophaga spp. such as P. helleri; Phyllotreta spp. such as P. chrysocephala, P. nemorum, P. striolata, P. vittula; Phyllopertha horticola, Popillia japonica, Premnotrypes spp., Psacothea hilaris, Psylliodes chrysocephala, Prostephanus truncates, Psylliodes spp., Ptinus spp., Pulga saltona, Rhizopertha dominica, Rhynchophorus spp. such as R. billineatus, R. ferrugineus, R. palmarum, R. phoenicis, R. vulneratus; Saperda Candida, Scolytus schevyrewi, Scyphophorus acupunctatus, Sitona lineatus, Sitophilus spp. such as S. granaria, S. oryzae, S. zeamais; Sphenophorus spp. such as S. levis; Stegobium paniceum, Sternechus spp. such as S. subsignatus; Strophomorphus ctenotus, Symphyletes spp., Tanymecus spp., Tenebrio molitor, Tenebrioides mauretanicus, Tribolium spp. such as T. castaneum; Trogoderma spp., Tychius spp., Xylotrechus spp. such as X. pyrrhoderus; and, Zabrus spp. such as Z. tenebrioides; insects from the order of Diptera for example Aedes spp. such as A. aegypti, A. albopictus, A. vexans; Anastrepha ludens, Anopheles spp. such as A. albimanus, A. crucians, A. freeborni, A. gambiae, A. leucosphyrus, A. maculipennis, A. minimus, A. quadrimaculatus, A. sinensis; Bactrocera invadens, Bibio hortulanus, Calliphora erythrocephala, Calliphora vicina, Ceratitis capitata, Chrysomyia spp. such as C. bezziana, C. hominivorax, C. macellaria; Chrysops atlanticus, Chrysops discalis, Chrysops silacea, Cochliomyia spp. such as C. hominivorax; Contarinia spp. such as C. sorghicola; Cordylobia anthropophaga, Culex spp. such as C. nigripalpus, C. pipiens, C. quinquefasciatus, C. tarsalis, C. tritaeniorhynchus; Culicoides furens, Culiseta inornata, Culiseta melanura, Cuterebra spp., Dacus cucurbitae, Dacus oleae, Dasineura brassicae, Dasineura oxycoccana, Delia spp. such as D. antique, D. coarctata, D. platura, D. radicum; Dermatobia hominis, Drosophila spp. such as D. suzukii, Fannia spp. such as F. canicularis; Gastraphilus spp. such as G. intestinalis; Geomyza tipunctata, Glossina spp. such as G. fuscipes, G. morsitans, G. palpalis, G. tachinoides; Haematobia irritans, Haplodiplosis equestris, Hippelates spp., Hylemyia spp. such as H. platura; Hypoderma spp. such as H. lineata; Hyppobosca spp., Hydrellia philippina, Leptoconops torrens, Liriomyza spp. such as L. sativae, L. trifolii; Lucilia spp. such as L. caprina, L. cuprina, L. sericata; Lycoria pectoralis, Mansonia titillanus, Mayetiola spp. such as M. destructor; Musca spp. such as M. autumnalis, M. domestica; Muscina stabulans, Oestrus spp. such as O. ovis; Opomyza florum, Oscinella spp. such as O. frit; Orseolia oryzae, Pegomya hysocyami, Phlebotomus argentipes, Phorbia spp. such as P. antiqua, P. brassicae, P. coarctata; Phytomyza gymnostoma, Prosimulium mixtum, Psila rosae, Psorophora columbiae, Psorophora discolor, Rhagoletis spp. such as R. cerasi, R. cingulate, R. indifferens, R. mendax, R. pomonella; Rivellia quadrifasciata, Sarcophaga spp. such as S. haemorrhoidalis; Simulium vittatum, Sitodiplosis mosellana, Stomoxys spp. such as S. calcitrans; Tabanus spp. such as T. atratus, T. bovinus, T. lineola, T. similis; Tannia spp., Thecodiplosis japonensis, Tipula oleracea, Tipula paludosa, and Wohlfahrtia spp;
insects from the order of Thysanoptera for example, Baliothrips biformis, Dichromothrips corbetti, Dichromothrips ssp., Echinothrips americanus, Enneothrips flavens, Frankliniella spp. such as F. fusca, F. occidentalis, F. tritici; Heliothrips spp., Hercinothrips femoralis, Kakothrips spp., Microcephalothrips abdominalis, Neohydatothrips samayunkur, Pezothrips kellyanus, Rhipiphorothrips cruentatus, Scirtothrips spp. such as S. citri, S. dorsalis, S. perseae; Stenchaetothrips spp, Taeniothrips cardamoni, Taeniothrips inconsequens, Thrips spp. such as T. imagines, T. hawaiiensis, T. oryzae, T. palmi, T. parvispinus, T. tabaci;
insects from the order of Hemiptera for example, Acizzia jamatonica, Acrosternum spp. such as A. hilare; Acyrthosipon spp. such as A. onobrychis, A. pisum; Adelges laricis, Adelges tsugae, Adelphocoris spp., such as A. rapidus, A. superbus; Aeneolamia spp., Agonoscena spp., Aulacorthum solani, Aleurocanthus woglumi, Aleurodes spp., Aleurodicus disperses, Aleurolobus barodensis, Aleurothrixus spp., Amrasca spp., Anasa tristis, Antestiopsis spp., Anuraphis cardui, Aonidiella spp., Aphanostigma piri, Aphidula nasturtii, Aphis spp. such as A. craccivora, A. fabae, A. forbesi, A. gossypii, A. grossulariae, A. maidiradicis, A. pomi, A. sambuci, A. schneideri, A. spiraecola; Arboridia apicalis, Arilus critatus, Aspidiella spp., Aspidiotus spp., Atanus spp., Aulacaspis yasumatsui, Aulacorthum solani, Bactericera cockerelli (Paratrioza cockerelli), Bemisia spp. such as B. argentifolii, B. tabaci (Aleurodes tabaci); Blissus spp. such as B. leucopterus; Brachycaudus spp. such as B. cardui, B. helichrysi, B. persicae, B. prunicola; Brachycolus spp., Brachycorynella asparagi, Brevicoryne brassicae, Cacopsylla spp. such as C. fulguralis, C. pyricola (Psylla piri); Calligypona marginata, Calocoris spp., Campylomma livida, Capitophorus horni, Cameocephala fulgida, Cavelerius spp., Ceraplastes spp., Ceratovacuna lanigera, Ceroplastes ceriferus, Cerosipha gossypii, Chaetosiphon fragaefolii, Chionaspis tegalensis, Chlorita onukii, Chromaphis juglandicola, Chrysomphalus ficus, Cicadulina mbila, Cimex spp. such as C. hemipterus, C. lectularius; Coccomytilus halli, Coccus spp. such as C. hesperidum, C. pseudomagnoliarum; Corythucha arcuata, Creontiades dilutus, Cryptomyzus ribis, Chrysomphalus aonidum, Cryptomyzus ribis, Ctenarytaina spatulata, Cyrtopeltis notatus, Dalbulus spp., Dasynus piperis, Dialeurodes spp. such as D. citrifolii; Dalbulus maidis, Diaphorina spp. such as D. citri; Diaspis spp. such as D. bromeliae; Dichelops furcatus, Diconocoris hewetti, Doralis spp., Dreyfusia nordmannianae, Dreyfusia piceae, Drosicha spp., Dysaphis spp. such as D. plantaginea, D. pyri, D. radicola; Dysaulacorthum pseudosolani, Dysdercus spp. such as D. cingulatus, D. intermedius; Dysmicoccus spp., Edes- sa spp., Geocoris spp., Empoasca spp. such as E. fabae, E. solana; Epidiaspis leperii, Eriosoma spp. such as E. lanigerum, E. pyricola; Erythroneura spp., Eurygaster spp. such as E. integriceps; Euscelis bilobatus, Euschistus spp. such as E. heros, E. impictiventris, E. servus; Fiorinia theae, Geococcus coffeae, Glycaspis brimblecombei, Halyomorpha spp. such as H. halys; Heliopeltis spp., Homalodisca vitripennis (=H. coagulata), Horcias nobilellus, Hyalopterus pruni, Hyperomyzus lactucae, lcerya spp. such as /. purchase; Idiocerus spp., Idioscopus spp., Laodelphax striatellus, Lecanium spp., Lecanoideus floccissimus, Lepidosaphes spp. such as L. ulmi; Leptocorisa spp., Leptoglossus phyllopus, Lipaphis erysimi, Lygus spp. such as L. hes- perus, L. lineolaris, L. pratensis; Maconellicoccus hirsutus, Marchalina hellenica, Macropes excavatus, Macrosiphum spp. such as M. rosae, M. avenae, M. euphorbiae; Macrosteles quadrilineatus, Mahanarva fimbriolata, Megacopta cribraria, Megoura viciae, Melanaphis pyrarius, Melanaphis sacchari, Melanocallis (=Tinocallis) caryaefoliae, Metcafiella spp., Metopolophium dirhodum, Monellia costalis, Monelliopsis pecanis, Myzocallis coryli, Murgantia spp., Myzus spp. such as M. ascalonicus, M. cerasi, M. nicotianae, M. persicae, M. varians; Nasonovia ribis-nigri, Neotoxoptera formosana, Neomegalotomus spp, Nephotettix spp. such as N. malayanus, N. nigropictus, N. parvus, N. virescens; Nezara spp. such as N. viridula; Nilaparvata lugens, Nysius huttoni, Oebalus spp. such as O. pugnax; Oncometopia spp., Orthezia praelonga, Oxycaraenus hyalinipennis, Parabemisia myricae, Parlatoria spp., Parthenolecanium spp. such as P. corni, P. persicae; Pemphigus spp. such as P. bursarius, P. populivenae; Peregrinus maidis, Perkinsiella saccharicida, Phenacoccus spp. such as P. aceris, P. gossypii; Phloeomyzus passerinii, Phorodon humuli, Phylloxera spp. such as P. devastatrix, Piesma quadrata, Piezodorus spp. such as P. guildinii; Pinnaspis aspidistrae, Planococcus spp. such as P. citri, P. ficus; Prosapia bicincta, Protopulvinaria pyriformis, Psallus seriatus, Pseudacysta persea, Pseudaulacaspis pentagona, Pseudococcus spp. such as P. comstocki; Psylla spp. such as P. mail; Pteromalus spp., Pulvinaria amygdali, Pyrilla spp., Quadraspidiotus spp., such as Q. perniciosus; Quesada gigas, Rastrococcus spp., Reduvius senilis, Rhizoecus americanus, Rhodnius spp., Rhopalomyzus ascalonicus, Rhopalosiphum spp. such as R. pseudobrassicas, R. insertum, R. maidis, R. padi; Sagatodes spp., Sahlbergella singularis, Saissetia spp., Sappaphis mala, Sappaphis mail, Scaptocoris spp., Scaphoides titanus, Schizaphis graminum, Schizoneura lanuginosa, Scotinophora spp., Selenaspidus articulatus, Sitobion avenae, Sogata spp., Sogatella furcifera, Solubea insularis, Spissistilus festinus (=Stictocephala festina), Stephanitis nashi, Stephanitis pyrioides, Stephanitis takeyai, Tenalaphara malayensis, Tetraleurodes perseae, Therioaphis maculate, Thyanta spp. such as T. accerra, T. perditor; Tibraca spp., Tomaspis spp., Toxoptera spp. such as T. aurantii; Trialeurodes spp. such as T. abutilonea, T. ricini, T. vaporariorum; Triatoma spp., Trioza spp., Typhlocyba spp., Unaspis spp. such as U. citri, U. yanonensis; and Viteus vitifolii,
Insects from the order Hymenoptera for example Acanthomyops interjectus, Athalia rosae, At- ta spp. such as A. capiguara, A. cephalotes, A. cephalotes, A. laevigata, A. robusta, A. sexdens, A. texana, Bombus spp., Brachymyrmex spp., Camponotus spp. such as C. floridanus, C. pennsylvanicus, C. modoc; Cardiocondyla nuda, Chalibion sp, Crematogaster spp., Dasymutilla occidentals, Diprion spp., Dolichovespula maculata, Dorymyrmex spp., Dryocosmus kuriphilus, Formica spp., Hoplocampa spp. such as H. minuta, H. testudinea; Iridomyrmex humilis, Lasius spp. such as L. niger, Linepithema humile, Liometopum spp., Leptocybe invasa, Monomorium spp. such as M. pharaonis, Monomorium, Nylandria fulva, Pachycondyla chinensis, Paratrechina longicornis, Paravespula spp., such as P. germanica, P. pennsylvanica, P. vulgaris; Pheidole spp. such as P. megacephala; Pogonomyrmex spp. such as P. barbatus, P. californicus, Polistes rubiginosa, Prenolepis impairs, Pseudomyrmex gracilis, Schelipron spp., Sirex cyaneus, Solenopsis spp. such as S. geminata, S.invicta, S. molesta, S. richteri, S. xyloni, Sphecius speciosus, Sphex spp., Tapinoma spp. such as T. melanocephalum, T. sessile; Tetramorium spp. such as T. caespitum, T. bicarinatum, Vespa spp. such as V. crabro; Vespula spp. such as V. squamosal; Wasmannia auropunctata, Xylocopa sp;
Insects from the order Orthoptera for example Acheta domesticus, Calliptamus italicus, Chortoicetes terminifera, Ceuthophilus spp., Diastrammena asynamora, Dociostaurus maroccanus, Gryllotalpa spp. such as G. africana, G. gryllotalpa; Gryllus spp., Hieroglyphus daganensis, Kraussaria angulifera, Locusta spp. such as L. migratoria, L. pardalina; Melanoplus spp. such as M. bivittatus, M. femurrubrum, M. mexicanus, M. sanguinipes, M. spretus; Nomadacris septemfasciata, Oedaleus senegalensis, Scapteriscus spp., Schistocerca spp. such as S. americana, S. gregaria, Stemopelmatus spp., Tachycines asynamorus, and Zonozerus variegatus;
Pests from the Class Arachnida for example Acari,e.g. of the families Argasidae, Ixodidae and Sarcoptidae, such as Amblyomma spp. (e.g. A. americanum, A. variegatum, A. maculatum), Argas spp. such as A. persicu), Boophilus spp. such as B. annulatus, B. decoloratus, B. microplus, Dermacentor spp. such as D.silvarum, D. andersoni, D. variabilis, Hyalomma spp. such as H. truncatum, Ixodes spp. such as /. ricinus, I. rubicundus, I. scapularis, I. holocyclus, I. pacificus, Rhipicephalus sanguineus, Ornithodorus spp. such as O. moubata, O. hermsi, O. turicata, Ornithonyssus bacoti, Otobius megnini, Dermanyssus gallinae, Psoroptes spp. such as P. ovis, Rhipicephalus spp. such as R. sanguineus, R. appendiculatus, Rhipicephalus evertsi, Rhizoglyphus spp., Sarcoptes spp. such asS. Scabiei; and Family Eriophyidae including Aceria spp. such as A. sheldoni, A. anthocoptes, Acallitus spp., Aculops spp. such as A. lycopersici, A. pelekassi; Aculus spp. such as A. schlechtendali; Colomerus vitis, Epitrimerus pyri, Phyllocoptruta oleivora; Eriophytes ribis and Eriophyes spp. such as Eriophyes sheldoni; Family Tarsonemidae including Hemitarsonemus spp., Phytonemus pallidus and Polyphagotarsonemus latus, Stenotarsonemus spp. Steneotarsonemus spinki; Family Tenuipalpidae including Brevipalpus spp. such as B. phoenicis; Family Tetranychidae including Eotetranychus spp., Eutetranychus spp., Oligonychus spp., Petrobia latens, Tetranychus spp. such as T. cinnabarinus, T. evansi, T. kanzawai, T, pacificus, T. phaseulus, T. telarius and T. urticae; Bryobia praetiosa; Panonychus spp. such as P. ulmi, P. citri; Metatetranychus spp. and Oligonychus spp. such as O. pratensis, O. perseae, Vasates lycopersici; Raoiella indica, Family Carpoglyphidae including Carpoglyphus spp.; Penthaleidae spp. such as Halotydeus destructor, Family Demodicidae with species such as Demodex spp.; Family Trombicidea including Trombicula spp.; Family Macronyssidae including Ornothonyssus spp.; Family Pyemotidae including Pyemotes tritici; Tyrophagus putrescentiae; Family Acaridae including Acarus siro; Family Araneida including Latrodectus mactans, Tegenaria agrestis, Chiracanthium sp, Lycosa sp Achaearanea tepidariorum and Loxosceles reclusa;
Pests from the Phylum Nematoda, for example, plant parasitic nematodes such as root-knot nematodes, Meloidogyne spp. such as M. hapla, M. incognita, M. javanica; cyst-forming nematodes, Globodera spp. such as G. rostochiensis; Heterodera spp. such as H. avenae, H.
glycines, H. schachtii, H. trifolii; Seed gall nematodes, Anguina spp.; Stem and foliar nematodes, Aphelenchoides spp. such as A. besseyi; Sting nematodes, Belonolaimus spp. such as
B. longicaudatus; Pine nematodes, Bursaphelenchus spp. such as B. lignicolus, B. xylophilus; Ring nematodes, Criconema spp., Criconemella spp. such as C. xenoplax and C. ornata; and,
Criconemoides spp. such as Criconemoides informis; Mesocriconema spp.; Stem and bulb nematodes, Ditylenchus spp. such as D. destructor, D. dipsaci; Awl nematodes, Dolichodorus spp.; Spiral nematodes, Heliocotylenchus multicinctus; Sheath and sheathoid nematodes, Hemicycliophora spp. and Hemicriconemoides spp.; Hirshmanniella spp.; Lance nematodes, Hoploaimus spp.; False rootknot nematodes, Nacobbus spp.; Needle nematodes, Longidorus spp. such as L. elongatus; Lesion nematodes, Pratylenchus spp. such as P. brachyurus, P. neglectus, P. penetrans, P. curvitatus, P. goodeyi; Burrowing nematodes, Radopholus spp. such as R. similis; Rhadopholus spp.; Rhodopholus spp.; Reniform nematodes, Rotylenchus spp. such as R. robustus, R. reniformis; Scutellonema spp.; Stubby-root nematode, Trichodorus spp. such as T. obtusus, T. primitivus; Paratrichodorus spp. such as P. minor; Stunt nematodes, Tylenchorhynchus spp. such as T. claytoni, T. dubius; Citrus nematodes, Tylenchulus spp. such as T. semipenetrans; Dagger nematodes, Xiphinema spp.; and other plant parasitic nematode species;
Insects from the order Isoptera for example Calotermes flavicollis, Coptotermes spp. such as C. formosanus, C. gestroi, C. acinaciformis; Cornitermes cumulans, Cryptotermes spp. such as
C. brevis, C. cavifrons; Globitermes sulfureus, Heterotermes spp. such as H. aureus, H. longiceps, H. tenuis; Leucotermes flavipes, Odontotermes spp., Incisitermes spp. such as /. minor, I. Snyder, Marginitermes hubbardi, Mastotermes spp. such as M. darwiniensis Neocapritermes spp. such as N. opacus, N. parvus; Neotermes spp., Procornitermes spp., Zootermopsis spp. such as Z. angusticollis, Z. nevadensis, Reticulitermes spp. such as R. hes- perus, R. tibialis, R. speratus, R. flavipes, R. grassei, R. lucifugus, R. santonensis, R. virginicus; Termes natalensis, Insects from the order Blattaria for example Blatta spp. such as B. orientalis, B. lateralis; Blattella spp. such as B. asahinae, B. germanica; Leucophaea maderae, Panchlora nivea, Periplaneta spp. such as P. americana, P. australasiae, P. brunnea, P. fuligginosa, P. japonica; Supella longipalpa, Pa rco blatta pennsylvanica, Eurycotis floridana, Pycnoscelus surinamensis, Insects from the order Siphonoptera for example Cediopsylla simples, Ceratophyllus spp., Ctenocephalides spp. such as C. felis, C. can is, Xenopsylla cheopis, Pulex irritans, Trichodectes canis, Tunga penetrans, and Nosopsyllus fasciatus,
Insects from the order Thysanura for example Lepisma saccharina , Ctenolepisma urbana, and Thermobia domestica,
Pests from the class Chilopoda for example Geophilus spp., Scutigera spp. such as Scutigera coleoptrata;
Pests from the class Diplopoda for example Blaniulus guttulatus, Julus spp., Narceus spp., Pests from the class Symphyla for example Scutigerella immaculata,
Insects from the order Dermaptera, for example Forficula auricularia,
Insects from the order Collembola, for example Onychiurus spp., such as Onychiurus armatus, Pests from the order Isopoda for example, Armadillidium vulgare, Oniscus asellus, Porcellio scaber,
Insects from the order Phthiraptera, for example Damalinia spp., Pediculus spp. such as Pediculus humanus capitis, Pediculus humanus corporis, Pediculus humanus humanus; Pthirus pubis, Haematopinus spp. such as Haematopinus eurysternus, Haematopinus suis; Linognathus spp. such as Linognathus vituli; Bovicola bovis, Menopon gallinae, Menacanthus stramineus and Solenopotes capillatus, Trichodectes spp.,
Examples of further pest species which may be controlled by compounds of fomula (I) include: from the Phylum Mollusca, class Bivalvia, for example, Dreissena spp.; class Gastropoda, for example, Arion spp., Biomphalaria spp., Bulinus spp., Deroceras spp., Galba spp., Lymnaea spp., Oncomelania spp., Pomacea canaliclata, Succinea spp.; from the class of the helminths, for example, Ancylostoma duodenale, Ancylostoma ceylanicum, Acylostoma braziliensis, Ancylostoma spp., Ascaris lubricoides, Ascaris spp., Brugia malayi, Brugia timori, Bunostomum spp., Chabertia spp., Clonorchis spp., Cooperia spp., Dicrocoelium spp., Dictyocaulus filaria, Diphyllobothrium latum, Dracunculus medinensis, Echinococcus granulosus, Echinococcus multilocularis, Enterobius vermicularis, Faciola spp., Haemonchus spp. such as Haemonchus contortus; Heterakis spp., Hymenolepis nana, Hyostrongulus spp., Loa Loa, Nematodirus spp., Oesophagostomum spp., Opisthorchis spp., Onchocerca volvulus, Ostertagia spp.,
Paragonimus spp., Schistosomen spp., Strongyloides fuelleborni, Strongyloides stercora lis, Stronyloides spp., Taenia saginata, Taenia solium, Trichinella spiralis, Trichinella nativa,
Trichinella britovi, Trichinella nelson i, Trichinella pseudopsiralis, Trichostrongulus spp., Trichuris trichuria, Wuchereria bancrofti.
The compounds of the present invention are suitable for use in treating or protecting animals against infestation or infection by parasites. Therefore, the present invention also relates to the use of a compound of the present invention for the manufacture of a medicament for the treatment or protection of animals against infestation or infection by parasites. Furthermore, the present invention relates to a method of treating or protecting animals against infestation and infec- tion by parasites, which comprises orally, topically or parenterally administering or applying to the animals a parasiticidally effective amount of a compound of the present invention.
The present invention also relates to the non-therapeutic use of compounds of the present invention for treating or protecting animals against infestation and infection by parasites. More- over, the present invention relates to a non-therapeutic method of treating or protecting animals against infestation and infection by parasites, which comprises applying to a locus a parasiticidally effective amount of a compound of the present invention.
The compounds of the present invention are further suitable for use in combating or controlling parasites in and on animals. Furthermore, the present invention relates to a method of combat- ing or controlling parasites in and on animals, which comprises contacting the parasites with a parasitically effective amount of a compound of the present invention.
The present invention also relates to the non-therapeutic use of compounds of the present invention for controlling or combating parasites. Moreover, the present invention relates to a non- therapeutic method of combating or controlling parasites, which comprises applying to a locus a parasiticidally effective amount of a compound of the present invention.
The compounds of the present invention can be effective through both contact (via soil, glass, wall, bed net, carpet, blankets or animal parts) and ingestion (e.g. baits). Furthermore, the compounds of the present invention can be applied to any and all developmental stages.
The compounds of the present invention can be applied as such or in form of compositions comprising the compounds of the present invention.
The compounds of the present invention can also be applied together with a mixing partner, which acts against pathogenic parasites, e.g. with synthetic coccidiosis compounds, polyetherantibiotics such as Amprolium, Robenidin, Toltrazuril, Monensin, Salinomycin, Maduramicin, Lasalocid, Narasin or Semduramicin, or with other mixing partners as defined above, or in form of compositions comprising said mixtures.
The compounds of the present invention and compositions comprising them can be applied orally, parenterally or topically, e.g. dermally. The compounds of the present invention can be systemically or non-systemically effective.
The application can be carried out prophylactically, therapeutically or non-therapeutically. Fur- thermore, the application can be carried out preventively to places at which occurrence of the parasites is expected.
As used herein, the term "contacting" includes both direct contact (applying the compounds/compositions directly on the parasite, including the application directly on the animal or excluding the application directly on the animal, e.g. at it's locus for the latter) and indirect con- tact (applying the compounds/compositions to the locus of the parasite). The contact of the parasite through application to its locus is an example of a non-therapeutic use of the compounds of the present invention.
The term "locus" means the habitat, food supply, breeding ground, area, material or environment in which a parasite is growing or may grow outside of the animal.
As used herein, the term "parasites" includes endo- and ectoparasites. In some embodiments of the present invention, endoparasites can be preferred. In other embodiments, ectoparasites can be preferred. Infestations in warm-blooded animals and fish include, but are not limited to, lice, biting lice, ticks, nasal bots, keds, biting flies, muscoid flies, flies, myiasitic fly larvae, chig- gers, gnats, mosquitoes and fleas.
The compounds of the present invention are especially useful for combating parasites of the following orders and species, respectively:
fleas (Siphonaptera), e.g. Ctenocephalides felis, Ctenocephalides cams, Xenopsylla cheopis, Pulex irritans, Tunga penetrans, and Nosopsyllus fasciatus; cockroaches (Blattaria - Blattodea), e.g. Blattella germanica, Blattella asahinae, Periplaneta americana, Periplaneta japonica, Periplaneta brunnea, Periplaneta fuligginosa, Periplaneta australasiae, and Blatta orientalis; flies, mosquitoes (Diptera), e.g. Aedes aegypti, Aedes albopictus, Aedes vexans, Anastrepha ludens, Anopheles maculipennis, Anopheles crucians, Anopheles albimanus, Anopheles gambiae, Anopheles freeborni, Anopheles leucosphyrus, Anopheles minimus, Anopheles quadrimaculatus, Calliphora vicina, Chrysomya bezziana, Chrysomya hominivorax, Chrysomya macellaria, Chrysops discalis, Chrysops silacea, Chrysops atlanticus, Cochliomyia hominivorax, Cordylobia anthropophaga, Culicoides furens, Culex pipiens, Culex nigripalpus, Culex quinquefasciatus, Culex tarsalis, Culiseta inornata, Culiseta melanura, Dermatobia hominis, Fannia canicularis, Gasterophilus intestinalis, Glossina morsitans, Glossina palpalis, Glossina fuscipes, Glossina tachinoides, Haematobia irritans, Haplodiplosis equestris, Hippelates spp., Hypoderma lineata, Leptoconops torrens, Lucilia caprina, Lucilia cuprina, Lucilia sericata, Lycoria pectoralis, Mansonia spp., Musca domestica, Muscina stabulans, Oestrus ovis,
Phlebotomus argentipes, Psorophora columbiae, Psorophora discolor, Prosimulium mixtum, Sarcophaga haemorrhoidalis, Sarcophaga sp., Simulium vittatum, Stomoxys calcitrans,
Tabanus bovinus, Tabanus atratus, Tabanus lineola, and Tabanus similis; lice (Phthiraptera), e.g. Pediculus humanus capitis, Pediculus humanus corporis, Pthirus pubis, Haematopinus eurysternus, Haematopinus suis, Linognathus vituli, Bovicola bovis, Menopon gallinae,
Menacanthus stramineus and Solenopotes capillatus; ticks and parasitic mites (Parasitiformes): ticks (Ixodida), e.g. Ixodes scapularis, Ixodes holocyclus, Ixodes pacificus, Rhiphicephalus sanguineus, Dermacentor andersoni, Dermacentor variabilis, Amblyomma americanum, Ambryomma maculatum, Ornithodorus hermsi, Ornithodorus turicata and parasitic mites (Mesostigmata), e.g. Omithonyssus bacoti and Dermanyssus gallinae; Actinedida (Prostigmata) und Acaridida (Astigmata), e.g. Acarapis spp., Cheyletiella spp., Ornithocheyletia spp., Myobia spp., Psorergates spp., Demodex spp., Trombicula spp., Listrophorus spp., Acarus spp., Tyrophagus spp., Caloglyphus spp., Hypodectes spp., Pterolichus spp., Psoroptes spp., Chorioptes spp., Otodectes spp., Sarcoptes spp., Notoedres spp.,Knemidocoptes spp.,
Cytodites spp., and Laminosioptes spp; Bugs (Heteropterida): Cimex lectularius, Cimex hemipterus, Reduvius senilis, Triatoma spp., Rhodnius ssp., Panstrongylus ssp., and Arilus critatus; Anoplurida, e.g. Haematopinus spp., Linognathus spp., Pediculus spp., Phtirus spp., and Solenopotes spp.; Mallophagida (suborders Arnblycerina and Ischnocerina), e.g.
Trimenopon spp., Menopon spp., Trinoton spp., Bovicola spp., Werneckiella spp., Lepikentron spp., Trichodectes spp., and Felicola spp.; Roundworms Nematoda: Wipeworms and Trichino- sis (Trichosyringida), e.g. Trichinellidae (Trichinella spp.), (Trichuridae,) Trichuris spp., Capillaria spp.; Rhabditida, e.g. Rhabditis spp., Strongyloides spp., Helicephalobus spp.; Strongylida, e.g. Strongylus spp., Ancylostoma spp., Necator americanus, Bunostomum spp. (Hookworm), Trichostrongylus spp., Haemonchus contortus, Ostertagia spp., Cooperia spp., Nematodirus spp., Dictyocaulus spp., Cyathostoma spp., Oesophagostomum spp., Stephanurus dentatus, Ollulanus spp., Chabertia spp., Stephanurus dentatus, Syngamus trachea, Ancylostoma spp., Uncinaria spp., Globocephalus spp., Necator spp., Metastrongylus spp., Muellerius capillaris, Protostrongylus spp., Angiostrongylus spp., Parelaphostrongylus spp., Aleurostrongylus abstrusus, and Dioctophyma renale; Intestinal roundworms (Ascaridida), e.g. Ascaris
lumbricoides, Ascaris suum, Ascaridia galli, Parascaris equorum, Enterobius vermicularis (Threadworm), Toxocara canis, Toxascaris leonine, Skrjabinema spp., and Oxyuris equi;
Camallanida, e.g. Dracunculus medinensis (guinea worm); Spirurida, e.g. Thelazia spp., Wuchereria spp., Brugia spp., Onchocerca spp., Dirofilari spp. a, Dipetalonema spp., Setaria spp., Elaeophora spp., Spirocerca lupi, and Habronema spp.; Thorny headed worms
(Acanthocephala), e.g. Acanthocephalus spp., Macracanthorhynchus hirudinaceus and
Oncicola spp.; Planarians (Plathelminthes): Flukes (Trematoda), e.g. Faciola spp., Fascioloides magna, Paragonimus spp., Dicrocoelium spp., Fasciolopsis buski, Clonorchis sinensis,
Schistosoma spp., Trichobilharzia spp., Alaria alata, Paragonimus spp., and Nanocyetes spp.; Cercomeromorpha, in particular Cestoda (Tapeworms), e.g. Diphyllobothrium spp., Tenia spp., Echinococcus spp., Dipylidium caninum, Multiceps spp., Hymenolepis spp., Mesocestoides spp., Vampirolepis spp., Moniezia spp., Anoplocephala spp., Sirometra spp., Anoplocephala spp., and Hymenolepis spp..
As used herein, the term "animal" includes warm-blooded animals (including humans) and fish. Preferred are mammals, such as cattle, sheep, swine, camels, deer, horses, pigs, poultry, rabbits, goats, dogs and cats, water buffalo, donkeys, fallow deer and reindeer, and also in fur- bearing animals such as mink, chinchilla and raccoon, birds such as hens, geese, turkeys and ducks and fish such as fresh- and salt-water fish such as trout, carp and eels. Particularly preferred are domestic animals, such as dogs or cats.
In general, "parasiticidally effective amount" means the amount of active ingredient needed to achieve an observable effect on growth, including the effects of necrosis, death, retardation, prevention, and removal, destruction, or otherwise diminishing the occurrence and activity of the target organism. The parasiticidally effective amount can vary for the various compounds/compositions used in the invention. A parasiticidally effective amount of the composi- tions will also vary according to the prevailing conditions such as desired parasiticidal effect and duration, target species, mode of application, and the like.
Generally, it is favorable to apply the compounds of the present invention in total amounts of 0.5 mg/kg to 100 mg/kg per day, preferably 1 mg/kg to 50 mg/kg per day.
For oral administration to warm-blooded animals, the formula I compounds may be formulated as animal feeds, animal feed premixes, animal feed concentrates, pills, solutions, pastes, suspensions, drenches, gels, tablets, boluses and capsules. In addition, the formula I compounds may be administered to the animals in their drinking water. For oral administration, the dosage form chosen should provide the animal with 0.01 mg/kg to 100 mg/kg of animal body weight per day of the formula I compound, preferably with 0.5 mg/kg to 100 mg/kg of animal body weight per day.
Alternatively, the formula I compounds may be administered to animals parenterally, for example, by intraruminal, intramuscular, intravenous or subcutaneous injection. The formula I compounds may be dispersed or dissolved in a physiologically acceptable carrier for subcuta- neous injection. Alternatively, the formula I compounds may be formulated into an implant for subcutaneous administration. In addition the formula I compound may be transdermally administered to animals. For parenteral administration, the dosage form chosen should provide the animal with 0.01 mg/kg to 100 mg/kg of animal body weight per day of the formula I compound. The formula I compounds may also be applied topically to the animals in the form of dips, dusts, powders, collars, medallions, sprays, shampoos, spot-on and pour-on formulations and in ointments or oil-in-water or water-in-oil emulsions. For topical application, dips and sprays usually contain 0.5 ppm to 5,000 ppm and preferably 1 ppm to 3,000 ppm of the formula I compound. In addition, the formula I compounds may be formulated as ear tags for animals, particu- larly quadrupeds such as cattle and sheep.
Suitable preparations are:
- Solutions such as oral solutions, concentrates for oral administration after dilution, solutions for use on the skin or in body cavities, pouring-on formulations, gels;
- Emulsions and suspensions for oral or dermal administration; semi-solid preparations;
- Formulations in which the active compound is processed in an ointment base or in an oil-in- water or water-in-oil emulsion base;
- Solid preparations such as powders, premixes or concentrates, granules, pellets, tablets, boluses, capsules; aerosols and inhalants, and active compound-containing shaped articles.
Compositions suitable for injection are prepared by dissolving the active ingredient in a suit- able solvent and optionally adding further auxiliaries such as acids, bases, buffer salts, preservatives, and solubilizers. Suitable auxiliaries for injection solutions are known in the art. The solutions are filtered and filled sterile.
Oral solutions are administered directly. Concentrates are administered orally after prior dilution to the use concentration. Oral solutions and concentrates are prepared according to the state of the art and as described above for injection solutions, sterile procedures not being necessary.
Solutions for use on the skin are trickled on, spread on, rubbed in, sprinkled on or sprayed on. Solutions for use on the skin are prepared according to the state of the art and according to what is described above for injection solutions, sterile procedures not being necessary.
Gels are applied to or spread on the skin or introduced into body cavities. Gels are prepared by treating solutions which have been prepared as described in the case of the injection solutions with sufficient thickener that a clear material having an ointment-like consistency results. Suitable thickeners are known in the art.
Pour-on formulations are poured or sprayed onto limited areas of the skin, the active com- pound penetrating the skin and acting systemically. Pour-on formulations are prepared by dissolving, suspending or emulsifying the active compound in suitable skin-compatible solvents or solvent mixtures. If appropriate, other auxiliaries such as colorants, bioabsorption-promoting substances, antioxidants, light stabilizers, adhesives are added. Suitable such auxiliaries are known in the art.
Emulsions can be administered orally, dermally or as injections. Emulsions are either of the water-in-oil type or of the oil-in-water type. They are prepared by dissolving the active compound either in the hydrophobic or in the hydrophilic phase and homogenizing this with the solvent of the other phase with the aid of suitable emulsifiers and, if appropriate, other auxiliaries such as colorants, absorption-promoting substances, preservatives, antioxidants, light stabilizers, viscosity-enhancing substances. Suitable hydrophobic phases (oils), suitable hydrophilic phases, suitable emulsifiers, and suitable further auxiliaries for emulsions are known in the art.
Suspensions can be administered orally or topically/dermally. They are prepared by suspend- ing the active compound in a suspending agent, if appropriate with addition of other auxiliaries such as wetting agents, colorants, bioabsorption-promoting substances, preservatives, antioxidants, light stabilizers. Suitable suspending agents, and suitable other auxiliaries for suspensions including wetting agents are known in the art.
Semi-solid preparations can be administered orally or topically/dermally. They differ from the suspensions and emulsions described above only by their higher viscosity.
For the production of solid preparations, the active compound is mixed with suitable excipi- ents, if appropriate with addition of auxiliaries, and brought into the desired form. Suitable auxiliaries for this purpose are known in the art.
The compositions which can be used in the invention can comprise generally from about 0.001 to 95% of the compound of the present invention.
Ready-to-use preparations contain the compounds acting against parasites, preferably ectoparasites, in concentrations of 10 ppm to 80 per cent by weight, preferably from 0.1 to 65 per cent by weight, more preferably from 1 to 50 per cent by weight, most preferably from 5 to 40 per cent by weight.
Preparations which are diluted before use contain the compounds acting against ectoparasites in concentrations of 0.5 to 90 per cent by weight, preferably of 1 to 50 per cent by weight.
Furthermore, the preparations comprise the compounds of formula I against endoparasites in concentrations of 10 ppm to 2 per cent by weight, preferably of 0.05 to 0.9 per cent by weight, very particularly preferably of 0.005 to 0.25 per cent by weight.
Topical application may be conducted with compound-containing shaped articles such as collars, medallions, ear tags, bands for fixing at body parts, and adhesive strips and foils.
Generally it is favorable to apply solid formulations which release compounds of the present invention in total amounts of 10 mg/kg to 300 mg/kg, preferably 20 mg/kg to 200 mg/kg, most preferably 25 mg/kg to 160 mg/kg body weight of the treated animal in the course of three weeks.

Claims

Claims:
Pyrazole compounds of formul
Figure imgf000072_0001
(I)
wherein
U is N or CRu;
T is S, O or NR1 b, wherein R1 b is selected from H , Ci-Cio-alkyl, Ci-C4-haloalkyl, C3-C10- cycloalkyl, C3-Cio-cycloalkylmethyl, C3-Cio-halocycloalkyl, C2-Cio-alkenyl, C2-C10- haloalkenyl, C2-Cio-alkynyl, Ci-Cio-alkoxy-Ci-C4-alkyl, ORa, heterocyclyl, heterocyclyl-
Ci-C4-alkyl, aryl, hetaryl, aryl-Ci-C4-alkyl and hetaryl-Ci-C4-alkyl, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from halogen, CN, NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and C1-C4- haloalkoxy;
RP1 , RP2, RP3, and Ru are independently of each other selected from H, halogen, Ci-C4-alkyl, Ci- C3-haloalkyl, Ci-C4-alkoxy, Ci-C3-haloalkoxy, Ci-C4-alkylthio, Ci-C3-haloalkylthio, C1-C4- alkylsulfinyl, Ci-C3-haloalkylsulfinyl, Ci-C4-alkylsulfonyl, Ci-C3-haloalkylsulfonyl, C3-C6- cycloalkyl, C3-C6-halocycloalkyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl and Ci- C4-alkoxy-Ci-C4-alkyl; and
R1 is
(i) C3-Cio-cycloalkenyl, C3-Cio-cycloalkenyloxy, C3-Cio-cycloalkenylthio or C3-C10- cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals Ry and Rx;
or
(ii) La-C3-Cio-cycloalkenyl, La-C3-Cio-cycloalkenyloxy, La-C3-Cio-cycloalkenylthio or La- C3-Cio-cycloalkenylamino , wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals Ry and Rx, and wherein
La is C(Y), C(Y)NR9, S(0)„, Ci-C8-alkylene, C2-C8-alkenylene, C2-C8-alkynylene, C3-
C6-cycloalkylene, phenylene, hetarylene, wherein the carbon chains and cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
or
(iii) Lb-La1-C3-Cio-cycloalkenyl, Lb-La1-C3-Cio-cycloalkenyloxy, L -La1-C3-Cio- cycloalkenylthio or Lb-La1-C3-Cio-cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals Ry and Rx, and wherein Lb is Ci-Ce-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2,
3, 4 or 5 identical or different substituents Rx; and
La1 is C(Y), C(Y)NR9, S(0)n, phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substitu- ents Rx;
or
(iv) Lc-Ld-C3-Cio-cycloalkenyl, Lc-Ld-C3-Cio-cycloalkenyloxy, Lc-Ld-C3-Cio-cycloalkenylthio or Lc-Ld-C3-Cio-cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx, and wherein
Lc is O, S, N Re, C(Y), C(Y)0, C(Y)N Rg, C(Y)N R'N Re, S(0)n, S(0)nN Re, phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx; and
Ld is Ci-Cs-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
or
(v) Lb-Lc-Ld-C3-Cio-cycloalkenyl, Lb-Lc-Ld-C3-Cio-cycloalkenyloxy, L -Lc-Ld-C3-Cio- cycloalkenylthio or Lb-Lc-Ld-C3-Cio-cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx, and wherein
Lb is Ci-Cs-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2,
3, 4 or 5 identical or different substituents Rx;
Lc is O, S, N Re, C(Y), C(Y)0, C(Y)NR9, C(Y)N R'N Re, S(0)n, S(0)nN Re, phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx; and
Ld is Ci-Cs-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
and wherein
R2 and R3 are independently of each other selected from H , halogen, CN , NO2, Ci-Cio-alkyl, C2- Cio-alkenyl, C2-Cio-alkynyl, wherein the C-atoms may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2 or 3 identical or different substituents Rx;
ORa, SRa, C(Y)R , C(Y)ORc, S(0)Rd, S(0)2Rd, N ReRf, C(Y)NR9Rh, heterocyclyl, hetaryl, C3-Cio-cycloalkyl, C3-Cio-cycloalkenyl, aryl, wherein the cyclic moieties may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx;
L-C3-Cio-cycloalkenyl, L-C3-Cio-cycloalkenyloxy and L-C3-Cio-cycloalkenylthio, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals Ry and Rx; and wherein
L is Ci-Cs-alkylene, C2-Cs-alkenylene, C2-Cs-alkynylene, or C3-C6-cycloalkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
and wherein is
(i) H, CN, NO2, Ci-Cio-alkyl, C2-Cio-alkenyl or C2-Cio-alkynyl, wherein the C-atoms may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2 or 3 identical or different substituents Rx; or
ORa, SRa, C(Y)Rb, C(Y)ORc, S(0)Rd, S(0)2Rd, N ReRf, C(Y)NR9Rh, S(0)mN ReRf,
C(Y)N R'N ReRf, Ci-C5-alkylene-ORa, Ci-C5-alkylene-CN, Ci-C5-alkylene-C(Y)Rb, C1-C5- alkylene-C(Y)ORc, Ci-C5-alkylene-N ReRf, Ci-C5-alkylene-C(Y)NR9Rh, Ci-C5-alkylene- S(0)mRd, Ci-C5-alkylene-S(0)mN ReRf, d-Cs-alkylene-NRNR^, heterocyclyl, hetaryl, C3-Cio-cycloalkyl, C3-Cio-cycloalkenyl, heterocyclyl-Ci-d-alkyl, hetaryl-d-Cs-alkyl, C3- Cio-cycloalkyl-Ci-C5-alkyl, C3-Cio-cycloalkenyl-Ci-C5-alkyl, aryl-Ci-Cs-alkyl or aryl, wherein the cyclic moieties may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents R ;
or
(ii) L-C3-Cio-cycloalkenyl, L-C3-Cio-cycloalkenyloxy or L-C3-Cio-cycloalkenylthio, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents Ry, and wherein
L is Ci-Cs-alkylene, C2-Cs-alkenylene, C2-Cs-alkynylene, or C3-C6-cycloalkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
or
(iii) any one of the following groups
Figure imgf000074_0001
(iiid);
or
(iv) any one of the following groups
Figure imgf000074_0002
wherein
R4a, R4b and R4c are independently of each other selected from H, halogen, CN, NO2, Ci- Cio-alkyl, C2-Cio-alkenyl, C2-Cio-alkynyl, wherein the C-atoms may be unsubstituted, may be partially or fully halogenated or may carry 1 , 2 or 3 identical or different substituents Rx;
Ci-Cio-haloalkyl, Ci-Cio-alkoxy, Ci-C4-alkoxy-Ci-Cio-alkyl, wherein the C-atoms may be unsubstituted, or partially or fully substituted by identical or different substituents Ry;
ORa, SRa, C(Y)Rb, C(Y)ORc, C(Y)NR9Rh, C(Y)NR'NReRf, S(0)mRd, S(0)mNReRf, Ci-C5-alkylen-ORa, Ci-C5-alkylen-CN, Ci-C5-alkylen-C(Y)Rb, Ci-C5-alkylen- C(Y)ORc, Ci-C5-alkylen-NReRf, Ci-C5-alkylen-C(Y)NR9Rh, Ci-C5-alkylen-S(0)mRd, Ci-C5-alkylen-S(0)mNReRf, d-Cs-alkylen-N R'N ReRf,
heterocyclyl, C3-Cio-cycloalkyl, C3-Cio-cycloalkenyl, hetaryl, aryl, heterocyclyl-Ci- C5-alkyl, C3-Cio-cycloalkyl-Ci-C5-alkyl, C3-Cio-cycloalkenyl-Ci-C5-alkyl, hetaryl- Ci-Ce-alkyl, and aryl-d-Cs-alkyl, wherein the cyclic moieties may be
unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents R ;
and wherein
A is a 3- to 12-membered non-aromatic carbo- or heterocycle, which heterocycle may contain 1 , 2, 3, 4 or 5 heteroatoms selected from N, O, and S, wherein S may be oxidised, and which carbo- or heterocycle may be partially or fully substituted by R and/or R' radicals;
and wherein
D is a direct bond, Ci-C6-alkylene, C2-C6-alkenylene, or C2-C6-alkynylene, which carbon chains can be partially or fully substituted RN;
E is a non-aromatic 3- to 12-membered carbo- or heterocycle, which may contain 1 , 2, 3, or 4 heteroatoms selected from N, O, and S, wherein S may be oxidised, which carbo- or heterocycle may be partially or fully substituted by RN and/or R' radicals;
and wherein
G is Ci-C6-alkylene, C2-C6-alkenylene, C2-C6-alkynylene, C3-C6-cycloalkylene, or
C3-C6-cycloalkenylene, wherein the C-atoms may be unsubstituted, or partially or fully substituted by RP;
R4D is Ci-C4-haloalkyl or C3-C6-cycloalkyl, which may be halogenated;
and wherein
Q is a direct bond, d-Cs-alkylene, d-Cs-alkenylene, or d-Cs-alkynylene, which carbon chains can be partially or fully substituted by RR;
R4E is H , d-Cs-alkyl, C2-C8-alkenyl, C2-C8-alkynyl, C3-C6-cycloalkyl, C3-C6- cycloalkenyl, 3- to 6-membered heterocycle, which may contain 1 or 2 heteroatoms selected from N, O, and S, wherein S may be oxidised, which groups can be unsubstituted, or partially or fully substituted by RR and/or R' radicals; or
R4E and Q together may form a 3- to 6-membered carbocyclic ring or a 4- to 6- membered heterocyclic ring with a direct bond to the pyrazole moiety, which ring may contain 1 or 2 heteroatom moieties selected from N, O, and S, wherein S may be oxidized, and which ring can be partially or fully substituted by RR and/or R' radicals;
M is O, S, N RM, NORM, or NSRM, wherein
RMis a group mentioned for R4E, or wherein
RM and Q may together form a 4- to 6-membered unsaturated, non-aromatic N- containing heterocyclic ring, which ring may contain an additional heteroatom selected from O, and S, wherein S may be oxidized, and which ring can be partially or fully substituted by RR;
and wherein
W is Ci-Cs-alkylene, d-Cs-cycloalkylene, d-Cs-heterocycloalkylene, d-Cs- alkenylene, d-d-cycloalkenylene, d-d-heterocycloalkenylene, or C2-C&- alkynylene, wherein W may be unsubstituted or may be partially or fully substi- tuted by substituents which, independently of each other, are selected from R1 and/or R1 radicals;
V is O, S or N R1 a, wherein R1 a is selected from H , Ci-Cio-alkyl, Ci-C4-haloalkyl, C3- Cio-cycloalkyl, C3-Cio-cycloalkylmethyl, C3-Cio-halocycloalkyl, C2-Cio-alkenyl, C2- Cio-haloalkenyl, C2-Cio-alkynyl, Ci-Cio-alkoxy-Ci-C4-alkyl, ORa, heterocyclyl, heterocyclyl-Ci-C4-alkyl, aryl, hetaryl, aryl-Ci-C4-alkyl and hetaryl-Ci-C4-alkyl, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from halogen, CN , NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy, or
wherein R1 a and R4^ together with the carbon atom to which R49 is bonded and the nitrogen atom to which R1 a is bonded as well as the nitrogen atom between said carbon atom and said nitrogen atom form a 4- to 8-membered heterocycle, which contains the two nitrogen atoms as heteroatoms, and may further contain 1 or 2 heteroatoms which, independently of each other, are selected from N , O, and S, wherein S may be oxidized, and/or wherein the heterocycle may be unsubstituted or may be partially or fully substituted by substituents which, independently of each other, are selected from R1 and/or R1 radicals;
R49 is H , d-Ce-alkyl, Ci-C6-alkyl-X, C3-C6-cycloalkyl or C3-C6-cycloalkyl-X, wherein X is selected from O, S, N H or N R', wherein the Ci-C6-alkyl or C3-C6-cycloalkyl may be unsubstituted or may be partially or fully substituted by substituents which, independently of each other, are selected from R1; and
R4f is Ci-C6-alkyl, Ci-C6-alkyl-X, C3-C6-cycloalkyl or C3-C6-cycloalkyl-X, wherein X is selected from O, S, N H or N R', wherein the Ci-C6-alkyl or C3-C6-cycloalkyl may be unsubstituted or may be partially or fully substituted by substituents which, in- dependently of each other, are selected from R1; or
R49 and R4f together with the carbon atom to which they are bonded form a 3- to 8- membered, saturated or unsaturated carbo- or heterocycle, which may contain 1 , 2, or 3 heteroatoms which, independently of each other, are selected from N , O, and S, wherein S may be oxidized and/or wherein the carbo- or heterocycle may be unsubstituted or may be partially or fully substituted by substituents which, independently of each other, are selected from R1 and/or R1 radicals; and wherein
Ra, Rb, Rc are independently of each other selected from H, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6- cycloalkyl, C3-C6-cycloalkylmethyl, C3-C6-halocycloalkyl, C3-C6-cycloalkenyl, C3-C6- cycloalkenylmethyl, C3-C6-halocycloalkenyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4- alkynyl, Ci-C4-alkoxy-Ci-C4-alkyl, heterocyclyl, heterocyclyl-Ci-C4-alkyl, aryl, hetaryl, ar- yl-Ci-C4-alkyl and hetaryl-Ci-C4-alkyl, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or substituents which, independently of each other, are selected from halogen, CN , NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy; Rd is selected from H , Ci-C4-alkoxy, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6- cycloalkylmethyl, C3-C6-halocycloalkyl, C3-C6-cycloalkenyl, C3-C6-cycloalkenylmethyl, C3- C6-halocycloalkenyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, Ci-C4-alkoxy-Ci- C4-alkyl, heterocyclyl, heterocyclyl-Ci-C4-alkyl, aryl, hetaryl, aryl-Ci-C4-alkyl and hetaryl- Ci-C4-alkyl, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 substituents which are independently of each other selected from halogen, CN, NO2, Ci- C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy;
Re, Rf are independently of each other selected from H, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6- cycloalkyl, C3-C6-cycloalkylmethyl, C3-C6-halocycloalkyl, C3-C6-cycloalkenyl, C3-C6- cycloalkenylmethyl, C3-C6-halocycloalkenyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4- alkynyl, Ci-C4-alkoxy-Ci-C4-alkyl, Ci-C4-alkylcarbonyl, Ci-C4-haloalkylcarbonyl, C1-C4- alkylsulfonyl, Ci-C4-haloalkylsulfonyl, heterocyclyl, heterocyclyl-Ci-C4-alkyl,
heterocyclylcarbonyl, heterocyclyl-Ci-C4-sulfonyl, aryl, arylcarbonyl, arylsulfonyl, hetaryl, hetarylcarbonyl, hetarylsulfonyl, aryl-Ci-C4-alkyl and hetaryl-Ci-C4-alkyl, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 substituents which, independently of each other, are selected from halogen, CN, NO2, Ci-C4-alkyl, C1-C4- haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy; or
Re and Rf together with the nitrogen atom to which they are bonded form a 5- or 6-membered, saturated or unsaturated heterocycle, which may carry a further heteroatom being selected from O, S and N as a ring member atom, and wherein the heterocycle may be unsubstituted or may carry 1 , 2, 3, 4 or 5 substituents which are independently of each other selected from halogen, CN, NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci- C4-haloalkoxy;
R9, Rh are independently of each other selected from H, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6- cycloalkyl, C3-C6-halocycloalkyl, C3-C6-cycloalkenyl, C3-C6-cycloalkenylmethyl, C3-C6- halocycloalkenyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, Ci-C4-alkoxy-Ci-C4- alkyl, heterocyclyl, heterocyclyl-Ci-C4-alkyl, aryl, hetaryl, aryl-Ci-C4-alkyl and hetaryl-Ci- C4-alkyl, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 substituents which are independently of each other selected from halogen, CN, NO2, Ci- C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy;
R' is selected from H, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, C3-C6-cycloalkylmethyl, C3-C6-halocycloalkyl, C3-C6-cycloalkenyl, C3-C6-cycloalkenylmethyl, C3-C6- halocycloalkenyl, C2-C4-alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl, Ci-C4-alkoxy-Ci-C4- alkyl, aryl, and aryl-Ci-C4-alkyl, wherein the aryl rings may be unsubstituted or may carry 1 , 2, 3, 4 or 5 substituents which are independently of each other selected from halogen, CN, NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy and Ci-C4-haloalkoxy;
Rj bonded to C is halogen, OH, CN , N02, Ci-Cio-alkyl, Ci-Cio-haloalkyl, Ci-Cio-alkoxy, Ci- Cio-haloalkoxy, or S(0)mRk, C3-C6-cycloalkyl, or 3- to 6-membered heterocycle, which may contain 1 or 2 heteroatoms selected from N, O, and S, wherein S may be oxidized, which Rj groups are unsubstituted or partially or fully substituted by Rm and/or R' radicals and wherein two groups Rj connected to the same or adjacent ring atoms may together form a 3- to 6-membered carbo- or heterocycle which heterocycle may contain 1 or 2 heteroatoms selected from N, O, and S, wherein S may be oxidised, which cycles may be partially or fully substituted by Rm and/or R' radicals; is H, Ci-C4-alkyl, Ci-C4-haloalkyl, or C3-C6-cycloalkyl, which cycle may be partially or fully substituted by R';
bonded to N is Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkylcarbonyl, Ci-C4-haloalkylcarbonyl, or Ci-C4-alkoxycarbonyl;
bonded to C is halogen, OH, CN, N02, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, Ci- C4-alkoxy, Ci-C4-haloalkoxy, or S(0)mRk;
bonded to C is halogen, CN, N02, Ci-C2-alkyl, Ci-C4-haloalkyl, C2-C6-alkenyl, C2-C6- alkynyl, C3-C6-cycloalkyl, C3-C6-cycloalkenyl, Ci-C4-alkoxy, Ci-C4-haloalkoxy, C1-C4- alkyliden, =0, =S, =NR1°, =NOR1°, =NSR1°, or S(0)mR1°, two adjacent groups Rn may form together with the atoms to which they are bonded a 3- to 8-membered carbo- or heterocycle, which may contain 1 , 2, 3, or 4 heteroatoms selected from N, O, and S, wherein S may be oxidised, which cyclic Rn moieties may be substituted by halogen, R°, and/or R' radicals;
is H, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, Ci-C4-alkoxy;
bonded to C is Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, Ci-C4-alkoxy, C1-C4- alkylcarbonyl, Ci-C4-haloalkylcarbonyl, or Ci-C4-alkoxycarbonyl;
is halogen, CN, N02, Ci-C2-alkyl, Ci-C2-haloalkyl, C3-C6-cycloalkyl, Ci-C4-alkoxy, or Cr C2-haloalkoxy, or two groups RP can together form a 3- to 6-membered carbo- or heterocyclic ring, which heterocycle contains 1 or 2 heteroatoms selected from N, O, and S, wherein S may be oxidised, which carbo- or heterocyclic ring is unsubstituted or partly or fully substituted by groups R^;
is halogen, CN, N02, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, Ci-C4-alkoxy, or Cr C4-haloalkoxy;
bonded to C is halogen, CN, N02, Ci-C2-alkyl, Ci-C2-haloalkyl, Ci-C4-alkoxy, Ci-C2- haloalkoxy, or S(0)mRk; or two groups Rr can together form a 3- to 6-membered carbo- or heterocyclic ring, which heterocycle contains 1 or 2 heteroatoms selected from N, O, and S, wherein S may be oxidized, and which carbo- or heterocyclic ring is unsubstituted or partially or fully substituted by Rs;
is halogen, CN, N02, Ci-C2-alkyl, Ci-C2-haloalkyl, C3-C6-cycloalkyl, Ci-C4-alkoxy, or Cr C2-haloalkoxy;
bonded to C is halogen, N02, CN, d-Ce-alkyl, d-Ce-alkoxy, d-Ce-haloalkyl, C-i-Ce- haloalkoxy, C3-C6-cycloalkyl, C3-C6-cycloalkoxy, C3-C6-halocycloalkyl, C3-C6- halocycloalkoxy, C2-C4-alkenyl, C2-C4-alkynyl, S(0)mRw, =0, =S, =NRV, =NORv, or =NSRV; or two R1 bonded to the same carbon atom or to adjacent carbon atoms together with the carbon atom(s) to which they are bonded form a 3- to 6-membered, saturated or unsaturated carbo- or heterocycle, which may contain 1 or 2 heteroatoms which, independently of each other, are selected from N, O, and S, wherein S may be oxidized, wherein N may be unsubstituted or substituted by R';
is Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, or C3-C6-halocycloalkyl;
is H, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C6-cycloalkyl, or C3-C6-halocycloalkyl, Ci-C4-alkoxy, or Ci-C4-haloalkoxy;
is selected from halogen, CN, N02, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, C1-C4- haloalkoxy, S(0)mRd, S(0)mNReRf, Ci-Cio-alkylcarbonyl, Ci-C4-haloalkylcarbonyl, C1-C4- alkoxycarbonyl, Ci-C4-haloalkoxycarbonyl, C3-C6-cycloalkyl, 5- to 7-membered heterocyclyl, 5- or 6-membered hetaryl, aryl, C3-C6-cycloalkoxy, 3- to 6-membered heterocyclyloxy and phenoxy, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 radicals Ry; and
Ry is selected from halogen, CN , NO2, Ci-C4-alkyl, Ci-C4-haloalkyl, Ci-C4-alkoxy, C1-C4- haloalkoxy, S(0)mRd, S(0)mN ReRf, Ci-C4-alkylcarbonyl, Ci-C4-haloalkylcarbonyl, C1-C4- alkoxycarbonyl, Ci-C4-haloalkoxycarbonyl, C3-C6-cycloalkyl, C3-C6-halocycloalkyl, C2-C4- alkenyl, C2-C4-haloalkenyl, C2-C4-alkynyl and Ci-C4-alkoxy-Ci-C4-alkyl;
and wherein
Y is O or S;
m is 0, 1 or 2; and
n is 1 or 2;
and the salts, stereoisomers, tautomers, and N-oxides thereof.
2. The compounds of formula I according to claim
wherein U is N or CH, and is preferably N , and
wherein T is O, and
wherein RP1 , RP2, and RP3 are H.
The compounds of formula I according to claim 1 or 2, wherein R1 is
(i) C3-Cio-cycloalkenyl, C3-Cio-cycloalkenyloxy, C3-Cio-cycloalkenylthio or C3-C10- cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx;
or
(ii) La-C3-Cio-cycloalkenyl, La-C3-Cio-cycloalkenyloxy, La-C3-Cio-cycloalkenylthio or La- C3-Cio-cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx, and wherein
La is C(Y), S(0)n, d-Cs-alkylene, C2-C8-alkenylene, C2-C8-alkynylene, C3-C6- cycloalkylene, phenylene, hetarylene, wherein the carbon chains and cyclic moie ties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
or
(iii) Lb-La1-C3-Cio-cycloalkenyl, Lb-La1-C3-Cio-cycloalkenyloxy, L -La1-C3-Cio- cycloalkenylthio or Lb-La1-C3-Cio-cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx, and wherein
Lb is d-Cs-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2,
3, 4 or 5 identical or different substituents Rx; and
La1 is C(Y), S(0)n, phenylene or hetarylene, wherein the cyclic moieties may be
unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx; or (iv) Lc-Ld-C3-Cio-cycloalkenyl, Lc-Ld-C3-Cio-cycloalkenyloxy, Lc-Ld-C3-Cio-cycloalkenylthio or Lc-Ld-C3-Cio-cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx, and wherein
Lc is O, S, NRe, C(Y), S(0)n, phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx; and
Ld is d-Ce-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
or
(v) Lb-Lc-Ld-C3-Cio-cycloalkenyl, Lb-Lc-Ld-C3-Cio-cycloalkenyloxy, L -Lc-Ld-C3-Cio- cycloalkenylthio or Lb-Lc-Ld-C3-Cio-cycloalkenylamino, wherein the cycloalkenyl rings may be unsubstituted, may be partially or fully halogenated, or may carry 1 , 2, 3, 4 or 5 identical or different substituents selected from the radicals R and Rx, and wherein
Lb is Ci-Cs-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
Lc is O, S, NRe, C(Y), S(0)n, phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx; and
Ld is Ci-Cs-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx.
The compounds of formula I according to any one of claims 1 to 3, wherein R1 is
(i) C3-C6-cycloalkenyl, C3-C6-cycloalkenyloxy or C3-C6-cycloalkenylthio, wherein the cycloalkenyl rings may be unsubstituted, or may be partially or fully halogenated;
or
(ii) La-C3-C6-cycloalkenyl, La-C3-C6-cycloalkenyloxy or La-C3-C6-cycloalkenylthio, wherein the cycloalkenyl rings may be unsubstituted, or may be partially or fully halogenated, and wherein
La is Ci-Cs-alkylene, phenylene, hetarylene, wherein the carbon chain and the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
or
(iii) L -La1-C3-C6-cycloalkenyl, L -La1-C3-C6-cycloalkenyloxy or L -La1-C3-C6- cycloalkenylthio, wherein the cycloalkenyl rings may be unsubstituted, or may be partially or fully halogenated, and wherein
Lb is Ci-C2-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 or 2 identical or different substituents Rx; and
La1 is phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx;
or (iv) Lc-Ld-C3-C6-cycloalkenyl, Lc-Ld-C3-C6-cycloalkenyloxy or Lc-Ld-C3-C6- cycloalkenylthio, wherein the cycloalkenyl rings may be unsubstituted, or may be partially or fully halogenated, and wherein
Lc is phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx; and
Ld is Ci-C2-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 or 2 identical or different substituents Rx;
or
(v) Lb-Lc-Ld-C3-C6-cycloalkenyl, Lb-Lc-Ld-C3-C6-cycloalkenyloxy or Lb-Lc-Ld-C3-C6- cycloalkenylthio, wherein the cycloalkenyl rings may be unsubstituted, or may be partially or fully halogenated, and wherein
Lb is Ci-C2-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 or 2 identical or different substituents Rx;
Lc is phenylene or hetarylene, wherein the cyclic moieties may be unsubstituted or may carry 1 , 2, 3, 4 or 5 identical or different substituents Rx; and Ld is Ci-C2-alkylene, wherein the C-atoms may be unsubstituted or may carry 1 or 2 identical or different substituents Rx.
The compounds of formula I according to any one of claims 1 to 4, wherein R1 is
(i) C3-C6-cycloalkenyl, wherein the cycloalkenyl ring may be unsubstituted, or may be partially or fully halogenated;
or
(ii) La-C3-C6-cycloalkenyl, wherein the cycloalkenyl ring may be unsubstituted, or may be partially or fully halogenated, and wherein
La is Ci-C2-alkylene;
6. The compounds of formula I according to any one of claims 1 to 5, wherein R2 and R3 are independently of each other selected from H, halogen, CN, Ci-C4-alkyl, Ci-C4-haloalkyl, C3-C4- cycloalkyl, C3-C4-halocycloalkyl, ORa, and SRa, wherein Ra is Ci-C4-alkyl, Ci-C4-haloalkyl, C3- C4-cycloalkyl, or C3-C4-halocycloalkyl.
7. The compounds of formula I according to any one of claims 1 to 6, wherein
R2 is Ci-C2-alkyl, Ci-C2-haloalkyl, C3-cycloalkyl, or C3-halocycloalkyl, and is preferably CH3 fluoromethyl; and wherein
R3 is H.
8. The compounds of formula I according to any one of claims 1 to 7, wherein R4 is any one of the following groups
Figure imgf000081_0001
(iiid);
Figure imgf000082_0001
wherein R4a, R4b, R4c, R4d, R4e, R4f, R49, A, D, E, G, M, Q, V, W and m are as defined in claim 1.
9. The compounds of formula I according to any one of claims 1 to 8, wherein R4 is any one of the following groups
Figure imgf000082_0002
(iiid);
wherein R4a, R4b, R4c, R4d, A, D, E, G and m are as defined in claim 1.
10. A composition comprising at least one compound according to any one of claims 1 to 9 and at least one inert liquid and/or solid carrier.
1 1 . An agricultural composition for combating animal pests comprising at least one compound as defined in any of claims 1 to 9 and at least one inert liquid and/or solid acceptable carrier and, if desired, at least one surfactant.
12. A method for combating or controlling invertebrate pests, which method comprises contacting said pest or its food supply, habitat or breeding grounds with a pesticidally effective amount of at least one compound as defined in any one of claims 1 to 9. 13. A method for protecting growing plants from attack or infestation by invertebrate pests, which method comprises contacting a plant, or soil or water in which the plant is growing, with a pesticidally effective amount of at least one compound as defined in any of claims 1 to 9.
14. Seed comprising a compound as defined in any of claims 1 to 9, or the enantiomers, diastereomers or salts thereof, in an amount of from 0.1 g to 10 kg per 100 kg of seed.
15. The use of the compounds as defined in any of claims 1 to 9 for protecting growing plants from attack or infestation by invertebrate pests.
PCT/EP2015/059695 2014-05-05 2015-05-04 Pyrazoles for controlling invertebrate pests WO2015169734A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14167020 2014-05-05
EP14167020.8 2014-05-05

Publications (1)

Publication Number Publication Date
WO2015169734A1 true WO2015169734A1 (en) 2015-11-12

Family

ID=50624509

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2015/059695 WO2015169734A1 (en) 2014-05-05 2015-05-04 Pyrazoles for controlling invertebrate pests

Country Status (1)

Country Link
WO (1) WO2015169734A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10440953B2 (en) 2015-08-07 2019-10-15 Basf Se Control of pests in maize by ginkgolides and bilobalide
US10513498B2 (en) 2014-07-31 2019-12-24 Basf Se Process for preparing pyrazoles
US10584102B2 (en) 2015-05-11 2020-03-10 Basf Se Process for preparing 4-amino-pyridazines
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1925613A1 (en) * 2005-08-12 2008-05-28 Nihon Nohyaku Co., Ltd. Substituted pyrazolecarboxylic acid anilide derivative or salt thereof, intermediate thereof, agent for agricultural and horticultural use, and use thereof
WO2009027393A2 (en) * 2007-08-27 2009-03-05 Basf Se Pyrazole compounds for controlling invertebrate pests
WO2010034737A1 (en) * 2008-09-24 2010-04-01 Basf Se Pyrazole compounds for controlling invertebrate pests
WO2010112177A1 (en) * 2009-04-03 2010-10-07 Bayer Cropscience Aktiengesellschaft Acylated aminopyridines and aminopyridazines as insecticides
WO2014064129A1 (en) * 2012-10-24 2014-05-01 Basf Se Pyrazole compounds for controlling invertebrate pests

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1925613A1 (en) * 2005-08-12 2008-05-28 Nihon Nohyaku Co., Ltd. Substituted pyrazolecarboxylic acid anilide derivative or salt thereof, intermediate thereof, agent for agricultural and horticultural use, and use thereof
WO2009027393A2 (en) * 2007-08-27 2009-03-05 Basf Se Pyrazole compounds for controlling invertebrate pests
WO2010034737A1 (en) * 2008-09-24 2010-04-01 Basf Se Pyrazole compounds for controlling invertebrate pests
WO2010112177A1 (en) * 2009-04-03 2010-10-07 Bayer Cropscience Aktiengesellschaft Acylated aminopyridines and aminopyridazines as insecticides
WO2014064129A1 (en) * 2012-10-24 2014-05-01 Basf Se Pyrazole compounds for controlling invertebrate pests

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10513498B2 (en) 2014-07-31 2019-12-24 Basf Se Process for preparing pyrazoles
US10584102B2 (en) 2015-05-11 2020-03-10 Basf Se Process for preparing 4-amino-pyridazines
US11046656B2 (en) 2015-05-11 2021-06-29 Basf Se Process for preparing 4-amino-pyridazines
US10440953B2 (en) 2015-08-07 2019-10-15 Basf Se Control of pests in maize by ginkgolides and bilobalide
US11034669B2 (en) 2018-11-30 2021-06-15 Nuvation Bio Inc. Pyrrole and pyrazole compounds and methods of use thereof

Similar Documents

Publication Publication Date Title
AU2017242539B2 (en) Bicyclic compounds
EP3615530B1 (en) Substituted succinimide derivatives as pesticides
EP3621967B1 (en) Bicyclic pesticidal compounds
US9955692B2 (en) Pyrazoles for controlling invertebrate pests
WO2015162133A1 (en) C3-c4-cycloalkenyl-comprising pyrazoles for controlling invertebrate pests
EP3638677A1 (en) Mesoionic imidazolium compounds and derivatives for combating animal pests
EP3696177A1 (en) Heterocyclic compounds for the control of invertebrate pests
WO2015169734A1 (en) Pyrazoles for controlling invertebrate pests
EP3453706A1 (en) Pesticidal imidazole compounds
EP3613736A1 (en) Substituted glutarimide derivatives
EP4342885A1 (en) N-(3-(aminomethyl)-phenyl)-5-(4-phenyl)-5-(trifluoromethyl)-4,5-dihydroisoxazol-3-amine derivatives and similar compounds as pesticides
EP4119547A1 (en) Triazole compounds for the control of invertebrate pests
EP4140995A1 (en) Pyrazine compounds for the control of invertebrate pests
EP4140986A1 (en) Pyrazine compounds for the control of invertebrate pests
EP4198023A1 (en) Pesticidally active thiosemicarbazone compounds
EP4194453A1 (en) Pyrazine compounds for the control of invertebrate pests
EP4238971A1 (en) Substituted isoxazoline derivatives
EP3909950A1 (en) Heterocyclic compounds for the control of invertebrate pests
WO2020109039A1 (en) Pesticidal compounds
WO2018234488A1 (en) Substituted cyclopropyl derivatives
BR112019022316B1 (en) COMPOUND, COMPOSITION, NON-THERAPEUTIC METHOD OF CONTROL OR COMBATING INVERTEBRATE PESTS, METHOD OF PLANT PROTECTION, COATED SEED AND USES OF A COMPOUND

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15720965

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15720965

Country of ref document: EP

Kind code of ref document: A1